No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 4qzwY, 1.0000, 0.00, 1.000, 212, 212, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2, 4qzwK, 0.9999, 0.02, 1.000, 212, 212, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3, 4r00Y, 0.9998, 0.08, 1.000, 212, 212, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
4, 4r00K, 0.9998, 0.08, 1.000, 212, 212, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
5, 4qv8Y, 0.9996, 0.10, 1.000, 212, 212, YCP BETA5-C52F MUTANT
6, 4qv8K, 0.9996, 0.10, 1.000, 212, 212, YCP BETA5-C52F MUTANT
7, 5d0vY, 0.9994, 0.13, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
8, 5d0vK, 0.9994, 0.13, 0.991, 218, 212, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
9, 4qzzY, 0.9994, 0.12, 0.995, 212, 212, YCP IN COMPLEX WITH OMURALIDE
10, 4qzzK, 0.9994, 0.12, 0.995, 212, 212, YCP IN COMPLEX WITH OMURALIDE
11, 5cz6K, 0.9992, 0.15, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
12, 5cz6Y, 0.9991, 0.16, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
13, 4qv5Y, 0.9991, 0.15, 0.991, 212, 212, YCP BETA5-M45I MUTANT
14, 4qv5K, 0.9991, 0.15, 0.991, 212, 212, YCP BETA5-M45I MUTANT
15, 4qv4Y, 0.9991, 0.16, 0.991, 212, 212, YCP BETA5-M45T MUTANT
16, 4qv4K, 0.9991, 0.15, 0.991, 212, 212, YCP BETA5-M45T MUTANT
17, 4qv1Y, 0.9991, 0.16, 0.991, 212, 212, YCP BETA5-M45A MUTANT
18, 4qv1K, 0.9991, 0.16, 0.991, 212, 212, YCP BETA5-M45A MUTANT
19, 4qv7Y, 0.9990, 0.17, 0.991, 212, 212, YCP BETA5-A50V MUTANT
20, 4qv7K, 0.9990, 0.17, 0.991, 212, 212, YCP BETA5-A50V MUTANT
21, 4qv3Y, 0.9990, 0.17, 0.991, 212, 212, YCP BETA5-M45V MUTANT
22, 4qv3K, 0.9990, 0.16, 0.991, 212, 212, YCP BETA5-M45V MUTANT
23, 4quxY, 0.9990, 0.17, 0.991, 212, 212, YCP BETA5-A49T-MUTANT
24, 4quxK, 0.9990, 0.16, 0.991, 212, 212, YCP BETA5-A49T-MUTANT
25, 4qv6Y, 0.9989, 0.17, 0.991, 212, 212, YCP BETA5-A49V MUTANT
26, 4qv6K, 0.9989, 0.17, 0.991, 212, 212, YCP BETA5-A49V MUTANT
27, 5fgaY, 0.9988, 0.18, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
28, 5fgaK, 0.9988, 0.18, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
29, 5fg9K, 0.9988, 0.19, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
30, 5d0wY, 0.9988, 0.18, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-T1S MUTANT
31, 5d0wK, 0.9988, 0.18, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-T1S MUTANT
32, 5czaY, 0.9988, 0.19, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-D166N MUTANT
33, 5czaK, 0.9988, 0.19, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-D166N MUTANT
34, 5bxlY, 0.9988, 0.18, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-G170A MUTANT
35, 5bxlK, 0.9988, 0.18, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-G170A MUTANT
36, 4y9yY, 0.9988, 0.18, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116E MUTANT
37, 4y9yK, 0.9988, 0.18, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116E MUTANT
38, 4rurY, 0.9988, 0.18, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
39, 4rurK, 0.9988, 0.18, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
40, 4quyY, 0.9988, 0.18, 0.991, 212, 212, YCP BETA5-A49S-MUTANT
41, 4quyK, 0.9988, 0.18, 0.991, 212, 212, YCP BETA5-A49S-MUTANT
42, 6gopY, 0.9987, 0.19, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
43, 6gopK, 0.9987, 0.19, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
44, 5fg9Y, 0.9987, 0.19, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
45, 5fg7Y, 0.9987, 0.19, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-T1A MUTANT
46, 5fg7K, 0.9987, 0.19, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-T1A MUTANT
47, 4z1lY, 0.9987, 0.19, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
48, 4z1lK, 0.9987, 0.19, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
49, 4qv9Y, 0.9987, 0.19, 0.991, 212, 212, YCP BETA5-C63F MUTANT
50, 4qv9K, 0.9987, 0.19, 0.991, 212, 212, YCP BETA5-C63F MUTANT
51, 5cz7Y, 0.9986, 0.20, 0.986, 217, 212, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
52, 5cz7K, 0.9986, 0.20, 0.986, 217, 212, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
53, 5cgfY, 0.9986, 0.20, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-G48C MUTANT
54, 5cgfK, 0.9986, 0.20, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-G48C MUTANT
55, 4ya4Y, 0.9986, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H114D MUTANT
56, 4ya4K, 0.9986, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H114D MUTANT
57, 4ya1Y, 0.9986, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116N MUTANT
58, 4ya1K, 0.9986, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116N MUTANT
59, 4y8nY, 0.9986, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
60, 4y8nK, 0.9986, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
61, 4y8mY, 0.9986, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
62, 4y8mK, 0.9986, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
63, 4y6vK, 0.9986, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
64, 5fgfY, 0.9985, 0.20, 0.986, 214, 212, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
65, 5fgfK, 0.9985, 0.20, 0.986, 214, 212, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
66, 5fgeY, 0.9985, 0.21, 0.991, 218, 212, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
67, 5fgeK, 0.9985, 0.21, 0.991, 218, 212, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
68, 5fgdY, 0.9985, 0.21, 0.991, 216, 212, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
69, 5fgdK, 0.9985, 0.21, 0.991, 215, 212, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
70, 5cz4K, 0.9985, 0.21, 0.995, 212, 212, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
71, 5bouY, 0.9985, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
72, 5bouK, 0.9985, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
73, 4ya5Y, 0.9985, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
74, 4ya5K, 0.9985, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
75, 4y8uY, 0.9985, 0.21, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
76, 4y8uK, 0.9985, 0.21, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
77, 4y8rY, 0.9985, 0.21, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116D MUTANT
78, 4y8rK, 0.9985, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116D MUTANT
79, 4y6vY, 0.9985, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
80, 4y69Y, 0.9985, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
81, 4y69K, 0.9985, 0.20, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
82, 5lajY, 0.9984, 0.21, 0.995, 212, 212, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
83, 5lajK, 0.9984, 0.21, 0.995, 212, 212, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
84, 5cz4Y, 0.9984, 0.21, 0.995, 212, 212, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
85, 4ya0Y, 0.9984, 0.22, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
86, 4ya0K, 0.9984, 0.21, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
87, 4y6aY, 0.9984, 0.22, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
88, 4y6aK, 0.9984, 0.22, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
89, 4qw0Y, 0.9984, 0.21, 0.986, 212, 212, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
90, 4qw0K, 0.9984, 0.21, 0.986, 212, 212, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
91, 2gplY, 0.9984, 0.21, 0.995, 212, 212, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
92, 2gplK, 0.9984, 0.21, 0.995, 212, 212, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
93, 5fhsY, 0.9983, 0.22, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
94, 4ya3Y, 0.9983, 0.22, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
95, 4ya3K, 0.9983, 0.22, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
96, 4qvyY, 0.9983, 0.22, 0.991, 212, 212, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
97, 4qvyK, 0.9983, 0.22, 0.991, 212, 212, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
98, 4y8tY, 0.9982, 0.23, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
99, 4y8tK, 0.9982, 0.23, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
100, 3gpwY, 0.9982, 0.22, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
101, 3gpwK, 0.9982, 0.22, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
102, 3gptY, 0.9982, 0.22, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
103, 3gptK, 0.9982, 0.22, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
104, 5fhsK, 0.9981, 0.23, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
105, 4lqiY, 0.9981, 0.23, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
106, 4lqiK, 0.9981, 0.23, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
107, 4j70Y, 0.9981, 0.23, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
108, 4j70K, 0.9981, 0.23, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
109, 3un8K, 0.9981, 0.23, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
110, 3hyeY, 0.9981, 0.23, 0.995, 212, 212, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
111, 3hyeK, 0.9981, 0.23, 0.995, 212, 212, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
112, 1rypL, 0.9981, 0.24, 0.991, 212, 212, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
113, 5nifL, 0.9980, 0.24, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
114, 3un8Y, 0.9980, 0.24, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
115, 3tddY, 0.9980, 0.24, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
116, 3tddK, 0.9980, 0.24, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
117, 1rypZ, 0.9980, 0.24, 0.991, 212, 212, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
118, 4zzgL, 0.9979, 0.24, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
119, 2fakY, 0.9979, 0.25, 0.995, 212, 212, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
120, 2fakK, 0.9979, 0.25, 0.995, 212, 212, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
121, 4qv0K, 0.9978, 0.27, 0.986, 212, 212, YCP BETA5-A49T-A50V-DOUBLE MUTANT
122, 4q1sK, 0.9977, 0.26, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
123, 3dy3K, 0.9977, 0.26, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
124, 5nifZ, 0.9976, 0.26, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
125, 4eu2Z, 0.9976, 0.26, 0.991, 212, 212, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
126, 3dy3Y, 0.9976, 0.26, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
127, 4zzgZ, 0.9975, 0.27, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
128, 4x6zZ, 0.9975, 0.27, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
129, 4qvvK, 0.9975, 0.27, 0.991, 212, 212, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
130, 4qv0Y, 0.9975, 0.29, 0.986, 212, 212, YCP BETA5-A49T-A50V-DOUBLE MUTANT
131, 4eu2L, 0.9975, 0.27, 0.991, 212, 212, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
132, 3e47Y, 0.9975, 0.27, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
133, 3e47K, 0.9975, 0.27, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
134, 4x6zL, 0.9974, 0.27, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
135, 4qvvY, 0.9974, 0.27, 0.991, 212, 212, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
136, 1g0uY, 0.9974, 0.27, 0.995, 212, 212, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
137, 1g0uK, 0.9974, 0.27, 0.995, 212, 212, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
138, 4fzgY, 0.9973, 0.28, 0.995, 212, 212, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
139, 4fzgK, 0.9973, 0.28, 0.995, 212, 212, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
140, 3shjY, 0.9973, 0.28, 0.995, 212, 212, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
141, 3shjK, 0.9973, 0.28, 0.995, 212, 212, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
142, 4qvwY, 0.9972, 0.28, 0.991, 212, 212, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
143, 4qvwK, 0.9972, 0.28, 0.991, 212, 212, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
144, 3dy4Y, 0.9972, 0.29, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
145, 3dy4K, 0.9972, 0.29, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
146, 4fzcY, 0.9971, 0.29, 0.995, 212, 212, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
147, 4fzcK, 0.9970, 0.29, 0.995, 212, 212, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
148, 4y7xY, 0.9966, 0.32, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
149, 4qw1Y, 0.9966, 0.32, 0.991, 212, 212, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
150, 4qw1K, 0.9966, 0.32, 0.991, 212, 212, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
151, 4y7xK, 0.9965, 0.32, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
152, 3wxrL, 0.9965, 0.32, 0.995, 212, 212, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
153, 5fghY, 0.9963, 0.33, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
154, 5fghK, 0.9963, 0.33, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
155, 3wxrZ, 0.9963, 0.33, 0.995, 212, 212, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
156, 4qvlY, 0.9962, 0.34, 0.995, 212, 212, YCP IN COMPLEX WITH BORTEZOMIB
157, 4qvlK, 0.9962, 0.34, 0.995, 212, 212, YCP IN COMPLEX WITH BORTEZOMIB
158, 5d0xY, 0.9959, 0.35, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
159, 5d0xK, 0.9959, 0.35, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
160, 4qw3Y, 0.9956, 0.36, 0.991, 212, 212, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
161, 4qw3K, 0.9956, 0.36, 0.991, 212, 212, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
162, 4qvmY, 0.9955, 0.37, 0.991, 212, 212, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
163, 4qvmK, 0.9955, 0.37, 0.991, 212, 212, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
164, 5bxnY, 0.9953, 0.37, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
165, 5bxnK, 0.9953, 0.37, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
166, 4v7oZ, 0.9952, 0.37, 0.991, 212, 212, 
167, 4v7oTA, 0.9952, 0.38, 0.991, 212, 212, 
168, 4v7oL, 0.9952, 0.37, 0.991, 212, 212, 
169, 4v7oHB, 0.9952, 0.38, 0.991, 212, 212, 
170, 4r02Y, 0.9952, 0.38, 0.995, 212, 212, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
171, 4qvpY, 0.9952, 0.38, 0.991, 212, 212, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
172, 4qvpK, 0.9952, 0.38, 0.991, 212, 212, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
173, 4jt0Y, 0.9952, 0.38, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
174, 4jt0K, 0.9952, 0.38, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
175, 1z7qL, 0.9947, 0.39, 0.991, 212, 212, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
176, 5jhrY, 0.9946, 0.40, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
177, 5jhrK, 0.9946, 0.40, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
178, 4qvnY, 0.9946, 0.40, 0.991, 212, 212, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
179, 4qvnK, 0.9946, 0.40, 0.991, 212, 212, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
180, 4qbyK, 0.9946, 0.40, 0.995, 212, 212, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
181, 1z7qZ, 0.9946, 0.40, 0.991, 212, 212, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
182, 4qbyY, 0.9945, 0.40, 0.995, 212, 212, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
183, 4y8kY, 0.9943, 0.41, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
184, 4y8kK, 0.9942, 0.42, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
185, 4r02K, 0.9941, 0.42, 0.995, 212, 212, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
186, 4qvqY, 0.9940, 0.42, 0.991, 212, 212, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
187, 3nzjY, 0.9940, 0.42, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
188, 4qvqK, 0.9939, 0.42, 0.991, 212, 212, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
189, 3nzjK, 0.9939, 0.42, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
190, 4r18Y, 0.9938, 0.21, 0.995, 211, 211, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
191, 4r18K, 0.9938, 0.21, 0.995, 211, 211, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
192, 3mg4Y, 0.9938, 0.43, 0.995, 212, 212, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
193, 5laiY, 0.9937, 0.21, 0.995, 211, 211, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
194, 5laiK, 0.9937, 0.21, 0.995, 211, 211, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
195, 1jd2R, 0.9937, 0.43, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
196, 4r17K, 0.9936, 0.22, 0.995, 211, 211, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
197, 4gk7Y, 0.9936, 0.43, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
198, 3bdmY, 0.9936, 0.43, 0.995, 212, 212, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
199, 4y7yK, 0.9935, 0.44, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
200, 4r17Y, 0.9935, 0.22, 0.995, 211, 211, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
201, 4gk7K, 0.9935, 0.44, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
202, 3bdmK, 0.9935, 0.44, 0.995, 212, 212, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
203, 1jd2K, 0.9935, 0.44, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
204, 5dkiY, 0.9934, 0.44, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
205, 5dkiK, 0.9934, 0.44, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
206, 4y7yY, 0.9934, 0.44, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
207, 4inuY, 0.9933, 0.45, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
208, 4inrY, 0.9933, 0.44, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
209, 4inrK, 0.9932, 0.45, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
210, 3mg0K, 0.9930, 0.46, 0.995, 212, 212, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
211, 5dkjY, 0.9929, 0.46, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
212, 5dkjK, 0.9929, 0.46, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
213, 4q1sY, 0.9928, 0.27, 0.995, 211, 211, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
214, 4inuK, 0.9928, 0.46, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
215, 4jsqY, 0.9927, 0.46, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
216, 4jsqK, 0.9927, 0.47, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
217, 3mg4K, 0.9927, 0.47, 0.995, 212, 212, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
218, 4no1Y, 0.9925, 0.47, 0.995, 212, 212, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
219, 4no1K, 0.9925, 0.47, 0.995, 212, 212, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
220, 3mg0Y, 0.9925, 0.47, 0.995, 212, 212, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
221, 4intY, 0.9924, 0.47, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
222, 4intK, 0.9923, 0.48, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
223, 3gpjY, 0.9923, 0.48, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
224, 2f16Y, 0.9923, 0.48, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
225, 2f16K, 0.9923, 0.48, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
226, 3gpjK, 0.9922, 0.48, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
227, 4jsuY, 0.9921, 0.48, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
228, 4jsuK, 0.9921, 0.48, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
229, 3un4Y, 0.9919, 0.49, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
230, 3un4K, 0.9919, 0.49, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
231, 1fntL, 0.9917, 0.50, 0.991, 212, 212, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
232, 1fntZ, 0.9916, 0.50, 0.991, 212, 212, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
233, 3oevY, 0.9913, 0.52, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
234, 5d0tY, 0.9909, 0.52, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
235, 5d0tK, 0.9909, 0.52, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
236, 5l5eY, 0.9908, 0.37, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
237, 5l5eK, 0.9908, 0.37, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
238, 5l5aK, 0.9906, 0.37, 0.773, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
239, 5l5aY, 0.9905, 0.38, 0.773, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
240, 5cghY, 0.9901, 0.54, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
241, 5cghK, 0.9901, 0.55, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
242, 5l5bY, 0.9900, 0.40, 0.768, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
243, 5l5bK, 0.9900, 0.40, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
244, 4qwuK, 0.9900, 0.62, 1.000, 212, 212, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
245, 4qwrY, 0.9900, 0.55, 1.000, 212, 212, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
246, 4qwrK, 0.9900, 0.55, 1.000, 212, 212, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
247, 5m2bY, 0.9899, 0.40, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
248, 5m2bK, 0.9899, 0.40, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
249, 3oevK, 0.9899, 0.56, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
250, 4qwuY, 0.9898, 0.63, 1.000, 212, 212, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
251, 5l64Y, 0.9897, 0.41, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
252, 5l5zY, 0.9897, 0.41, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
253, 5l5zK, 0.9897, 0.41, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
254, 4y8sY, 0.9897, 0.56, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
255, 5l64K, 0.9896, 0.41, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
256, 5l5rY, 0.9896, 0.41, 0.758, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
257, 5l5rK, 0.9896, 0.41, 0.758, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
258, 4y8sK, 0.9896, 0.56, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
259, 5l5fY, 0.9895, 0.42, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
260, 5l5fK, 0.9895, 0.42, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
261, 2zcyY, 0.9895, 0.56, 0.995, 212, 212, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
262, 2zcyK, 0.9894, 0.56, 0.995, 212, 212, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
263, 5l5dY, 0.9893, 0.43, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
264, 5l5wY, 0.9892, 0.43, 0.825, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
265, 5l5dK, 0.9892, 0.43, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
266, 4ltcY, 0.9892, 0.57, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
267, 5l5wK, 0.9891, 0.43, 0.825, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
268, 5fggY, 0.9891, 0.57, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
269, 5fggK, 0.9891, 0.57, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
270, 4qwjY, 0.9891, 0.57, 0.991, 212, 212, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
271, 4qwjK, 0.9891, 0.57, 0.991, 212, 212, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
272, 5l63Y, 0.9890, 0.43, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
273, 5l63K, 0.9890, 0.43, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
274, 5l60Y, 0.9889, 0.44, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
275, 5l60K, 0.9889, 0.44, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
276, 5l62Y, 0.9888, 0.44, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
277, 5l62K, 0.9888, 0.44, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
278, 3nzxY, 0.9888, 0.58, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
279, 3nzxK, 0.9888, 0.58, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
280, 5l61Y, 0.9887, 0.45, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
281, 5l61K, 0.9887, 0.45, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
282, 5l5iK, 0.9887, 0.45, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
283, 5l5iY, 0.9886, 0.45, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
284, 4qwkY, 0.9886, 0.59, 0.986, 212, 212, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
285, 4qwkK, 0.9886, 0.59, 0.986, 212, 212, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
286, 4ltcK, 0.9886, 0.59, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
287, 5mp9l, 0.9884, 0.59, 0.995, 212, 212, 26S PROTEASOME IN PRESENCE OF ATP (S1)
288, 5l6bY, 0.9884, 0.46, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
289, 5l6bK, 0.9884, 0.45, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
290, 5l5oY, 0.9884, 0.46, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
291, 5l6cY, 0.9883, 0.46, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
292, 5l6cK, 0.9883, 0.46, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
293, 5l5xY, 0.9883, 0.46, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
294, 5l5xK, 0.9883, 0.46, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
295, 5l5oK, 0.9883, 0.46, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
296, 5l5jY, 0.9883, 0.46, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
297, 5l5jK, 0.9883, 0.46, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
298, 5cz9Y, 0.9883, 0.59, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
299, 5cz9K, 0.9883, 0.59, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
300, 4qz6Y, 0.9883, 0.59, 0.986, 212, 212, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
301, 4qz6K, 0.9883, 0.59, 0.986, 212, 212, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
302, 5l67Y, 0.9882, 0.46, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
303, 5l67K, 0.9882, 0.46, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
304, 5l5tY, 0.9882, 0.46, 0.758, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
305, 5l5tK, 0.9882, 0.46, 0.758, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
306, 5mp95, 0.9881, 0.60, 0.995, 212, 212, 26S PROTEASOME IN PRESENCE OF ATP (S1)
307, 5l65K, 0.9881, 0.47, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
308, 5l65Y, 0.9880, 0.47, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
309, 5l5vY, 0.9880, 0.47, 0.758, 211, 211,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
310, 5l5vK, 0.9880, 0.47, 0.758, 211, 211,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
311, 5l5uY, 0.9880, 0.47, 0.758, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
312, 5l5uK, 0.9880, 0.47, 0.758, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
313, 5l5pK, 0.9880, 0.47, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
314, 5l68Y, 0.9879, 0.47, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
315, 5l68K, 0.9879, 0.47, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
316, 5l5pY, 0.9879, 0.47, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
317, 4no8Y, 0.9879, 0.60, 0.995, 212, 212, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
318, 4no8K, 0.9879, 0.60, 0.995, 212, 212, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
319, 5l6aY, 0.9878, 0.48, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
320, 5l5yY, 0.9878, 0.47, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
321, 5l5yK, 0.9878, 0.47, 0.820, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
322, 5l6aK, 0.9877, 0.48, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
323, 5cggY, 0.9877, 0.61, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
324, 5cggK, 0.9877, 0.61, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
325, 5lttY, 0.9876, 0.48, 0.768, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
326, 5l66Y, 0.9876, 0.48, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
327, 5l66K, 0.9876, 0.48, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
328, 5lttK, 0.9874, 0.49, 0.768, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
329, 4no6Y, 0.9874, 0.62, 0.995, 212, 212, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
330, 5l5sY, 0.9873, 0.49, 0.758, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
331, 5l5sK, 0.9873, 0.49, 0.758, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
332, 4ya2Y, 0.9873, 0.62, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
333, 4ya2K, 0.9873, 0.62, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
334, 4no6K, 0.9873, 0.62, 0.995, 212, 212, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
335, 5l5qY, 0.9872, 0.49, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
336, 5l5qK, 0.9872, 0.49, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
337, 5l5hY, 0.9872, 0.49, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
338, 5l5hK, 0.9872, 0.49, 0.763, 211, 211, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
339, 4qwiY, 0.9872, 0.62, 0.991, 212, 212, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
340, 4qwiK, 0.9872, 0.62, 0.991, 212, 212, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
341, 4qwgK, 0.9871, 0.62, 0.991, 212, 212, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
342, 4y78Y, 0.9870, 0.63, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
343, 4qwgY, 0.9870, 0.63, 0.991, 212, 212, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
344, 4qw7Y, 0.9870, 0.62, 0.991, 212, 212, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
345, 4qw7K, 0.9870, 0.62, 0.991, 212, 212, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
346, 4hnpK, 0.9870, 0.63, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
347, 4y70Y, 0.9869, 0.63, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
348, 4y70K, 0.9869, 0.63, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
349, 4qwlY, 0.9869, 0.63, 0.991, 212, 212, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
350, 4ya7Y, 0.9868, 0.63, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
351, 4ya7K, 0.9868, 0.63, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
352, 4y8qY, 0.9868, 0.63, 0.995, 212, 212, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
353, 4y8qK, 0.9868, 0.63, 0.995, 212, 212, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
354, 4y8lY, 0.9868, 0.63, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
355, 4y8lK, 0.9868, 0.63, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
356, 4y7wY, 0.9868, 0.63, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
357, 4y78K, 0.9868, 0.63, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
358, 4qwlK, 0.9868, 0.63, 0.991, 212, 212, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
359, 4y9zY, 0.9867, 0.63, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
360, 4y9zK, 0.9867, 0.63, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
361, 4y8pY, 0.9867, 0.63, 0.995, 212, 212, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
362, 4y8pK, 0.9867, 0.63, 0.995, 212, 212, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
363, 4y80Y, 0.9867, 0.63, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
364, 4y80K, 0.9867, 0.63, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
365, 4y7wK, 0.9867, 0.63, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
366, 5cz5Y, 0.9866, 0.64, 0.995, 212, 212, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
367, 5cz5K, 0.9866, 0.64, 0.995, 212, 212, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
368, 4ya9Y, 0.9866, 0.64, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
369, 4y6zY, 0.9866, 0.64, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
370, 4y6zK, 0.9866, 0.64, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
371, 4hnpY, 0.9866, 0.64, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
372, 4ya9K, 0.9865, 0.64, 0.995, 212, 212, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
373, 4qw6Y, 0.9865, 0.64, 0.991, 212, 212, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
374, 4qw6K, 0.9865, 0.64, 0.991, 212, 212, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
375, 5l69Y, 0.9864, 0.52, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
376, 5l69K, 0.9864, 0.52, 0.773, 211, 211, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
377, 5jhsY, 0.9864, 0.64, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
378, 5jhsK, 0.9864, 0.64, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
379, 5d0sY, 0.9864, 0.64, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
380, 5d0sK, 0.9864, 0.64, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
381, 4qwsY, 0.9864, 0.64, 0.991, 212, 212, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
382, 4qwsK, 0.9864, 0.64, 0.991, 212, 212, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
383, 5d0zY, 0.9863, 0.64, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
384, 5d0zK, 0.9863, 0.64, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
385, 4y8hY, 0.9863, 0.64, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
386, 4y8hK, 0.9863, 0.64, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
387, 4y82Y, 0.9863, 0.64, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
388, 4y82K, 0.9863, 0.64, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
389, 4qwfY, 0.9863, 0.64, 0.991, 212, 212, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
390, 4qwfK, 0.9863, 0.64, 0.991, 212, 212, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
391, 4qw5Y, 0.9863, 0.64, 0.991, 212, 212, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
392, 4qw5K, 0.9863, 0.64, 0.991, 212, 212, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
393, 5mpal, 0.9862, 0.65, 0.995, 212, 212, 26S PROTEASOME IN PRESENCE OF ATP (S2)
394, 4y8jY, 0.9862, 0.65, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
395, 4y8jK, 0.9862, 0.64, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
396, 4y8gY, 0.9862, 0.65, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
397, 4y81Y, 0.9862, 0.65, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
398, 4y81K, 0.9862, 0.65, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
399, 4y77Y, 0.9862, 0.65, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
400, 4y77K, 0.9862, 0.65, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
401, 4qz5Y, 0.9862, 0.65, 0.991, 212, 212, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
402, 4qz5K, 0.9862, 0.65, 0.991, 212, 212, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
403, 4nnnY, 0.9862, 0.65, 0.995, 212, 212, YCP IN COMPLEX WITH MG132
404, 4nnnK, 0.9862, 0.65, 0.995, 212, 212, YCP IN COMPLEX WITH MG132
405, 3jcpUA, 0.9862, 0.64, 0.995, 212, 212, 
406, 3jcpG, 0.9862, 0.64, 0.995, 212, 212, 
407, 5fgiY, 0.9861, 0.65, 0.995, 212, 212, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
408, 5fgiK, 0.9861, 0.65, 0.995, 212, 212, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
409, 4y8iY, 0.9861, 0.65, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
410, 4y8iK, 0.9861, 0.65, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
411, 4y8gK, 0.9861, 0.65, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
412, 4y75Y, 0.9861, 0.65, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
413, 4y75K, 0.9861, 0.65, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
414, 4y74Y, 0.9861, 0.65, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
415, 4y74K, 0.9861, 0.65, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
416, 4hrcY, 0.9861, 0.65, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
417, 4y84Y, 0.9860, 0.65, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
418, 4hrcK, 0.9860, 0.65, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
419, 3nzwY, 0.9860, 0.65, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
420, 3nzwK, 0.9860, 0.65, 0.995, 212, 212, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
421, 1g65K, 0.9860, 0.65, 0.995, 212, 212, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
422, 4y84K, 0.9859, 0.65, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
423, 4qw4Y, 0.9859, 0.65, 0.995, 212, 212, YCP IN COMPLEX WITH CARFILZOMIB
424, 4qw4K, 0.9859, 0.65, 0.995, 212, 212, YCP IN COMPLEX WITH CARFILZOMIB
425, 4no9Y, 0.9859, 0.65, 0.995, 212, 212, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
426, 4no9K, 0.9859, 0.65, 0.995, 212, 212, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
427, 5ahjY, 0.9857, 0.66, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
428, 5ahjK, 0.9857, 0.66, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
429, 4qz3K, 0.9857, 0.66, 0.991, 212, 212, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
430, 1g65Y, 0.9857, 0.66, 0.995, 212, 212, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
431, 5cz8Y, 0.9856, 0.66, 0.991, 221, 212, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
432, 4y8oY, 0.9856, 0.66, 0.995, 212, 212, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
433, 4qz3Y, 0.9856, 0.66, 0.991, 212, 212, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
434, 3oeuY, 0.9856, 0.67, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
435, 5cz8K, 0.9855, 0.67, 0.991, 220, 212, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
436, 4y8oK, 0.9855, 0.66, 0.995, 212, 212, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
437, 5mpa5, 0.9854, 0.66, 0.995, 212, 212, 26S PROTEASOME IN PRESENCE OF ATP (S2)
438, 4qz7Y, 0.9854, 0.66, 0.991, 212, 212, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
439, 4qz7K, 0.9854, 0.66, 0.991, 212, 212, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
440, 4hrdK, 0.9854, 0.66, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
441, 5l55Y, 0.9852, 0.67, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
442, 5l55K, 0.9852, 0.67, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
443, 5l54Y, 0.9852, 0.67, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
444, 5l54K, 0.9852, 0.67, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
445, 4hrdY, 0.9852, 0.67, 0.995, 212, 212, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
446, 3okjY, 0.9852, 0.67, 0.995, 212, 212, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
447, 3okjK, 0.9852, 0.67, 0.995, 212, 212, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
448, 5cgiY, 0.9851, 0.67, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
449, 5cgiK, 0.9851, 0.67, 0.991, 212, 212, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
450, 5l52Y, 0.9850, 0.67, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
451, 5l52K, 0.9850, 0.67, 0.995, 212, 212, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
452, 3oeuK, 0.9849, 0.68, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
453, 4qzxY, 0.9848, 0.68, 0.991, 212, 212, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
454, 4qzxK, 0.9848, 0.68, 0.991, 212, 212, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
455, 4qxjK, 0.9848, 0.68, 0.991, 212, 212, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
456, 3mg7Y, 0.9848, 0.69, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
457, 4qxjY, 0.9847, 0.68, 0.991, 212, 212, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
458, 4qwxK, 0.9847, 0.68, 0.995, 212, 212, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
459, 3d29Y, 0.9847, 0.68, 0.995, 212, 212, PROTEASOME INHIBITION BY FELLUTAMIDE B
460, 3d29K, 0.9847, 0.68, 0.995, 212, 212, PROTEASOME INHIBITION BY FELLUTAMIDE B
461, 4qltY, 0.9846, 0.68, 0.995, 212, 212, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
462, 4qltK, 0.9846, 0.68, 0.995, 212, 212, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
463, 3sdiK, 0.9845, 0.69, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
464, 3mg7K, 0.9845, 0.69, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
465, 4qz4Y, 0.9844, 0.69, 0.991, 212, 212, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
466, 4qz4K, 0.9844, 0.69, 0.991, 212, 212, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
467, 4qz1Y, 0.9844, 0.69, 0.991, 212, 212, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
468, 4qz1K, 0.9844, 0.69, 0.991, 212, 212, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
469, 4qz0Y, 0.9844, 0.69, 0.991, 212, 212, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
470, 4qz0K, 0.9844, 0.69, 0.991, 212, 212, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
471, 4qwxY, 0.9844, 0.69, 0.995, 212, 212, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
472, 3sdiY, 0.9844, 0.69, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
473, 3mg6K, 0.9843, 0.69, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
474, 4qlvY, 0.9842, 0.69, 0.995, 212, 212, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
475, 4qlvK, 0.9842, 0.69, 0.995, 212, 212, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
476, 4qluY, 0.9842, 0.69, 0.995, 212, 212, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
477, 4qluK, 0.9842, 0.69, 0.995, 212, 212, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
478, 3mg6Y, 0.9842, 0.70, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
479, 4qlsY, 0.9841, 0.69, 0.995, 212, 212, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
480, 4qlsK, 0.9841, 0.69, 0.995, 212, 212, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
481, 3sdkY, 0.9841, 0.70, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
482, 3mg8Y, 0.9841, 0.70, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
483, 4qz2Y, 0.9840, 0.70, 0.991, 212, 212, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
484, 4qz2K, 0.9840, 0.70, 0.991, 212, 212, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
485, 4nnwY, 0.9838, 0.70, 0.995, 212, 212, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
486, 3sdkK, 0.9838, 0.71, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
487, 4nnwK, 0.9837, 0.70, 0.995, 212, 212, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
488, 3mg8K, 0.9837, 0.71, 0.995, 212, 212, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
489, 4g4sL, 0.9834, 0.71, 0.995, 212, 212, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
490, 4qlqY, 0.9824, 0.73, 0.995, 212, 212, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
491, 4qlqK, 0.9824, 0.73, 0.995, 212, 212, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
492, 3jcoUA, 0.9788, 0.80, 0.995, 212, 212, 
493, 3jcoG, 0.9787, 0.81, 0.995, 212, 212, 
494, 5mpcL, 0.9771, 0.85, 0.995, 212, 212, 
495, 5wvkE, 0.9726, 0.93, 0.995, 212, 212, 
496, 5mpbZ, 0.9718, 0.94, 0.995, 212, 212, 
497, 5mpcZ, 0.9713, 0.98, 0.995, 212, 212, 
498, 5mpbL, 0.9659, 1.05, 0.995, 212, 212, 
499, 5wvkL, 0.9631, 1.08, 0.995, 212, 212, 
500, 5wviIA, 0.9483, 1.30, 0.995, 212, 212, 
501, 5wviSA, 0.9479, 1.31, 0.995, 212, 212, 
502, 4r3oZ, 0.9378, 0.57, 0.662, 201, 201, HUMAN CONSTITUTIVE 20S PROTEASOME
503, 4r3oL, 0.9377, 0.58, 0.662, 201, 201, HUMAN CONSTITUTIVE 20S PROTEASOME
504, 3uneK, 0.9364, 0.62, 0.662, 201, 201, MOUSE CONSTITUTIVE 20S PROTEASOME
505, 5gjrRA, 0.9361, 0.62, 0.662, 201, 201, 
506, 5gjrDA, 0.9360, 0.62, 0.662, 201, 201, 
507, 1iruL, 0.9357, 0.64, 0.662, 201, 201, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
508, 1iruZ, 0.9356, 0.64, 0.662, 201, 201, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
509, 5gjqs, 0.9355, 0.63, 0.662, 201, 201, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
510, 3uneY, 0.9355, 0.64, 0.662, 201, 201, MOUSE CONSTITUTIVE 20S PROTEASOME
511, 3une1, 0.9353, 0.64, 0.662, 201, 201, MOUSE CONSTITUTIVE 20S PROTEASOME
512, 5le5K, 0.9350, 0.66, 0.662, 201, 201, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
513, 3unem, 0.9347, 0.66, 0.662, 201, 201, MOUSE CONSTITUTIVE 20S PROTEASOME
514, 5gjqe, 0.9346, 0.66, 0.657, 201, 201, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
515, 4r67L, 0.9332, 0.69, 0.662, 201, 201, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
516, 4r673, 0.9332, 0.69, 0.662, 201, 201, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
517, 4r67Z, 0.9331, 0.69, 0.662, 201, 201, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
518, 5lf3Y, 0.9329, 0.70, 0.662, 201, 201, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
519, 4r67n, 0.9329, 0.70, 0.662, 201, 201, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
520, 5lexK, 0.9324, 0.59, 0.665, 200, 200, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
521, 5l4gZ, 0.9323, 0.71, 0.662, 201, 201, 
522, 5l4gL, 0.9321, 0.72, 0.662, 201, 201, 
523, 5lf1Y, 0.9320, 0.72, 0.662, 201, 201, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
524, 5lf0Y, 0.9319, 0.73, 0.662, 201, 201, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
525, 5vfqL, 0.9313, 0.74, 0.657, 201, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
526, 5lf7Y, 0.9312, 2.06, 0.200, 213, 195, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
527, 5vfpL, 0.9309, 0.74, 0.662, 201, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
528, 5lf4Y, 0.9307, 0.74, 0.657, 201, 201, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
529, 5vfuCA, 0.9305, 2.00, 0.240, 215, 200, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
530, 5vftR, 0.9305, 0.75, 0.662, 201, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
531, 5vfoR, 0.9303, 0.75, 0.657, 201, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
532, 5vfsL, 0.9302, 0.75, 0.657, 201, 201, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
533, 5vfqKA, 0.9301, 0.76, 0.657, 201, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
534, 5vfor, 0.9300, 0.76, 0.657, 201, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
535, 5vfpJA, 0.9297, 2.03, 0.200, 213, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
536, 5lf3K, 0.9297, 0.76, 0.657, 201, 201, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
537, 5vfrR, 0.9296, 0.76, 0.662, 201, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
538, 3unb1, 0.9294, 0.77, 0.657, 201, 201, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
539, 5vfsKA, 0.9293, 0.66, 0.665, 200, 200, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
540, 5t0cJB, 0.9290, 0.77, 0.657, 201, 201, 
541, 5t0cDA, 0.9290, 0.78, 0.662, 201, 201, 
542, 3unbY, 0.9290, 0.78, 0.657, 201, 201, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
543, 5vfrr, 0.9289, 0.78, 0.657, 201, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
544, 5lf6Y, 0.9288, 0.78, 0.657, 201, 201, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
545, 5lf0K, 0.9287, 0.78, 0.662, 201, 201, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
546, 5lf1K, 0.9286, 0.79, 0.662, 201, 201, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
547, 3unhY, 0.9285, 0.79, 0.657, 201, 201, MOUSE 20S IMMUNOPROTEASOME
548, 3unhK, 0.9285, 0.69, 0.665, 200, 200, MOUSE 20S IMMUNOPROTEASOME
549, 5lexY, 0.9281, 0.69, 0.665, 200, 200, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
550, 5lf7K, 0.9277, 0.80, 0.617, 201, 201, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
551, 5le5Y, 0.9276, 0.80, 0.617, 201, 201, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
552, 5lezK, 0.9274, 0.58, 0.668, 199, 199, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
553, 3unbK, 0.9274, 0.71, 0.665, 200, 200, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
554, 3unbm, 0.9273, 0.60, 0.668, 199, 199, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
555, 5lf4K, 0.9270, 0.72, 0.665, 200, 200, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
556, 5vfuQA, 0.9267, 0.82, 0.662, 201, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
557, 5vftr, 0.9267, 0.82, 0.662, 201, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
558, 5leyK, 0.9267, 0.73, 0.665, 200, 200, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
559, 5t0gR, 0.9259, 0.83, 0.657, 201, 201, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
560, 5lf6K, 0.9254, 0.83, 0.657, 201, 201, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
561, 3unfY, 0.9245, 0.73, 0.665, 200, 200, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
562, 3unfK, 0.9245, 0.85, 0.657, 201, 201, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
563, 5lezY, 0.9226, 0.76, 0.665, 200, 200, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
564, 6avoD, 0.9221, 0.88, 0.617, 201, 201, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
565, 6avoC, 0.9221, 0.87, 0.617, 201, 201, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
566, 5leyY, 0.9220, 0.72, 0.663, 199, 199, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
567, 5m32Y, 0.9214, 0.92, 0.597, 201, 201, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
568, 4cr45, 0.9184, 0.92, 0.597, 201, 201, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
569, 5m32K, 0.9182, 0.74, 0.668, 199, 199, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
570, 4cr25, 0.9127, 0.94, 0.657, 201, 201, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
571, 5a5b5, 0.9126, 1.70, 0.976, 212, 209, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
572, 4cr35, 0.9126, 0.91, 0.660, 200, 200, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
573, 5t0hR, 0.9100, 2.00, 0.971, 212, 210, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
574, 5t0iR, 0.8978, 1.81, 0.976, 212, 209, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
575, 5t0jR, 0.8944, 1.81, 0.976, 212, 209, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
576, 5gjqo, 0.8825, 1.12, 0.657, 201, 201, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
577, 5gjrNA, 0.8819, 1.37, 0.657, 201, 201, 
578, 3mi0V, 0.8818, 1.38, 0.657, 201, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
579, 3mi0R, 0.8818, 1.73, 0.272, 202, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
580, 5gjrZ, 0.8817, 1.74, 0.272, 202, 202, 
581, 4r3oV, 0.8816, 2.55, 0.231, 239, 212, HUMAN CONSTITUTIVE 20S PROTEASOME
582, 4r3oH, 0.8816, 2.55, 0.231, 239, 212, HUMAN CONSTITUTIVE 20S PROTEASOME
583, 3uneN, 0.8806, 1.75, 0.272, 202, 202, MOUSE CONSTITUTIVE 20S PROTEASOME
584, 3unep, 0.8805, 1.75, 0.272, 202, 202, MOUSE CONSTITUTIVE 20S PROTEASOME
585, 5gjqa, 0.8804, 1.75, 0.272, 202, 202, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
586, 3uneb, 0.8803, 1.77, 0.267, 202, 202, MOUSE CONSTITUTIVE 20S PROTEASOME
587, 3une4, 0.8799, 1.77, 0.267, 202, 202, MOUSE CONSTITUTIVE 20S PROTEASOME
588, 5le5N, 0.8797, 1.76, 0.272, 202, 202, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
589, 5le5b, 0.8791, 1.76, 0.267, 202, 202, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
590, 5lf1N, 0.8789, 1.76, 0.267, 202, 202, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
591, 5lf1b, 0.8788, 1.76, 0.272, 202, 202, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
592, 4r67H, 0.8786, 1.77, 0.272, 203, 202, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
593, 4r67x, 0.8785, 1.78, 0.272, 202, 202, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
594, 4r67V, 0.8785, 1.78, 0.272, 203, 202, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
595, 5lf0N, 0.8784, 1.78, 0.272, 202, 202, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
596, 4r67j, 0.8784, 1.78, 0.272, 202, 202, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
597, 5a0qZ, 0.8783, 1.78, 0.272, 202, 202, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
598, 5a0qL, 0.8783, 1.78, 0.272, 202, 202, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
599, 5lf0b, 0.8779, 1.79, 0.272, 202, 202, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
600, 5leyN, 0.8778, 0.97, 0.677, 192, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
601, 5leyb, 0.8778, 0.97, 0.677, 192, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
602, 5l4gM, 0.8778, 1.80, 0.272, 203, 202, 
603, 5lf3N, 0.8777, 1.80, 0.272, 202, 202, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
604, 5lf3b, 0.8775, 1.80, 0.272, 203, 202, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
605, 5lf7N, 0.8771, 1.57, 0.275, 200, 200, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
606, 5lf7b, 0.8771, 1.81, 0.272, 202, 202, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
607, 1iruV, 0.8771, 1.81, 0.272, 203, 202, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
608, 1iruH, 0.8771, 1.82, 0.272, 202, 202, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
609, 5lexb, 0.8770, 1.81, 0.272, 203, 202, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
610, 5lexN, 0.8769, 1.82, 0.272, 202, 202, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
611, 5lf6N, 0.8766, 1.82, 0.272, 202, 202, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
612, 5lf6b, 0.8766, 1.82, 0.272, 203, 202, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
613, 5m32b, 0.8763, 1.83, 0.272, 202, 202, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
614, 5m32N, 0.8761, 1.82, 0.272, 202, 202, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
615, 1pmaY, 0.8759, 1.81, 0.272, 203, 202, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
616, 1j2qN, 0.8759, 1.82, 0.272, 203, 202, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
617, 1j2qL, 0.8759, 1.84, 0.272, 202, 202, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
618, 1j2qK, 0.8759, 2.16, 0.259, 203, 201, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
619, 1j2qJ, 0.8759, 2.09, 0.308, 202, 201, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
620, 1j2qM, 0.8758, 2.09, 0.308, 202, 201, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
621, 1j2qI, 0.8758, 2.09, 0.308, 202, 201, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
622, 1j2qH, 0.8758, 2.09, 0.308, 202, 201, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
623, 1pma1, 0.8757, 2.09, 0.308, 202, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
624, 5lf4N, 0.8756, 2.09, 0.308, 202, 201, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
625, 1pmaZ, 0.8756, 2.09, 0.308, 202, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
626, 5lf4b, 0.8755, 2.17, 0.259, 203, 201, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
627, 5vy3Z, 0.8753, 1.82, 0.272, 202, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
628, 5vy3X, 0.8753, 2.18, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
629, 5vy3V, 0.8753, 1.83, 0.272, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
630, 5vy3T, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
631, 5vy3R, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
632, 5vy3P, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
633, 5vy3N, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
634, 5vy3L, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
635, 5vy3J, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
636, 5vy3H, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
637, 5vy3F, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
638, 5vy3D, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
639, 5vy3B, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
640, 5vy31, 0.8753, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
641, 1pmaW, 0.8753, 2.19, 0.259, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
642, 5vy4Z, 0.8752, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
643, 5vy4X, 0.8752, 2.19, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
644, 5vy4V, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
645, 5vy4T, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
646, 5vy4R, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
647, 5vy4P, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
648, 5vy4N, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
649, 5vy4L, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
650, 5vy4J, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
651, 5vy4H, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
652, 5vy4F, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
653, 5vy4D, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
654, 5vy4BA, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
655, 5vy4B, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
656, 5vy41, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
657, 3unb4, 0.8752, 2.18, 0.259, 203, 201, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
658, 3c92Z, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
659, 3c92X, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
660, 3c92L, 0.8752, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
661, 3c92J, 0.8752, 1.84, 0.267, 202, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
662, 3c91Z, 0.8752, 2.16, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
663, 3c91X, 0.8752, 2.17, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
664, 3c91L, 0.8752, 2.16, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
665, 3c91J, 0.8752, 2.17, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
666, 1pmaS, 0.8752, 2.16, 0.259, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
667, 1pmaQ, 0.8752, 2.17, 0.259, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
668, 1pmaB, 0.8752, 2.16, 0.259, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
669, 5lezN, 0.8751, 2.17, 0.259, 203, 201, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
670, 3unbb, 0.8751, 2.16, 0.259, 203, 201, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
671, 3c92W, 0.8751, 2.17, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
672, 3c92V, 0.8751, 2.18, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
673, 3c92I, 0.8751, 1.83, 0.272, 202, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
674, 3c92H, 0.8751, 1.82, 0.267, 202, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
675, 3c91W, 0.8751, 2.17, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
676, 3c91V, 0.8751, 2.18, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
677, 3c91I, 0.8751, 2.17, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
678, 3c91H, 0.8751, 2.18, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
679, 1pmaP, 0.8751, 2.17, 0.259, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
680, 1pma2, 0.8751, 2.18, 0.254, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
681, 3unbp, 0.8750, 2.17, 0.259, 203, 201, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
682, 3c92N, 0.8750, 2.18, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
683, 3c922, 0.8750, 2.17, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
684, 3c91N, 0.8750, 2.17, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
685, 3c912, 0.8750, 1.85, 0.267, 202, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
686, 1pmaV, 0.8750, 2.17, 0.259, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
687, 1pmaU, 0.8750, 2.17, 0.259, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
688, 3unbN, 0.8749, 2.17, 0.259, 203, 201, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
689, 1ya7M, 0.8749, 2.17, 0.259, 203, 201, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
690, 5lezb, 0.8748, 2.18, 0.254, 203, 201, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
691, 3jseM, 0.8748, 2.17, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
692, 3jseK, 0.8748, 1.85, 0.267, 202, 202, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
693, 3c92Y, 0.8748, 2.22, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
694, 3c92M, 0.8748, 1.84, 0.272, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
695, 3c92K, 0.8748, 2.22, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
696, 3c921, 0.8748, 2.22, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
697, 3c91Y, 0.8748, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
698, 3c91M, 0.8748, 2.19, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
699, 3c91K, 0.8748, 2.18, 0.259, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
700, 3c911, 0.8748, 2.19, 0.254, 203, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
701, 1pmaT, 0.8748, 2.18, 0.259, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
702, 1pmaR, 0.8748, 2.19, 0.254, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
703, 3jseL, 0.8747, 2.18, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
704, 3jseJ, 0.8747, 2.19, 0.254, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
705, 3jseH, 0.8747, 2.19, 0.254, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
706, 3jseN, 0.8746, 2.18, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
707, 3jseI, 0.8746, 2.22, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
708, 1pmaX, 0.8746, 2.22, 0.254, 203, 201, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
709, 1yauM, 0.8744, 2.22, 0.259, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
710, 1yarM, 0.8743, 2.22, 0.254, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
711, 1ya7J, 0.8743, 2.22, 0.254, 203, 201, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
712, 6avoF, 0.8742, 2.17, 0.259, 203, 201, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
713, 5lzpN, 0.8742, 2.23, 0.259, 203, 201, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
714, 1ya7K, 0.8742, 2.22, 0.259, 203, 201, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
715, 1ya7H, 0.8742, 2.21, 0.254, 203, 201, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
716, 6avoA, 0.8741, 1.54, 0.296, 199, 199, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
717, 3jtlM, 0.8741, 2.58, 0.229, 234, 210, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
718, 3jtlL, 0.8741, 2.21, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
719, 3jtlJ, 0.8741, 2.21, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
720, 3jtlI, 0.8741, 1.54, 0.296, 199, 199, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
721, 1yauL, 0.8741, 2.22, 0.259, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
722, 1yauJ, 0.8741, 2.22, 0.254, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
723, 1ya7L, 0.8741, 2.22, 0.254, 203, 201, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
724, 5lzpP, 0.8740, 2.22, 0.254, 203, 201, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
725, 3jtlN, 0.8740, 2.22, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
726, 3jtlK, 0.8740, 2.22, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
727, 3jtlH, 0.8740, 2.22, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
728, 3jrmM, 0.8740, 2.61, 0.229, 234, 210, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
729, 3jrmL, 0.8740, 2.22, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
730, 3jrmK, 0.8740, 2.22, 0.254, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
731, 3jrmH, 0.8740, 2.22, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
732, 3jrmJ, 0.8739, 2.24, 0.254, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
733, 3jrmI, 0.8739, 2.24, 0.254, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
734, 1yarJ, 0.8739, 2.24, 0.254, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
735, 3jrmN, 0.8738, 2.24, 0.254, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
736, 1yauN, 0.8738, 2.24, 0.254, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
737, 1yauK, 0.8738, 2.24, 0.254, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
738, 1yarK, 0.8738, 2.23, 0.254, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
739, 1ya7N, 0.8738, 2.24, 0.254, 203, 201, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
740, 1ya7I, 0.8738, 2.24, 0.254, 203, 201, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
741, 1yauI, 0.8737, 2.22, 0.254, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
742, 1yarN, 0.8737, 2.22, 0.254, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
743, 1yarL, 0.8737, 2.23, 0.254, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
744, 1yarI, 0.8736, 2.23, 0.259, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
745, 1yauH, 0.8735, 2.24, 0.254, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
746, 1yarH, 0.8731, 2.23, 0.259, 203, 201, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
747, 3krdV, 0.8730, 2.22, 0.254, 203, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
748, 3krdR, 0.8729, 2.23, 0.254, 203, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
749, 3h4pl, 0.8725, 2.23, 0.259, 203, 201, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
750, 3h4pf, 0.8719, 2.23, 0.259, 203, 201, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
751, 5l4gAA, 0.8718, 2.71, 0.232, 229, 211, 
752, 3h4pa, 0.8716, 2.51, 0.225, 229, 209, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
753, 3h4pj, 0.8715, 2.10, 0.295, 202, 200, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
754, 3h4ph, 0.8715, 2.12, 0.295, 202, 200, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
755, 3h4pn, 0.8714, 1.60, 0.276, 199, 199, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
756, 3h4pi, 0.8714, 2.12, 0.295, 202, 200, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
757, 3h4pd, 0.8714, 2.13, 0.295, 202, 200, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
758, 3h4pk, 0.8712, 2.11, 0.295, 202, 200, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
759, 3j9iZ, 0.8711, 2.23, 0.289, 202, 201, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
760, 3j9iY, 0.8711, 2.11, 0.295, 202, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
761, 3j9iX, 0.8711, 2.12, 0.295, 202, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
762, 3j9iW, 0.8711, 2.12, 0.295, 202, 200, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
763, 3j9iV, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
764, 3j9iN, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
765, 3j9iM, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
766, 3j9iL, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
767, 3j9iK, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
768, 3j9iJ, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
769, 3j9iI, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
770, 3j9iH, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
771, 3j9i2, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
772, 3j9i1, 0.8711, 2.29, 0.257, 203, 202, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
773, 3h4pg, 0.8711, 2.29, 0.257, 203, 202, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
774, 3h4pm, 0.8707, 2.29, 0.257, 203, 202, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
775, 3h4pc, 0.8706, 2.29, 0.257, 203, 202, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
776, 3h4pb, 0.8705, 2.29, 0.257, 203, 202, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
777, 1q5qN, 0.8705, 2.11, 0.295, 202, 200, THE RHODOCOCCUS 20S PROTEASOME
778, 1q5qJ, 0.8705, 2.11, 0.295, 202, 200, THE RHODOCOCCUS 20S PROTEASOME
779, 3h4pe, 0.8704, 2.13, 0.295, 202, 200, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
780, 1q5qM, 0.8704, 2.11, 0.295, 202, 200, THE RHODOCOCCUS 20S PROTEASOME
781, 1q5qL, 0.8704, 2.15, 0.263, 224, 205, THE RHODOCOCCUS 20S PROTEASOME
782, 1q5qK, 0.8704, 2.15, 0.263, 224, 205, THE RHODOCOCCUS 20S PROTEASOME
783, 1q5qI, 0.8704, 2.13, 0.295, 202, 200, THE RHODOCOCCUS 20S PROTEASOME
784, 1q5qH, 0.8704, 2.15, 0.263, 224, 205, THE RHODOCOCCUS 20S PROTEASOME
785, 6avoE, 0.8699, 2.15, 0.263, 224, 205, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
786, 6avoB, 0.8699, 2.15, 0.263, 224, 205, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
787, 3hfaX, 0.8697, 2.15, 0.263, 224, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
788, 6bdfZ, 0.8695, 2.15, 0.263, 224, 205, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
789, 6bdfX, 0.8695, 1.23, 0.285, 219, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
790, 6bdfV, 0.8695, 1.23, 0.285, 219, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
791, 6bdfT, 0.8695, 2.43, 0.232, 224, 207, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
792, 6bdfR, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
793, 6bdfP, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
794, 6bdfN, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
795, 6bdfL, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
796, 6bdfJ, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
797, 6bdfH, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
798, 6bdfF, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
799, 6bdfD, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
800, 6bdfB, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
801, 6bdf1, 0.8695, 2.18, 0.260, 201, 200, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
802, 3hfaZ, 0.8693, 2.18, 0.260, 201, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
803, 3hfaV, 0.8691, 2.18, 0.260, 201, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
804, 3unhN, 0.8687, 2.18, 0.260, 201, 200, MOUSE 20S IMMUNOPROTEASOME
805, 3unhb, 0.8687, 2.18, 0.260, 201, 200, MOUSE 20S IMMUNOPROTEASOME
806, 3unhV, 0.8686, 2.47, 0.232, 224, 207, MOUSE 20S IMMUNOPROTEASOME
807, 3unhH, 0.8686, 2.48, 0.232, 226, 207, MOUSE 20S IMMUNOPROTEASOME
808, 3hfaT, 0.8685, 1.62, 0.281, 199, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
809, 3hfaN, 0.8685, 1.62, 0.281, 199, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
810, 5l4gBA, 0.8684, 1.26, 0.280, 219, 193, 
811, 3mi0L, 0.8683, 1.26, 0.280, 219, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
812, 3mi02, 0.8683, 2.37, 0.233, 223, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
813, 5lf1H, 0.8682, 2.37, 0.233, 223, 206, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
814, 5le5H, 0.8682, 1.28, 0.254, 220, 193, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
815, 3hfaE, 0.8682, 2.38, 0.233, 223, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
816, 3mi0E, 0.8681, 2.37, 0.233, 223, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
817, 3hfaH, 0.8681, 1.30, 0.254, 220, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
818, 5lf1V, 0.8680, 1.30, 0.254, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
819, 3mi0Z, 0.8680, 2.38, 0.238, 223, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
820, 4r3oI, 0.8679, 2.37, 0.233, 223, 206, HUMAN CONSTITUTIVE 20S PROTEASOME
821, 3unfN, 0.8679, 2.38, 0.233, 223, 206, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
822, 5trgL, 0.8678, 1.30, 0.254, 220, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
823, 3unfb, 0.8678, 2.37, 0.233, 223, 206, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
824, 3mi0T, 0.8678, 1.30, 0.254, 220, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
825, 4r3oW, 0.8677, 1.62, 0.286, 199, 199, HUMAN CONSTITUTIVE 20S PROTEASOME
826, 5vfuNA, 0.8676, 2.36, 0.233, 223, 206, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
827, 5vfto, 0.8676, 1.62, 0.286, 199, 199, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
828, 5lzpU, 0.8676, 2.38, 0.233, 223, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
829, 5le5V, 0.8676, 1.30, 0.254, 220, 193, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
830, 3unfH, 0.8676, 1.29, 0.254, 220, 193, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
831, 4r67k, 0.8675, 1.29, 0.254, 220, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
832, 4q1sV, 0.8675, 2.39, 0.228, 223, 206, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
833, 3unfV, 0.8675, 1.30, 0.254, 220, 193, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
834, 3unex, 0.8675, 1.27, 0.280, 219, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
835, 3mi0X, 0.8675, 1.30, 0.254, 220, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
836, 5gjrAA, 0.8674, 1.29, 0.280, 222, 193, 
837, 4r67y, 0.8674, 1.28, 0.280, 219, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
838, 4r67W, 0.8674, 1.31, 0.254, 220, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
839, 5trsL, 0.8673, 2.39, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
840, 5lzpO, 0.8673, 1.30, 0.254, 220, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
841, 5lf0H, 0.8673, 1.30, 0.254, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
842, 5l6cV, 0.8673, 1.30, 0.254, 220, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
843, 5l6cH, 0.8673, 2.37, 0.233, 223, 206, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
844, 4r67I, 0.8673, 2.39, 0.228, 223, 206, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
845, 4q1sH, 0.8673, 1.31, 0.254, 220, 193, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
846, 3uneV, 0.8673, 1.30, 0.280, 226, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
847, 5trrL, 0.8672, 1.30, 0.280, 226, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
848, 5lf3H, 0.8672, 1.30, 0.254, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
849, 5lexH, 0.8672, 1.30, 0.280, 222, 193, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
850, 5gjrOA, 0.8672, 1.32, 0.254, 220, 193, 
851, 1iruW, 0.8672, 2.38, 0.233, 223, 206, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
852, 1iruI, 0.8672, 1.32, 0.254, 220, 193, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
853, 5lzpI, 0.8671, 1.32, 0.254, 220, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
854, 5lf0V, 0.8671, 1.30, 0.254, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
855, 5l5tV, 0.8671, 1.30, 0.254, 220, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
856, 5l5tH, 0.8671, 1.31, 0.254, 220, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
857, 4zzgI, 0.8671, 2.39, 0.223, 223, 206, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
858, 3unej, 0.8671, 1.31, 0.254, 220, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
859, 5lzpC, 0.8670, 1.30, 0.280, 226, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
860, 5lf3V, 0.8670, 1.30, 0.280, 226, 193, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
861, 5l5pV, 0.8670, 1.29, 0.280, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
862, 5l5pH, 0.8670, 1.31, 0.254, 220, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
863, 3tddH, 0.8670, 2.38, 0.223, 223, 206, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
864, 5nifI, 0.8669, 1.32, 0.254, 220, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
865, 5l67V, 0.8669, 1.30, 0.280, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
866, 5l67H, 0.8669, 1.30, 0.280, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
867, 5l5oV, 0.8669, 1.31, 0.280, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
868, 5l5oH, 0.8669, 1.30, 0.280, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
869, 3tddV, 0.8669, 1.30, 0.280, 226, 193, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
870, 5trsY, 0.8668, 1.30, 0.280, 226, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
871, 5trgY, 0.8668, 1.31, 0.280, 226, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
872, 5lf7H, 0.8668, 1.31, 0.280, 226, 193, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
873, 5lexV, 0.8668, 1.31, 0.280, 222, 193, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
874, 5l5vV, 0.8668, 2.37, 0.233, 223, 206,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
875, 5l5vH, 0.8668, 2.37, 0.233, 223, 206,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
876, 5l4gN, 0.8668, 1.32, 0.254, 220, 193, 
877, 4v7oW, 0.8668, 1.32, 0.254, 220, 193, 
878, 4v7oI, 0.8668, 1.30, 0.280, 226, 193, 
879, 4v7oEB, 0.8668, 1.30, 0.280, 226, 193, 
880, 3uneH, 0.8668, 1.32, 0.254, 220, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
881, 5tryL, 0.8667, 1.30, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
882, 5lzpT, 0.8667, 1.30, 0.280, 222, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
883, 5l64V, 0.8667, 1.30, 0.280, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
884, 5l64H, 0.8667, 1.32, 0.254, 220, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
885, 4v7oQA, 0.8667, 2.39, 0.233, 223, 206, 
886, 3mg6V, 0.8667, 2.39, 0.223, 223, 206, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
887, 3hfaR, 0.8667, 1.31, 0.280, 226, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
888, 5vfuZ, 0.8666, 1.31, 0.280, 226, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
889, 5vftO, 0.8666, 1.30, 0.280, 222, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
890, 5l6aV, 0.8666, 1.30, 0.280, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
891, 5l6aH, 0.8666, 2.34, 0.234, 222, 205, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
892, 5l62V, 0.8666, 1.31, 0.254, 220, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
893, 5l62H, 0.8666, 1.31, 0.254, 220, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
894, 5l5uV, 0.8666, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
895, 5l5uH, 0.8666, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
896, 5l5qV, 0.8666, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
897, 5l5qH, 0.8666, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
898, 4j70V, 0.8666, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
899, 4j70H, 0.8666, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
900, 4inuH, 0.8666, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
901, 5nifW, 0.8665, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
902, 5lttH, 0.8665, 1.31, 0.280, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
903, 5leyH, 0.8665, 1.31, 0.280, 222, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
904, 5l69V, 0.8665, 1.31, 0.280, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
905, 5l69H, 0.8665, 1.30, 0.280, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
906, 5l61H, 0.8665, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
907, 5l5jV, 0.8665, 1.33, 0.254, 220, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
908, 5l5jH, 0.8665, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
909, 5cz4H, 0.8665, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
910, 5bouH, 0.8665, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
911, 4z1lV, 0.8665, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
912, 4z1lH, 0.8665, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
913, 4y8mV, 0.8665, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
914, 4y8mH, 0.8665, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
915, 4qz7V, 0.8665, 1.31, 0.280, 226, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
916, 4qz7H, 0.8665, 1.31, 0.280, 226, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
917, 4qw3V, 0.8665, 1.31, 0.280, 226, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
918, 4qw3H, 0.8665, 1.31, 0.280, 226, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
919, 4inuV, 0.8665, 1.31, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
920, 3unbx, 0.8665, 1.31, 0.280, 222, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
921, 3hfaL, 0.8665, 1.31, 0.280, 226, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
922, 5lzpR, 0.8664, 1.31, 0.280, 226, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
923, 5lttV, 0.8664, 1.31, 0.280, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
924, 5lf7V, 0.8664, 1.32, 0.254, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
925, 5l68V, 0.8664, 2.35, 0.234, 222, 205, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
926, 5l68H, 0.8664, 2.40, 0.223, 223, 206, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
927, 5l61V, 0.8664, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
928, 5d0xV, 0.8664, 1.32, 0.254, 220, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
929, 5d0xH, 0.8664, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
930, 5bouV, 0.8664, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
931, 4zzgW, 0.8664, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
932, 3mi0N, 0.8664, 1.31, 0.280, 226, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
933, 3hfaP, 0.8664, 1.31, 0.280, 226, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
934, 5trrb, 0.8663, 1.31, 0.280, 226, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
935, 5m2bV, 0.8663, 1.30, 0.280, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
936, 5m2bH, 0.8663, 2.36, 0.234, 222, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
937, 5lf4H, 0.8663, 2.35, 0.234, 222, 205, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
938, 5leyV, 0.8663, 2.40, 0.233, 223, 206, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
939, 5l63V, 0.8663, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
940, 5l60V, 0.8663, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
941, 5l60H, 0.8663, 1.33, 0.254, 220, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
942, 4hnpV, 0.8663, 1.32, 0.254, 220, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
943, 3hfaG, 0.8663, 1.32, 0.280, 226, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
944, 3hfaC, 0.8663, 1.31, 0.280, 226, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
945, 3hfa2, 0.8663, 1.31, 0.280, 226, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
946, 3e47V, 0.8663, 1.32, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
947, 3e47H, 0.8663, 2.35, 0.234, 222, 205, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
948, 5laiV, 0.8662, 2.35, 0.234, 222, 205, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
949, 5laiH, 0.8662, 2.35, 0.234, 222, 205, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
950, 5l63H, 0.8662, 1.31, 0.280, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
951, 5l5sH, 0.8662, 1.31, 0.280, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
952, 5l5rV, 0.8662, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
953, 5l5rH, 0.8662, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
954, 5l5iV, 0.8662, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
955, 5l5iH, 0.8662, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
956, 5l5hV, 0.8662, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
957, 5l5hH, 0.8662, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
958, 5fg9V, 0.8662, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
959, 5fg9H, 0.8662, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
960, 4r17H, 0.8662, 1.31, 0.280, 226, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
961, 4r00H, 0.8662, 1.31, 0.280, 226, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
962, 4qvvV, 0.8662, 1.31, 0.280, 230, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
963, 4qvvH, 0.8662, 1.31, 0.280, 230, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
964, 4inrV, 0.8662, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
965, 3hfaJ, 0.8662, 1.31, 0.280, 226, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
966, 3dy4V, 0.8662, 1.31, 0.280, 226, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
967, 5ts0W, 0.8661, 1.31, 0.280, 226, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
968, 5thoL, 0.8661, 1.31, 0.280, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
969, 5l5sV, 0.8661, 2.35, 0.234, 222, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
970, 5cghH, 0.8661, 1.31, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
971, 4rurV, 0.8661, 2.38, 0.233, 223, 206, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
972, 4rurH, 0.8661, 2.38, 0.233, 223, 206, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
973, 4r17V, 0.8661, 1.31, 0.280, 226, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
974, 4r00V, 0.8661, 1.31, 0.280, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
975, 4qzzV, 0.8661, 1.31, 0.280, 226, 193, YCP IN COMPLEX WITH OMURALIDE
976, 4qzzH, 0.8661, 1.31, 0.280, 226, 193, YCP IN COMPLEX WITH OMURALIDE
977, 4qw0V, 0.8661, 1.32, 0.280, 226, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
978, 4qw0H, 0.8661, 1.31, 0.280, 226, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
979, 4qvmV, 0.8661, 1.32, 0.280, 226, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
980, 4qvmH, 0.8661, 1.32, 0.280, 226, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
981, 4hnpH, 0.8661, 1.32, 0.280, 226, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
982, 4eu2W, 0.8661, 1.32, 0.280, 226, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
983, 3mg8V, 0.8661, 1.32, 0.280, 226, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
984, 3mg7V, 0.8661, 1.32, 0.280, 226, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
985, 3dy4H, 0.8661, 1.31, 0.280, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
986, 1z7qW, 0.8661, 1.31, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
987, 1z7qI, 0.8661, 1.31, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
988, 5lf4V, 0.8660, 1.31, 0.280, 222, 193, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
989, 5lezH, 0.8660, 1.31, 0.280, 222, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
990, 5l5wV, 0.8660, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
991, 5l5wH, 0.8660, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
992, 5l5bV, 0.8660, 1.33, 0.254, 220, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
993, 5l5bH, 0.8660, 1.33, 0.254, 220, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
994, 5l55V, 0.8660, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
995, 5l55H, 0.8660, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
996, 5dkiV, 0.8660, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
997, 5cz7V, 0.8660, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
998, 5cz7H, 0.8660, 1.31, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
999, 5cghV, 0.8660, 1.31, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1000, 4ya1V, 0.8660, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1001, 4ya1H, 0.8660, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1002, 4y6vV, 0.8660, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1003, 4y6vH, 0.8660, 1.31, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1004, 4qzxV, 0.8660, 1.32, 0.280, 226, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1005, 4qzxH, 0.8660, 1.32, 0.280, 226, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1006, 4quxV, 0.8660, 1.32, 0.280, 226, 193, YCP BETA5-A49T-MUTANT
1007, 4quxH, 0.8660, 1.32, 0.280, 226, 193, YCP BETA5-A49T-MUTANT
1008, 4inrH, 0.8660, 1.31, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1009, 5tryb, 0.8659, 1.31, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1010, 5l6bV, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1011, 5l6bH, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1012, 5l66V, 0.8659, 1.31, 0.280, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1013, 5l66H, 0.8659, 2.40, 0.233, 223, 206, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1014, 5l5zV, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1015, 5l5zH, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1016, 5l5fV, 0.8659, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1017, 5l5fH, 0.8659, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1018, 5dkjV, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1019, 5dkjH, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1020, 5dkiH, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1021, 5d0tV, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1022, 5d0tH, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1023, 4ya5H, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1024, 4ya3H, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1025, 4y8nV, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1026, 4y8nH, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1027, 4y7xV, 0.8659, 1.32, 0.285, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1028, 4y7xH, 0.8659, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1029, 4qvqV, 0.8659, 1.32, 0.280, 226, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1030, 4qvqH, 0.8659, 1.32, 0.280, 226, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1031, 4intV, 0.8659, 1.31, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1032, 5ts0L, 0.8658, 1.31, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1033, 5trgW, 0.8658, 1.32, 0.280, 226, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1034, 5lajV, 0.8658, 1.32, 0.280, 226, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1035, 5lajH, 0.8658, 1.32, 0.280, 222, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1036, 5l5dV, 0.8658, 2.39, 0.233, 223, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1037, 5l5dH, 0.8658, 2.38, 0.233, 223, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1038, 5l5aV, 0.8658, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1039, 5fghV, 0.8658, 1.31, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1040, 5fghH, 0.8658, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1041, 5cz6V, 0.8658, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1042, 5cz6H, 0.8658, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1043, 5cz4V, 0.8658, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1044, 5cgfV, 0.8658, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1045, 5cgfH, 0.8658, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1046, 4ya5V, 0.8658, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1047, 4ya3V, 0.8658, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1048, 4qwjV, 0.8658, 1.32, 0.280, 226, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1049, 4qwjH, 0.8658, 1.32, 0.280, 226, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1050, 4qvyV, 0.8658, 1.32, 0.285, 226, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1051, 4intH, 0.8658, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1052, 3sdiH, 0.8658, 1.32, 0.280, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1053, 3ipmM, 0.8658, 1.32, 0.280, 222, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1054, 3ipmK, 0.8658, 1.32, 0.280, 226, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1055, 5trrW, 0.8657, 1.32, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1056, 5trra, 0.8657, 1.31, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1057, 5trgI, 0.8657, 2.32, 0.259, 203, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1058, 5trgb, 0.8657, 2.32, 0.259, 203, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1059, 5trga, 0.8657, 2.40, 0.233, 223, 206, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1060, 5lf6H, 0.8657, 2.41, 0.233, 223, 206, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1061, 5l5aH, 0.8657, 2.35, 0.234, 222, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1062, 5l52V, 0.8657, 2.39, 0.233, 223, 206, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1063, 5l52H, 0.8657, 2.39, 0.233, 223, 206, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1064, 5jhsV, 0.8657, 1.34, 0.254, 220, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1065, 5jhsH, 0.8657, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1066, 4y69V, 0.8657, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1067, 4x6zW, 0.8657, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1068, 4r02H, 0.8657, 1.32, 0.280, 222, 193, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1069, 4qxjV, 0.8657, 1.32, 0.280, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1070, 4qxjH, 0.8657, 1.32, 0.280, 226, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1071, 4qvyH, 0.8657, 1.32, 0.280, 220, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1072, 4jsqV, 0.8657, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1073, 4jsqH, 0.8657, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1074, 3un8V, 0.8657, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1075, 3sdiV, 0.8657, 1.32, 0.280, 226, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1076, 3mi0J, 0.8657, 1.32, 0.280, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
1077, 3ipmN, 0.8657, 1.32, 0.280, 222, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1078, 3ipmL, 0.8657, 1.32, 0.280, 222, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1079, 3ipmJ, 0.8657, 1.32, 0.280, 222, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1080, 3ipmI, 0.8657, 2.36, 0.234, 222, 205, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1081, 3ipmH, 0.8657, 2.32, 0.259, 203, 201, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
1082, 5lezV, 0.8656, 2.32, 0.259, 203, 201, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1083, 5cgiH, 0.8656, 2.32, 0.259, 203, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1084, 4y8kV, 0.8656, 2.32, 0.259, 203, 201, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1085, 4y8kH, 0.8656, 2.32, 0.259, 203, 201, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1086, 4y84V, 0.8656, 1.34, 0.254, 220, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1087, 4qvwV, 0.8656, 1.32, 0.280, 222, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1088, 4qvwH, 0.8656, 1.32, 0.280, 222, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1089, 3oevV, 0.8656, 1.32, 0.280, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1090, 3mi0G, 0.8656, 1.32, 0.280, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
1091, 3mi0C, 0.8656, 1.33, 0.280, 226, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
1092, 1fntW, 0.8656, 1.33, 0.280, 226, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1093, 5vfsI, 0.8655, 1.31, 0.280, 222, 193, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1094, 5lf6V, 0.8655, 2.36, 0.234, 222, 205, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1095, 5l5xV, 0.8655, 2.36, 0.234, 222, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1096, 5l5xH, 0.8655, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1097, 5l5eV, 0.8655, 1.33, 0.254, 220, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1098, 5l5eH, 0.8655, 2.06, 0.210, 204, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1099, 5cgiV, 0.8655, 1.34, 0.254, 220, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1100, 4y84H, 0.8655, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1101, 4y6aV, 0.8655, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1102, 4y6aH, 0.8655, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1103, 4y69H, 0.8655, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1104, 4r02V, 0.8655, 1.32, 0.280, 222, 193, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1105, 4qz2V, 0.8655, 1.32, 0.280, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1106, 4qz2H, 0.8655, 1.32, 0.285, 226, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1107, 4qvpV, 0.8655, 1.32, 0.285, 226, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1108, 4qvpH, 0.8655, 1.32, 0.280, 226, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1109, 4qv7V, 0.8655, 1.32, 0.280, 226, 193, YCP BETA5-A50V MUTANT
1110, 4qv7H, 0.8655, 1.32, 0.280, 222, 193, YCP BETA5-A50V MUTANT
1111, 3oeuV, 0.8655, 1.32, 0.280, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1112, 3mg7H, 0.8655, 1.33, 0.280, 226, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1113, 3mg6H, 0.8655, 1.33, 0.280, 226, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1114, 3mg0H, 0.8655, 1.32, 0.280, 226, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1115, 1fntI, 0.8655, 1.32, 0.280, 226, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1116, 5trya, 0.8654, 1.31, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1117, 5trgK, 0.8654, 1.32, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1118, 5d0wV, 0.8654, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1119, 5d0wH, 0.8654, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1120, 5czaH, 0.8654, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1121, 4y9yV, 0.8654, 2.41, 0.233, 223, 206, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1122, 4y8uH, 0.8654, 2.41, 0.233, 223, 206, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1123, 4x6zI, 0.8654, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1124, 4qz0V, 0.8654, 1.32, 0.280, 226, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1125, 4qz0H, 0.8654, 1.32, 0.280, 226, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1126, 4qwgV, 0.8654, 1.33, 0.280, 226, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1127, 4qwgH, 0.8654, 1.32, 0.285, 226, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1128, 4qv3V, 0.8654, 1.32, 0.280, 221, 193, YCP BETA5-M45V MUTANT
1129, 4qv3H, 0.8654, 1.32, 0.280, 222, 193, YCP BETA5-M45V MUTANT
1130, 4qlvV, 0.8654, 1.32, 0.280, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1131, 4qlvH, 0.8654, 1.32, 0.280, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1132, 3wxrI, 0.8654, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1133, 3unbH, 0.8654, 1.32, 0.280, 226, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1134, 3un8H, 0.8654, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1135, 3mg8H, 0.8654, 1.31, 0.280, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1136, 3d29H, 0.8654, 1.31, 0.280, 222, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
1137, 5t0cGB, 0.8653, 1.33, 0.280, 222, 193, 
1138, 5t0cAA, 0.8653, 1.34, 0.254, 220, 193, 
1139, 5mp9i, 0.8653, 1.32, 0.280, 222, 193, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1140, 5lzpG, 0.8653, 1.32, 0.280, 222, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1141, 5l5yV, 0.8653, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1142, 5l5yH, 0.8653, 1.33, 0.254, 220, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1143, 5gjqb, 0.8653, 1.33, 0.254, 220, 193, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1144, 5fgaV, 0.8653, 1.30, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1145, 5fgaH, 0.8653, 2.37, 0.229, 222, 205, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1146, 5czaV, 0.8653, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1147, 5cggV, 0.8653, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1148, 5cggH, 0.8653, 1.33, 0.254, 220, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1149, 4ya0V, 0.8653, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1150, 4y9yH, 0.8653, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1151, 4y8uV, 0.8653, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1152, 4y8hV, 0.8653, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1153, 4y8hH, 0.8653, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1154, 4y80V, 0.8653, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1155, 4y80H, 0.8653, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1156, 4qzwH, 0.8653, 1.32, 0.285, 226, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1157, 4qwkV, 0.8653, 1.32, 0.280, 222, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1158, 4qwkH, 0.8653, 1.33, 0.280, 222, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1159, 4qvlV, 0.8653, 1.33, 0.280, 222, 193, YCP IN COMPLEX WITH BORTEZOMIB
1160, 4qvlH, 0.8653, 1.33, 0.280, 222, 193, YCP IN COMPLEX WITH BORTEZOMIB
1161, 4eu2I, 0.8653, 1.33, 0.280, 222, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1162, 3mg0V, 0.8653, 1.32, 0.280, 222, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1163, 3hyeV, 0.8653, 1.32, 0.280, 222, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1164, 3hyeH, 0.8653, 1.33, 0.280, 226, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1165, 3gptV, 0.8653, 1.33, 0.280, 226, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1166, 3gptH, 0.8653, 1.32, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1167, 3d29V, 0.8653, 1.33, 0.280, 222, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
1168, 5vfsHA, 0.8652, 1.33, 0.280, 222, 193, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1169, 5trsb, 0.8652, 1.33, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1170, 5trgV, 0.8652, 1.33, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1171, 5thob, 0.8652, 1.33, 0.280, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1172, 5l65V, 0.8652, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1173, 5l65H, 0.8652, 1.33, 0.254, 220, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1174, 5jhrH, 0.8652, 2.40, 0.233, 223, 206, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1175, 4ya0H, 0.8652, 2.40, 0.233, 223, 206, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1176, 4y8rV, 0.8652, 2.40, 0.233, 223, 206, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1177, 4y8rH, 0.8652, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1178, 4qzwV, 0.8652, 1.33, 0.280, 226, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1179, 4qz1V, 0.8652, 1.33, 0.280, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1180, 4qz1H, 0.8652, 1.33, 0.280, 226, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1181, 4qw1V, 0.8652, 1.33, 0.285, 226, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1182, 4qw1H, 0.8652, 1.33, 0.285, 226, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1183, 4qv4V, 0.8652, 1.33, 0.280, 222, 193, YCP BETA5-M45T MUTANT
1184, 4qv4H, 0.8652, 1.33, 0.280, 222, 193, YCP BETA5-M45T MUTANT
1185, 3sdkV, 0.8652, 1.33, 0.280, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1186, 3oevH, 0.8652, 1.33, 0.280, 226, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1187, 3nzwV, 0.8652, 1.33, 0.280, 226, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1188, 3nzwH, 0.8652, 1.32, 0.280, 226, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1189, 3mi0H, 0.8652, 1.32, 0.280, 226, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
1190, 5tryI, 0.8651, 1.32, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1191, 5trrV, 0.8651, 1.32, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1192, 5jhrV, 0.8651, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1193, 4ya4V, 0.8651, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1194, 4ya4H, 0.8651, 2.37, 0.234, 222, 205, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1195, 4y8qV, 0.8651, 2.36, 0.234, 222, 205, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1196, 4y8qH, 0.8651, 2.41, 0.233, 223, 206, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1197, 4y8gV, 0.8651, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1198, 4y8gH, 0.8651, 1.33, 0.285, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1199, 4y82V, 0.8651, 1.33, 0.285, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1200, 4y82H, 0.8651, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1201, 4qv1V, 0.8651, 1.32, 0.280, 222, 193, YCP BETA5-M45A MUTANT
1202, 4qv1H, 0.8651, 1.33, 0.280, 222, 193, YCP BETA5-M45A MUTANT
1203, 3sdkH, 0.8651, 1.33, 0.280, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1204, 5trsa, 0.8650, 1.33, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1205, 5trrI, 0.8650, 1.33, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1206, 5thoa, 0.8650, 1.33, 0.280, 226, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1207, 5fhsV, 0.8650, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1208, 5fhsH, 0.8650, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1209, 5fgiV, 0.8650, 2.42, 0.233, 223, 206, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1210, 4y8lH, 0.8650, 2.35, 0.234, 222, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1211, 4y6zV, 0.8650, 2.41, 0.233, 223, 206, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1212, 4y6zH, 0.8650, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1213, 4qz3V, 0.8650, 1.33, 0.280, 222, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1214, 4qz3H, 0.8650, 1.32, 0.275, 234, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1215, 4qvnH, 0.8650, 1.33, 0.280, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1216, 4qv8V, 0.8650, 1.33, 0.280, 222, 193, YCP BETA5-C52F MUTANT
1217, 4qv8H, 0.8650, 1.33, 0.280, 222, 193, YCP BETA5-C52F MUTANT
1218, 4qv5V, 0.8650, 1.33, 0.280, 222, 193, YCP BETA5-M45I MUTANT
1219, 4qv5H, 0.8650, 1.33, 0.280, 222, 193, YCP BETA5-M45I MUTANT
1220, 4qv0V, 0.8650, 1.34, 0.280, 226, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1221, 4qv0H, 0.8650, 1.32, 0.280, 226, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1222, 4quyV, 0.8650, 1.32, 0.280, 226, 193, YCP BETA5-A49S-MUTANT
1223, 4quyH, 0.8650, 1.33, 0.280, 226, 193, YCP BETA5-A49S-MUTANT
1224, 4no9V, 0.8650, 1.33, 0.280, 226, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1225, 4no9H, 0.8650, 1.33, 0.280, 226, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1226, 3wxrW, 0.8650, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1227, 3oeuH, 0.8650, 1.33, 0.280, 226, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1228, 3mi0P, 0.8650, 1.33, 0.280, 226, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
1229, 6gopV, 0.8649, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1230, 6gopH, 0.8649, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1231, 5trrY, 0.8649, 1.32, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1232, 5thoW, 0.8649, 1.32, 0.280, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1233, 5lzpA, 0.8649, 2.37, 0.234, 222, 205, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1234, 5fgdV, 0.8649, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1235, 5fgdH, 0.8649, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1236, 5cz9V, 0.8649, 2.39, 0.233, 223, 206, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1237, 5cz9H, 0.8649, 2.39, 0.233, 223, 206, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1238, 4y81V, 0.8649, 2.38, 0.229, 222, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1239, 4y81H, 0.8649, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1240, 4y7yV, 0.8649, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1241, 4y7yH, 0.8649, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1242, 4qwxV, 0.8649, 1.33, 0.280, 222, 193, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1243, 4qwxH, 0.8649, 1.33, 0.280, 222, 193, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1244, 4qvnV, 0.8649, 1.33, 0.280, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1245, 5trsW, 0.8648, 1.33, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1246, 5lzpF, 0.8648, 1.33, 0.280, 222, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1247, 5gjqp, 0.8648, 1.33, 0.280, 222, 193, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1248, 5fgeV, 0.8648, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1249, 5fgeH, 0.8648, 1.34, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1250, 5cz5V, 0.8648, 2.40, 0.233, 223, 206, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1251, 5cz5H, 0.8648, 2.38, 0.229, 222, 205, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1252, 4y8lV, 0.8648, 1.33, 0.254, 220, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1253, 4y8iV, 0.8648, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1254, 4qwsV, 0.8648, 1.33, 0.280, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1255, 4qwsH, 0.8648, 1.33, 0.280, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1256, 4qwiV, 0.8648, 1.33, 0.280, 222, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1257, 4qwiH, 0.8648, 1.33, 0.280, 222, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1258, 4qlsV, 0.8648, 1.33, 0.280, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1259, 4qlsH, 0.8648, 1.33, 0.280, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1260, 4qlqV, 0.8648, 1.33, 0.280, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1261, 4qlqH, 0.8648, 1.33, 0.280, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1262, 3bdmV, 0.8648, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1263, 3bdmH, 0.8648, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1264, 2f16V, 0.8648, 1.33, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1265, 2f16H, 0.8648, 1.33, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1266, 5ts0a, 0.8647, 1.33, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1267, 5fg7V, 0.8647, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1268, 5fg7H, 0.8647, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1269, 4y8iH, 0.8647, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1270, 4qv9V, 0.8647, 1.34, 0.280, 222, 193, YCP BETA5-C63F MUTANT
1271, 4qv9H, 0.8647, 2.43, 0.238, 223, 206, YCP BETA5-C63F MUTANT
1272, 4qbyV, 0.8647, 1.33, 0.275, 228, 193, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1273, 4qbyH, 0.8647, 1.33, 0.275, 228, 193, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1274, 3nzjV, 0.8647, 1.33, 0.280, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1275, 3nzjH, 0.8647, 1.33, 0.280, 226, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1276, 2fakV, 0.8647, 1.33, 0.280, 226, 193, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1277, 2fakH, 0.8647, 1.33, 0.280, 226, 193, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1278, 6bgoZ, 0.8646, 1.33, 0.280, 226, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1279, 6bgoY, 0.8646, 1.33, 0.280, 222, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1280, 6bgoX, 0.8646, 1.32, 0.280, 222, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1281, 6bgoW, 0.8646, 1.33, 0.280, 222, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1282, 6bgoV, 0.8646, 1.33, 0.280, 222, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1283, 6bgoU, 0.8646, 2.38, 0.234, 222, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1284, 6bgoT, 0.8646, 2.38, 0.234, 222, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1285, 6bgoS, 0.8646, 2.38, 0.234, 222, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1286, 6bgoR, 0.8646, 2.38, 0.234, 222, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1287, 6bgoQ, 0.8646, 2.38, 0.234, 222, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1288, 6bgoP, 0.8646, 2.38, 0.234, 222, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1289, 6bgoc, 0.8646, 2.38, 0.234, 222, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1290, 6bgob, 0.8646, 2.38, 0.234, 222, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1291, 6bgoa, 0.8646, 2.38, 0.234, 222, 205, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
1292, 6bglZ, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1293, 6bglY, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1294, 6bglX, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1295, 6bglW, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1296, 6bglV, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1297, 6bglU, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1298, 6bglT, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1299, 6bglS, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1300, 6bglR, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1301, 6bglQ, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1302, 6bglP, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1303, 6bglc, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1304, 6bglb, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1305, 6bgla, 0.8646, 2.38, 0.234, 222, 205, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
1306, 5tryW, 0.8646, 2.38, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1307, 5trsI, 0.8646, 2.38, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1308, 5thoM, 0.8646, 2.38, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1309, 5cz5N, 0.8646, 2.38, 0.234, 222, 205, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1310, 4y77V, 0.8646, 2.38, 0.234, 222, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1311, 4y77H, 0.8646, 2.40, 0.233, 223, 206, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1312, 4ltcV, 0.8646, 2.37, 0.234, 222, 205, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1313, 3nzxV, 0.8646, 2.40, 0.233, 223, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1314, 3nzxH, 0.8646, 1.51, 0.260, 206, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1315, 2gplV, 0.8646, 1.34, 0.280, 222, 193, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1316, 2gplH, 0.8646, 1.34, 0.280, 222, 193, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1317, 5ts0b, 0.8645, 1.33, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1318, 5tryY, 0.8645, 1.33, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1319, 5thoV, 0.8645, 1.33, 0.280, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1320, 5lzpL, 0.8645, 1.34, 0.280, 222, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1321, 5lzpE, 0.8645, 1.34, 0.280, 222, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1322, 5l54V, 0.8645, 2.40, 0.233, 223, 206, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1323, 5l54H, 0.8645, 2.40, 0.233, 223, 206, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1324, 5fgiH, 0.8645, 2.41, 0.233, 223, 206, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1325, 4y70V, 0.8645, 2.38, 0.229, 222, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1326, 4y70H, 0.8645, 2.38, 0.224, 222, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1327, 4qz6V, 0.8645, 1.33, 0.280, 222, 193, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1328, 4qz6H, 0.8645, 1.33, 0.280, 222, 193, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1329, 4qwuV, 0.8645, 1.33, 0.275, 234, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1330, 4qwuH, 0.8645, 1.34, 0.280, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1331, 4qluV, 0.8645, 1.34, 0.280, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1332, 4qluH, 0.8645, 1.34, 0.280, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1333, 4jt0V, 0.8645, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1334, 4jt0H, 0.8645, 1.34, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1335, 1g0uH, 0.8645, 1.34, 0.280, 226, 193, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1336, 5trsN, 0.8644, 1.33, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1337, 5trgM, 0.8644, 1.33, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1338, 5lzpK, 0.8644, 1.34, 0.280, 222, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
1339, 5d0sV, 0.8644, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1340, 5d0sH, 0.8644, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1341, 4y78V, 0.8644, 2.39, 0.233, 223, 206, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1342, 4y78H, 0.8644, 2.36, 0.234, 222, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1343, 4qv6V, 0.8644, 2.38, 0.224, 222, 205, YCP BETA5-A49V MUTANT
1344, 4qv6H, 0.8644, 1.34, 0.280, 222, 193, YCP BETA5-A49V MUTANT
1345, 4fzcV, 0.8644, 1.34, 0.280, 222, 193, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1346, 4fzcH, 0.8644, 1.34, 0.280, 222, 193, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1347, 3mg4V, 0.8644, 1.34, 0.280, 222, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1348, 1g0uV, 0.8644, 1.34, 0.280, 226, 193, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1349, 4y8jV, 0.8643, 1.34, 0.280, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1350, 4y8jH, 0.8643, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1351, 4y7wV, 0.8643, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1352, 4y7wH, 0.8643, 1.32, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1353, 4r18V, 0.8643, 1.34, 0.280, 222, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1354, 4r18H, 0.8643, 1.34, 0.280, 222, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1355, 4qz4V, 0.8643, 1.34, 0.280, 222, 193, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1356, 4qz4H, 0.8643, 1.34, 0.280, 222, 193, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1357, 4qwrV, 0.8643, 1.34, 0.280, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1358, 4qwrH, 0.8643, 1.33, 0.280, 226, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1359, 4no1V, 0.8643, 1.33, 0.280, 226, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1360, 4no1H, 0.8643, 1.34, 0.280, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1361, 3unbj, 0.8643, 1.34, 0.280, 222, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1362, 3gpwV, 0.8643, 1.34, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1363, 3gpwH, 0.8643, 1.34, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1364, 5trgX, 0.8642, 1.34, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1365, 5d0zV, 0.8642, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1366, 5d0zH, 0.8642, 1.35, 0.254, 220, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1367, 4y8mN, 0.8642, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1368, 4y8mb, 0.8642, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1369, 4y74V, 0.8642, 2.36, 0.234, 222, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1370, 4y74H, 0.8642, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1371, 4qz5V, 0.8642, 1.34, 0.280, 222, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1372, 4qz5H, 0.8642, 1.52, 0.260, 196, 196, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1373, 4ltcH, 0.8642, 1.52, 0.260, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1374, 4hrcH, 0.8642, 1.34, 0.280, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1375, 4hnpb, 0.8642, 1.34, 0.280, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1376, 3unbV, 0.8642, 1.34, 0.280, 222, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1377, 3gpjV, 0.8642, 1.34, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1378, 5fgfV, 0.8641, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1379, 5fgfH, 0.8641, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1380, 5czaN, 0.8641, 1.52, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1381, 5czab, 0.8641, 1.35, 0.254, 220, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1382, 5bouN, 0.8641, 1.35, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1383, 4y8oH, 0.8641, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1384, 4lqiV, 0.8641, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1385, 4lqiH, 0.8641, 1.52, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1386, 4jsuV, 0.8641, 1.52, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1387, 3mg4H, 0.8641, 1.53, 0.260, 196, 196, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1388, 3gpjH, 0.8641, 1.34, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1389, 5mp92, 0.8640, 1.34, 0.280, 222, 193, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1390, 5l5bN, 0.8640, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1391, 5l5bb, 0.8640, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1392, 5boub, 0.8640, 1.33, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1393, 4ya1N, 0.8640, 1.35, 0.280, 222, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1394, 4ya1b, 0.8640, 1.33, 0.280, 226, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1395, 4y8oV, 0.8640, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1396, 4y6aN, 0.8640, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1397, 4qw4V, 0.8640, 1.53, 0.260, 196, 196, YCP IN COMPLEX WITH CARFILZOMIB
1398, 4qw4H, 0.8640, 1.53, 0.260, 196, 196, YCP IN COMPLEX WITH CARFILZOMIB
1399, 4q1sb, 0.8640, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1400, 4jsuH, 0.8640, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1401, 4hrdN, 0.8640, 1.53, 0.260, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1402, 4hrdH, 0.8640, 1.34, 0.280, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1403, 4g4sI, 0.8640, 1.34, 0.280, 222, 193, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
1404, 3sdkN, 0.8640, 1.53, 0.260, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1405, 3dy3V, 0.8640, 1.34, 0.280, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1406, 3dy3H, 0.8640, 1.52, 0.265, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1407, 5mpai, 0.8639, 1.35, 0.280, 222, 193, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1408, 5l5aN, 0.8639, 1.34, 0.280, 220, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1409, 5l5ab, 0.8639, 1.52, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1410, 5fggV, 0.8639, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1411, 5fggH, 0.8639, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1412, 5fgab, 0.8639, 1.32, 0.280, 226, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1413, 5cz6N, 0.8639, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1414, 5cz6b, 0.8639, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1415, 5cgfN, 0.8639, 1.35, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1416, 5cgfb, 0.8639, 1.35, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1417, 5bxnH, 0.8639, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1418, 4z1lN, 0.8639, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1419, 4z1lb, 0.8639, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1420, 4y6ab, 0.8639, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1421, 4qwlV, 0.8639, 1.53, 0.260, 196, 196, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1422, 4qwlH, 0.8639, 1.74, 0.272, 222, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1423, 4qw7V, 0.8639, 1.53, 0.260, 196, 196, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1424, 4no6V, 0.8639, 1.53, 0.260, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1425, 4no6H, 0.8639, 1.53, 0.260, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1426, 3oeuN, 0.8639, 1.35, 0.280, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1427, 5trsV, 0.8638, 1.35, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1428, 5trrM, 0.8638, 1.35, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1429, 5trgN, 0.8638, 1.35, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1430, 5fgaN, 0.8638, 1.35, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1431, 5fg9N, 0.8638, 1.52, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1432, 5bxlN, 0.8638, 2.42, 0.233, 223, 206, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1433, 5bxlb, 0.8638, 2.37, 0.234, 222, 205, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1434, 4ya4N, 0.8638, 2.41, 0.233, 223, 206, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1435, 4ya4b, 0.8638, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1436, 4y9yN, 0.8638, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1437, 4y9yb, 0.8638, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1438, 4y8pV, 0.8638, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1439, 4y8pH, 0.8638, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1440, 4qzzb, 0.8638, 1.53, 0.260, 196, 196, YCP IN COMPLEX WITH OMURALIDE
1441, 4qw7H, 0.8638, 1.53, 0.260, 196, 196, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1442, 4qw6V, 0.8638, 1.53, 0.260, 196, 196, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1443, 4qw6H, 0.8638, 1.35, 0.280, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1444, 4quxN, 0.8638, 1.35, 0.280, 222, 193, YCP BETA5-A49T-MUTANT
1445, 4quxb, 0.8638, 1.53, 0.260, 196, 196, YCP BETA5-A49T-MUTANT
1446, 4qltV, 0.8638, 1.35, 0.280, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1447, 5thoY, 0.8637, 1.35, 0.280, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1448, 5lajN, 0.8637, 1.35, 0.280, 222, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1449, 5lajb, 0.8637, 1.53, 0.260, 196, 196, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1450, 5l5rb, 0.8637, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1451, 5jhrN, 0.8637, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1452, 5jhrb, 0.8637, 2.40, 0.233, 223, 206, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1453, 5fg9b, 0.8637, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1454, 5d0wN, 0.8637, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1455, 5d0wb, 0.8637, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1456, 4y8uN, 0.8637, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1457, 4y8ub, 0.8637, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1458, 4y6vN, 0.8637, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1459, 4rurN, 0.8637, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1460, 4rurb, 0.8637, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1461, 4qzzN, 0.8637, 1.53, 0.265, 196, 196, YCP IN COMPLEX WITH OMURALIDE
1462, 4qw5V, 0.8637, 1.53, 0.265, 196, 196, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1463, 4qw5H, 0.8637, 1.53, 0.260, 196, 196, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1464, 4qw0N, 0.8637, 1.53, 0.260, 196, 196, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1465, 4qw0b, 0.8637, 1.53, 0.260, 196, 196, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1466, 4qv7N, 0.8637, 1.53, 0.260, 196, 196, YCP BETA5-A50V MUTANT
1467, 4qv7b, 0.8637, 1.35, 0.280, 222, 193, YCP BETA5-A50V MUTANT
1468, 4qltH, 0.8637, 1.35, 0.280, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1469, 4hrdV, 0.8637, 1.53, 0.265, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1470, 3sdk2, 0.8637, 1.53, 0.265, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1471, 3mg62, 0.8637, 1.53, 0.265, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1472, 5laiN, 0.8636, 1.53, 0.265, 196, 196, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1473, 5laib, 0.8636, 1.34, 0.280, 222, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1474, 5l5rN, 0.8636, 1.35, 0.280, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1475, 5l5eN, 0.8636, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1476, 5l5eb, 0.8636, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1477, 5fgeN, 0.8636, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1478, 5fgeb, 0.8636, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1479, 5fg7N, 0.8636, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1480, 5fg7b, 0.8636, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1481, 5cz8V, 0.8636, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1482, 5cz8H, 0.8636, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1483, 5cz4N, 0.8636, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1484, 5cz4b, 0.8636, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1485, 5cghN, 0.8636, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1486, 5cghb, 0.8636, 1.35, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1487, 5ahjV, 0.8636, 1.35, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1488, 5ahjH, 0.8636, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1489, 4y69b, 0.8636, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1490, 4r17N, 0.8636, 1.53, 0.265, 196, 196, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1491, 4r17b, 0.8636, 1.53, 0.265, 196, 196, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1492, 4r00N, 0.8636, 1.35, 0.280, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1493, 4r00b, 0.8636, 1.35, 0.280, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1494, 4qvyN, 0.8636, 1.53, 0.260, 196, 196, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1495, 4qvyb, 0.8636, 1.53, 0.260, 196, 196, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1496, 4qv4N, 0.8636, 1.53, 0.260, 196, 196, YCP BETA5-M45T MUTANT
1497, 4qv4b, 0.8636, 1.53, 0.265, 196, 196, YCP BETA5-M45T MUTANT
1498, 4qv3N, 0.8636, 1.53, 0.265, 196, 196, YCP BETA5-M45V MUTANT
1499, 4qv3b, 0.8636, 1.53, 0.260, 196, 196, YCP BETA5-M45V MUTANT
1500, 4no8V, 0.8636, 1.53, 0.260, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1501, 4no8H, 0.8636, 1.53, 0.260, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1502, 4hrdb, 0.8636, 1.53, 0.260, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1503, 4hrcV, 0.8636, 1.53, 0.265, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1504, 4hnpN, 0.8636, 1.53, 0.265, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1505, 3un4V, 0.8636, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1506, 3un4H, 0.8636, 1.34, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1507, 2zcyV, 0.8636, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1508, 2gplN, 0.8636, 1.36, 0.280, 222, 193, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1509, 2gpl2, 0.8636, 1.53, 0.260, 196, 196, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1510, 1rypI, 0.8636, 1.35, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1511, 1g65V, 0.8636, 1.35, 0.280, 222, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1512, 5ts0V, 0.8635, 1.36, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1513, 5ts0I, 0.8635, 1.53, 0.260, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1514, 5trsK, 0.8635, 1.53, 0.260, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1515, 5m2bN, 0.8635, 1.35, 0.280, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1516, 5m2bb, 0.8635, 1.36, 0.280, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1517, 5l5oN, 0.8635, 2.41, 0.233, 223, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1518, 5l5ob, 0.8635, 2.37, 0.234, 222, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1519, 5cz9N, 0.8635, 2.44, 0.233, 223, 206, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1520, 4ya5N, 0.8635, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1521, 4ya5b, 0.8635, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1522, 4y9zV, 0.8635, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1523, 4y9zH, 0.8635, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1524, 4y8rN, 0.8635, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1525, 4y8rb, 0.8635, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1526, 4y75V, 0.8635, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1527, 4y6vb, 0.8635, 1.35, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1528, 4qvvN, 0.8635, 1.35, 0.280, 222, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1529, 4qvvb, 0.8635, 1.53, 0.260, 196, 196, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1530, 4qv8N, 0.8635, 1.53, 0.260, 196, 196, YCP BETA5-C52F MUTANT
1531, 4qv8b, 0.8635, 1.35, 0.280, 222, 193, YCP BETA5-C52F MUTANT
1532, 4qv5b, 0.8635, 1.53, 0.260, 196, 196, YCP BETA5-M45I MUTANT
1533, 4qv1N, 0.8635, 1.53, 0.265, 196, 196, YCP BETA5-M45A MUTANT
1534, 4qv1b, 0.8635, 1.53, 0.265, 196, 196, YCP BETA5-M45A MUTANT
1535, 2zcyH, 0.8635, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1536, 5trsZ, 0.8634, 1.53, 0.265, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1537, 5trrZ, 0.8634, 1.53, 0.265, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1538, 5trgH, 0.8634, 1.54, 0.260, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1539, 5lttb, 0.8634, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1540, 5fgfN, 0.8634, 1.36, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1541, 5fgdN, 0.8634, 2.36, 0.234, 222, 205, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1542, 5cz9b, 0.8634, 2.36, 0.234, 222, 205, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1543, 5cggN, 0.8634, 2.37, 0.234, 222, 205, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1544, 5cggb, 0.8634, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1545, 4ya2V, 0.8634, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1546, 4ya2H, 0.8634, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1547, 4y75H, 0.8634, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1548, 4y69N, 0.8634, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1549, 4qwfV, 0.8634, 1.53, 0.265, 196, 196, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1550, 4qwfH, 0.8634, 1.35, 0.280, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1551, 4qw3N, 0.8634, 1.35, 0.280, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1552, 4qw3b, 0.8634, 1.35, 0.280, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1553, 4qv5N, 0.8634, 1.53, 0.260, 196, 196, YCP BETA5-M45I MUTANT
1554, 4quyN, 0.8634, 1.35, 0.280, 222, 193, YCP BETA5-A49S-MUTANT
1555, 4quyb, 0.8634, 1.35, 0.280, 222, 193, YCP BETA5-A49S-MUTANT
1556, 4no9N, 0.8634, 1.53, 0.265, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1557, 4no9b, 0.8634, 1.53, 0.265, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1558, 4nnnH, 0.8634, 1.53, 0.265, 196, 196, YCP IN COMPLEX WITH MG132
1559, 4eu2V, 0.8634, 1.53, 0.260, 196, 196, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1560, 3shjV, 0.8634, 1.53, 0.260, 196, 196, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1561, 3oevN, 0.8634, 1.53, 0.265, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1562, 3mg72, 0.8634, 1.53, 0.265, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1563, 1g65H, 0.8634, 1.35, 0.280, 222, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1564, 5ts0H, 0.8633, 1.53, 0.265, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1565, 5thoI, 0.8633, 1.35, 0.280, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1566, 5lttN, 0.8633, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1567, 5l6cN, 0.8633, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1568, 5l6cb, 0.8633, 1.36, 0.280, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1569, 5l6aN, 0.8633, 2.37, 0.234, 222, 205, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1570, 5l6ab, 0.8633, 2.38, 0.234, 222, 205, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1571, 5l67b, 0.8633, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1572, 5l65N, 0.8633, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1573, 5l64N, 0.8633, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1574, 5l64b, 0.8633, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1575, 5l5pN, 0.8633, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1576, 5l5pb, 0.8633, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1577, 5l55N, 0.8633, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1578, 5l55b, 0.8633, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1579, 5jhsN, 0.8633, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1580, 5jhsb, 0.8633, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1581, 5fhsN, 0.8633, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1582, 5fhsb, 0.8633, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1583, 5fgfb, 0.8633, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1584, 5fgdb, 0.8633, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1585, 5cz7N, 0.8633, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1586, 5cz7b, 0.8633, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1587, 5bxnV, 0.8633, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1588, 4ya7V, 0.8633, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1589, 4ya7H, 0.8633, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1590, 4y8nN, 0.8633, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1591, 4y7xN, 0.8633, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1592, 4y7xb, 0.8633, 1.53, 0.273, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1593, 4r18N, 0.8633, 1.36, 0.285, 222, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1594, 4r18b, 0.8633, 1.36, 0.285, 222, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1595, 4qwsN, 0.8633, 1.53, 0.260, 196, 196, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1596, 4qwsb, 0.8633, 1.53, 0.265, 196, 196, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1597, 4qvmN, 0.8633, 1.54, 0.265, 196, 196, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1598, 4qv9N, 0.8633, 1.54, 0.260, 196, 196, YCP BETA5-C63F MUTANT
1599, 4qv9b, 0.8633, 1.54, 0.260, 196, 196, YCP BETA5-C63F MUTANT
1600, 4nnnV, 0.8633, 1.53, 0.265, 196, 196, YCP IN COMPLEX WITH MG132
1601, 3shjH, 0.8633, 1.53, 0.265, 196, 196, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1602, 3oev2, 0.8633, 1.53, 0.265, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1603, 5trsH, 0.8632, 1.54, 0.260, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1604, 5l67N, 0.8632, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1605, 5l65b, 0.8632, 1.36, 0.280, 222, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1606, 5l63N, 0.8632, 1.35, 0.280, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1607, 5l63b, 0.8632, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1608, 5l5vN, 0.8632, 2.38, 0.234, 222, 205,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1609, 5l5vb, 0.8632, 1.54, 0.260, 196, 196,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1610, 5l5tN, 0.8632, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1611, 5l5tb, 0.8632, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1612, 5l5fN, 0.8632, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1613, 5l5fb, 0.8632, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1614, 5l5dN, 0.8632, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1615, 5l5db, 0.8632, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1616, 5fghN, 0.8632, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1617, 5fghb, 0.8632, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1618, 5d0zb, 0.8632, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1619, 4ya3b, 0.8632, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1620, 4y8sH, 0.8632, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1621, 4y8kb, 0.8632, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1622, 4qvwN, 0.8632, 1.54, 0.265, 196, 196, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1623, 4qvwb, 0.8632, 1.53, 0.265, 196, 196, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1624, 4qvpN, 0.8632, 1.54, 0.260, 196, 196, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1625, 4qvpb, 0.8632, 1.36, 0.285, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1626, 4qvmb, 0.8632, 1.53, 0.265, 196, 196, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1627, 4qv0N, 0.8632, 1.53, 0.265, 196, 196, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1628, 4qv0b, 0.8632, 1.53, 0.265, 196, 196, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1629, 4no1N, 0.8632, 1.53, 0.265, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1630, 4no1b, 0.8632, 1.53, 0.265, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1631, 4ltcb, 0.8632, 1.53, 0.265, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1632, 4fzgV, 0.8632, 1.53, 0.265, 196, 196, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1633, 4fzgH, 0.8632, 1.53, 0.265, 196, 196, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1634, 3sdi2, 0.8632, 1.54, 0.265, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1635, 3okjV, 0.8632, 1.54, 0.265, 196, 196, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1636, 3okjH, 0.8632, 1.54, 0.260, 196, 196, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1637, 3krdT, 0.8632, 1.36, 0.280, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1638, 1rypW, 0.8632, 1.36, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1639, 5l62N, 0.8631, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1640, 5l62b, 0.8631, 1.35, 0.280, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1641, 5l5wN, 0.8631, 1.36, 0.280, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1642, 5l5wb, 0.8631, 2.37, 0.229, 222, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1643, 5l5iN, 0.8631, 1.36, 0.280, 222, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1644, 5l5ib, 0.8631, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1645, 5l5hN, 0.8631, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1646, 5l5hb, 0.8631, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1647, 5d0zN, 0.8631, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1648, 5d0xN, 0.8631, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1649, 5d0xb, 0.8631, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1650, 5d0vV, 0.8631, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1651, 5d0vH, 0.8631, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1652, 5d0tN, 0.8631, 1.53, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1653, 5d0tb, 0.8631, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1654, 4ya3N, 0.8631, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1655, 4y8sV, 0.8631, 1.36, 0.280, 222, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1656, 4y8nb, 0.8631, 1.36, 0.280, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1657, 4qwjb, 0.8631, 1.54, 0.265, 196, 196, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1658, 4q1sN, 0.8631, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1659, 4lqib, 0.8631, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1660, 3mg82, 0.8631, 1.36, 0.285, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1661, 3krdL, 0.8631, 1.54, 0.260, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1662, 3krdE, 0.8631, 1.53, 0.265, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1663, 5trrN, 0.8630, 1.54, 0.260, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1664, 5l60N, 0.8630, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1665, 5l60b, 0.8630, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1666, 5l5uN, 0.8630, 2.37, 0.234, 222, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1667, 5l5qN, 0.8630, 2.36, 0.234, 222, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1668, 5l5qb, 0.8630, 2.41, 0.233, 223, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1669, 5fggN, 0.8630, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1670, 5fggb, 0.8630, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1671, 5cz5b, 0.8630, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1672, 4y8tV, 0.8630, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1673, 4y8tH, 0.8630, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1674, 4y80N, 0.8630, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1675, 4y80b, 0.8630, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1676, 4y70N, 0.8630, 1.53, 0.260, 206, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1677, 4y70b, 0.8630, 1.36, 0.285, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1678, 4x6zH, 0.8630, 1.36, 0.285, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1679, 4qwkN, 0.8630, 1.54, 0.265, 196, 196, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1680, 4qwkb, 0.8630, 1.54, 0.265, 196, 196, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1681, 4qwjN, 0.8630, 1.54, 0.265, 196, 196, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1682, 4qwiN, 0.8630, 1.54, 0.265, 196, 196, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1683, 4qw7N, 0.8630, 1.54, 0.260, 196, 196, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1684, 4qw7b, 0.8630, 1.54, 0.265, 196, 196, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1685, 4lqiN, 0.8630, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1686, 3sdiN, 0.8630, 1.53, 0.265, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1687, 5trrK, 0.8629, 1.54, 0.265, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1688, 5thoK, 0.8629, 1.54, 0.265, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1689, 5l6bN, 0.8629, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1690, 5l6bb, 0.8629, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1691, 5l68N, 0.8629, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1692, 5l68b, 0.8629, 2.44, 0.233, 223, 206, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1693, 5l66N, 0.8629, 2.43, 0.233, 223, 206, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1694, 5l66b, 0.8629, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1695, 5l5zN, 0.8629, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1696, 5l5zb, 0.8629, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1697, 5l5yN, 0.8629, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1698, 5l5yb, 0.8629, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1699, 5l5ub, 0.8629, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1700, 5l5sN, 0.8629, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1701, 5l5sb, 0.8629, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1702, 5l5jN, 0.8629, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1703, 5l5jb, 0.8629, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1704, 5dkjN, 0.8629, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1705, 5dkjb, 0.8629, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1706, 5d0sN, 0.8629, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1707, 5d0sb, 0.8629, 1.55, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1708, 4y8kN, 0.8629, 1.55, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1709, 4y7yN, 0.8629, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1710, 4y7yb, 0.8629, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1711, 4qwib, 0.8629, 1.54, 0.265, 196, 196, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1712, 4qwgN, 0.8629, 1.54, 0.265, 196, 196, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1713, 4qwgb, 0.8629, 1.54, 0.265, 196, 196, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1714, 4qw6N, 0.8629, 1.54, 0.265, 196, 196, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1715, 4qw6b, 0.8629, 1.54, 0.265, 196, 196, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1716, 4qvqN, 0.8629, 1.54, 0.265, 196, 196, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1717, 4qvqb, 0.8629, 1.54, 0.265, 196, 196, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1718, 4qvnN, 0.8629, 1.54, 0.265, 196, 196, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1719, 4qvnb, 0.8629, 1.54, 0.265, 196, 196, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1720, 4qvlN, 0.8629, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH BORTEZOMIB
1721, 4qvlb, 0.8629, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH BORTEZOMIB
1722, 4qlsb, 0.8629, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1723, 4j70b, 0.8629, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1724, 3mg8N, 0.8629, 1.54, 0.265, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1725, 3mg7N, 0.8629, 1.54, 0.265, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1726, 3mg6N, 0.8629, 1.54, 0.265, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1727, 5bxnN, 0.8628, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1728, 5bxnb, 0.8628, 1.55, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1729, 5ahjN, 0.8628, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1730, 5ahjb, 0.8628, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1731, 4y78b, 0.8628, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1732, 4y74N, 0.8628, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1733, 4y6zb, 0.8628, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1734, 4x6zV, 0.8628, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1735, 4qwrN, 0.8628, 1.54, 0.265, 196, 196, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1736, 4qwrb, 0.8628, 1.54, 0.265, 196, 196, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1737, 4qw1N, 0.8628, 1.54, 0.265, 196, 196, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1738, 4qw1b, 0.8628, 1.54, 0.265, 196, 196, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1739, 4qlsN, 0.8628, 1.55, 0.260, 196, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1740, 4ltcN, 0.8628, 1.54, 0.265, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1741, 3krdN, 0.8628, 1.54, 0.265, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1742, 3krdJ, 0.8628, 1.54, 0.265, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1743, 1z7qV, 0.8628, 1.54, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1744, 1z7qH, 0.8628, 1.54, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1745, 6gopN, 0.8627, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1746, 5thoZ, 0.8627, 2.38, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1747, 5l69N, 0.8627, 2.38, 0.234, 222, 205, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1748, 5l69b, 0.8627, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1749, 5l61N, 0.8627, 1.53, 0.260, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1750, 5l61b, 0.8627, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1751, 5l54N, 0.8627, 2.37, 0.234, 222, 205, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1752, 5d0vN, 0.8627, 1.55, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1753, 5d0vb, 0.8627, 1.55, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1754, 4ya9V, 0.8627, 1.55, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1755, 4ya9H, 0.8627, 1.55, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1756, 4y7wN, 0.8627, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1757, 4y7wb, 0.8627, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1758, 4y74b, 0.8627, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1759, 4qwfN, 0.8627, 1.37, 0.285, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1760, 4qwfb, 0.8627, 1.37, 0.285, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1761, 4qw5N, 0.8627, 1.54, 0.265, 196, 196, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1762, 4qw5b, 0.8627, 1.54, 0.265, 196, 196, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1763, 4qlvN, 0.8627, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1764, 4qlvb, 0.8627, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1765, 4nnnN, 0.8627, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH MG132
1766, 4nnnb, 0.8627, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH MG132
1767, 3krd2, 0.8627, 1.54, 0.265, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1768, 6gopb, 0.8626, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1769, 5ts0N, 0.8626, 1.54, 0.265, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1770, 5ts0K, 0.8626, 1.54, 0.265, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1771, 5tryV, 0.8626, 1.54, 0.265, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1772, 5trsM, 0.8626, 2.37, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1773, 5l5xN, 0.8626, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1774, 5l5xb, 0.8626, 2.41, 0.233, 223, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1775, 5l54b, 0.8626, 2.44, 0.233, 223, 206, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1776, 4ya9N, 0.8626, 2.43, 0.233, 223, 206, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1777, 4ya9b, 0.8626, 2.39, 0.234, 222, 205, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1778, 4ya0N, 0.8626, 1.55, 0.260, 196, 196, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1779, 4y78N, 0.8626, 1.55, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1780, 4r02N, 0.8626, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1781, 4qwlN, 0.8626, 1.54, 0.265, 196, 196, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1782, 4qwlb, 0.8626, 1.54, 0.265, 196, 196, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1783, 4qw4N, 0.8626, 1.54, 0.260, 196, 196, YCP IN COMPLEX WITH CARFILZOMIB
1784, 4qw4b, 0.8626, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH CARFILZOMIB
1785, 4qv6N, 0.8626, 1.55, 0.265, 196, 196, YCP BETA5-A49V MUTANT
1786, 4qv6b, 0.8626, 1.54, 0.265, 196, 196, YCP BETA5-A49V MUTANT
1787, 4hrcN, 0.8626, 1.54, 0.265, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1788, 4fzgN, 0.8626, 1.54, 0.265, 196, 196, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1789, 4eu2H, 0.8626, 1.54, 0.265, 196, 196, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1790, 3tddN, 0.8626, 1.55, 0.260, 196, 196, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1791, 3tdd2, 0.8626, 1.55, 0.260, 196, 196, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1792, 3oeu2, 0.8626, 1.55, 0.260, 196, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1793, 3nzx2, 0.8626, 1.55, 0.260, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1794, 5trrX, 0.8625, 1.53, 0.265, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1795, 5trrH, 0.8625, 1.54, 0.265, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1796, 5t0gO, 0.8625, 1.54, 0.265, 196, 196, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1797, 5cz8N, 0.8625, 1.54, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1798, 5cz8b, 0.8625, 1.55, 0.260, 196, 196, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1799, 4ya7N, 0.8625, 2.38, 0.234, 222, 205, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1800, 4ya7b, 0.8625, 2.38, 0.234, 222, 205, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1801, 4ya0b, 0.8625, 1.37, 0.254, 220, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1802, 4y8jN, 0.8625, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1803, 4y77N, 0.8625, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1804, 4y6zN, 0.8625, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1805, 4r02b, 0.8625, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1806, 4qluN, 0.8625, 1.54, 0.260, 196, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1807, 4qlub, 0.8625, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1808, 4j70N, 0.8625, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1809, 4fzgb, 0.8625, 1.55, 0.265, 196, 196, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1810, 3un8b, 0.8625, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1811, 3nzxN, 0.8625, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1812, 3nzwN, 0.8625, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1813, 3nzw2, 0.8625, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1814, 3mkaV, 0.8625, 1.55, 0.260, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
1815, 5tryK, 0.8624, 1.55, 0.260, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1816, 5trrJ, 0.8624, 1.55, 0.260, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
1817, 5dkib, 0.8624, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1818, 5cgib, 0.8624, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1819, 4y8tN, 0.8624, 2.42, 0.228, 249, 206, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1820, 4y8tb, 0.8624, 2.45, 0.233, 223, 206, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1821, 4y8sN, 0.8624, 2.39, 0.234, 222, 205, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1822, 4y8sb, 0.8624, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1823, 4y75b, 0.8624, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1824, 4qzxN, 0.8624, 1.55, 0.265, 196, 196, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1825, 4qzxb, 0.8624, 1.55, 0.265, 196, 196, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1826, 4qltN, 0.8624, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1827, 4qltb, 0.8624, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1828, 4qlqN, 0.8624, 1.55, 0.265, 196, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1829, 4qlqb, 0.8624, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1830, 4no8b, 0.8624, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1831, 3un8N, 0.8624, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1832, 3nzjN, 0.8624, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1833, 3nzj2, 0.8624, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1834, 5ts0Y, 0.8623, 1.55, 0.265, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1835, 5tryN, 0.8623, 1.55, 0.265, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1836, 5trgZ, 0.8623, 1.56, 0.260, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1837, 5thoH, 0.8623, 1.55, 0.260, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1838, 5fgiN, 0.8623, 1.55, 0.260, 196, 196, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1839, 5fgib, 0.8623, 2.41, 0.233, 223, 206, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1840, 5cgiN, 0.8623, 2.42, 0.233, 223, 206, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1841, 4y9zb, 0.8623, 2.39, 0.234, 222, 205, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1842, 4y8lb, 0.8623, 2.39, 0.234, 222, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1843, 4qzwN, 0.8623, 1.54, 0.260, 213, 196, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1844, 4qzwb, 0.8623, 1.54, 0.260, 213, 196, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1845, 4qz6N, 0.8623, 1.54, 0.265, 196, 196, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1846, 4qz6b, 0.8623, 1.55, 0.265, 196, 196, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1847, 4qz0N, 0.8623, 1.55, 0.265, 196, 196, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1848, 4qz0b, 0.8623, 1.55, 0.265, 196, 196, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1849, 4qwuN, 0.8623, 1.55, 0.265, 196, 196, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1850, 4qwub, 0.8623, 1.54, 0.265, 196, 196, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1851, 4no8N, 0.8623, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1852, 4jt0N, 0.8623, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1853, 4jt0b, 0.8623, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1854, 3krdC, 0.8623, 1.54, 0.265, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1855, 3e47N, 0.8623, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1856, 3e472, 0.8623, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1857, 5tryZ, 0.8622, 1.55, 0.265, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1858, 5trgJ, 0.8622, 1.55, 0.265, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
1859, 5l52N, 0.8622, 2.39, 0.234, 222, 205, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1860, 5l52b, 0.8622, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1861, 5dkiN, 0.8622, 1.54, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1862, 4y9zN, 0.8622, 2.38, 0.234, 222, 205, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1863, 4y8jb, 0.8622, 2.39, 0.234, 222, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1864, 4y84N, 0.8622, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1865, 4y84b, 0.8622, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1866, 4y82N, 0.8622, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1867, 4y82b, 0.8622, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1868, 4y77b, 0.8622, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1869, 4qz2N, 0.8622, 1.55, 0.265, 196, 196, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1870, 4qz2b, 0.8622, 1.55, 0.265, 196, 196, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1871, 4qwxN, 0.8622, 1.55, 0.265, 196, 196, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1872, 4qwxb, 0.8622, 1.55, 0.265, 196, 196, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1873, 4no6N, 0.8622, 1.55, 0.265, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1874, 4no6b, 0.8622, 1.54, 0.265, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1875, 3hyeN, 0.8622, 1.54, 0.265, 196, 196, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1876, 3hye2, 0.8622, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1877, 3gptN, 0.8622, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1878, 3gpt2, 0.8622, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1879, 4y8lN, 0.8621, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1880, 4y8ib, 0.8621, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1881, 4qz1N, 0.8621, 1.55, 0.265, 196, 196, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1882, 4qz1b, 0.8621, 1.55, 0.265, 196, 196, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1883, 4qxjN, 0.8621, 1.55, 0.265, 196, 196, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1884, 4qxjb, 0.8621, 1.55, 0.265, 196, 196, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1885, 4jsub, 0.8621, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1886, 4hrcb, 0.8621, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1887, 4fzcb, 0.8621, 1.55, 0.265, 196, 196, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1888, 3mkaL, 0.8621, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
1889, 3krdG, 0.8621, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1890, 5tryH, 0.8620, 1.56, 0.260, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1891, 5thoJ, 0.8620, 1.55, 0.260, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1892, 4qz3N, 0.8620, 1.56, 0.260, 196, 196, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1893, 4qz3b, 0.8620, 2.51, 0.227, 251, 207, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1894, 4jsuN, 0.8620, 2.39, 0.234, 222, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1895, 4inrN, 0.8620, 2.39, 0.234, 222, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1896, 4inrb, 0.8620, 2.40, 0.234, 222, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1897, 4fzcN, 0.8620, 1.55, 0.265, 196, 196, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1898, 3mg4N, 0.8620, 1.55, 0.265, 196, 196, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1899, 3mg0N, 0.8620, 1.55, 0.265, 196, 196, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1900, 2f162, 0.8620, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1901, 1jd2O, 0.8620, 1.56, 0.260, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1902, 4y8hN, 0.8619, 1.56, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1903, 4qz7N, 0.8619, 1.55, 0.265, 196, 196, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1904, 4qz7b, 0.8619, 1.55, 0.265, 196, 196, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1905, 4gk7V, 0.8619, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1906, 4gk7H, 0.8619, 1.38, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1907, 3mg02, 0.8619, 1.55, 0.265, 196, 196, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1908, 2f16N, 0.8619, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1909, 1jd2H, 0.8619, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1910, 1g0uN, 0.8619, 1.38, 0.280, 222, 193, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1911, 5ts0M, 0.8618, 1.38, 0.280, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1912, 5tryM, 0.8618, 1.56, 0.265, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1913, 5trsX, 0.8618, 1.55, 0.265, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1914, 4y8qN, 0.8618, 1.38, 0.280, 222, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1915, 4y8pN, 0.8618, 1.56, 0.260, 196, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1916, 4y8pb, 0.8618, 2.40, 0.234, 222, 205, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1917, 4y8iN, 0.8618, 2.39, 0.234, 222, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1918, 4y8gN, 0.8618, 2.40, 0.234, 222, 205, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1919, 4nnwV, 0.8618, 1.55, 0.265, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1920, 4nnwH, 0.8618, 1.55, 0.265, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1921, 3krdZ, 0.8618, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1922, 5thoN, 0.8617, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1923, 4y8qb, 0.8617, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1924, 4y8hb, 0.8617, 1.38, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1925, 4y8gb, 0.8617, 1.38, 0.280, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1926, 4y75N, 0.8617, 2.38, 0.234, 222, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1927, 4qz5N, 0.8617, 2.38, 0.234, 222, 205, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1928, 4qz4N, 0.8617, 1.55, 0.265, 196, 196, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1929, 4qz4b, 0.8617, 1.55, 0.265, 196, 196, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1930, 3krdX, 0.8617, 1.55, 0.265, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1931, 1g0u2, 0.8617, 1.56, 0.265, 196, 196, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1932, 5ts0Z, 0.8616, 1.55, 0.265, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1933, 5ts0J, 0.8616, 1.55, 0.265, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1934, 5tryX, 0.8616, 1.55, 0.265, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
1935, 5trsJ, 0.8616, 2.40, 0.234, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
1936, 5m32H, 0.8616, 1.56, 0.260, 196, 196, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1937, 4ya2N, 0.8616, 2.38, 0.234, 222, 205, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1938, 4ya2b, 0.8616, 2.39, 0.229, 222, 205, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1939, 4y81N, 0.8616, 2.39, 0.234, 222, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1940, 4y81b, 0.8616, 2.40, 0.234, 222, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1941, 4qz5b, 0.8616, 1.38, 0.254, 221, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1942, 4intN, 0.8616, 1.55, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1943, 3shj2, 0.8616, 1.55, 0.265, 196, 196, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1944, 3gpwN, 0.8616, 1.56, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1945, 3gpw2, 0.8616, 1.56, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1946, 5ts0X, 0.8615, 1.55, 0.265, 196, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
1947, 5thoX, 0.8615, 1.57, 0.260, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
1948, 5m32V, 0.8615, 1.57, 0.260, 196, 196, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1949, 4jsqN, 0.8615, 1.56, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1950, 4jsqb, 0.8615, 1.56, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1951, 4gk7N, 0.8615, 2.40, 0.234, 222, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1952, 3shjN, 0.8615, 2.39, 0.234, 222, 205, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1953, 3mg42, 0.8615, 1.38, 0.254, 220, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1954, 1rypH, 0.8615, 1.57, 0.260, 196, 196, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1955, 4y8ob, 0.8614, 1.57, 0.260, 196, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1956, 4intb, 0.8614, 1.56, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1957, 4gk7b, 0.8614, 1.57, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1958, 4zzgH, 0.8613, 1.56, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1959, 4y8oN, 0.8613, 1.56, 0.255, 205, 196, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1960, 4qbyN, 0.8613, 1.56, 0.265, 196, 196, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1961, 4qbyb, 0.8613, 1.57, 0.260, 196, 196, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1962, 4nnwN, 0.8613, 1.56, 0.265, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1963, 4nnwb, 0.8613, 1.56, 0.265, 196, 196, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1964, 4inub, 0.8612, 1.56, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1965, 3krdH, 0.8612, 1.56, 0.265, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1966, 4inuN, 0.8611, 1.56, 0.265, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1967, 3wxrV, 0.8610, 1.56, 0.265, 196, 196, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1968, 3mkaP, 0.8610, 1.56, 0.265, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
1969, 2fakN, 0.8610, 1.57, 0.260, 196, 196, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1970, 2fak2, 0.8610, 2.40, 0.234, 222, 205, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1971, 5nifH, 0.8609, 1.57, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1972, 3mkaE, 0.8609, 1.57, 0.260, 199, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
1973, 3krdP, 0.8609, 2.39, 0.229, 250, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
1974, 1jd2N, 0.8609, 1.57, 0.260, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1975, 3wxrH, 0.8608, 1.57, 0.260, 196, 196, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1976, 1jd2U, 0.8608, 1.57, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1977, 3un4N, 0.8607, 2.42, 0.228, 248, 206, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1978, 3un4b, 0.8607, 2.40, 0.229, 222, 205, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1979, 2fhhH, 0.8607, 1.57, 0.260, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1980, 1rypV, 0.8607, 1.57, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1981, 3mkaR, 0.8606, 1.58, 0.260, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
1982, 2fhhZ, 0.8606, 1.57, 0.260, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1983, 2fhhX, 0.8606, 1.57, 0.260, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1984, 2fhhG, 0.8606, 2.40, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1985, 2fhhR, 0.8605, 1.57, 0.260, 205, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1986, 2fhhC, 0.8605, 2.40, 0.229, 246, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1987, 1g65N, 0.8605, 2.40, 0.229, 222, 205, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1988, 4zzgV, 0.8604, 2.40, 0.229, 222, 205, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1989, 2fhhP, 0.8604, 2.40, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1990, 2fhhN, 0.8604, 2.40, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1991, 3dy4N, 0.8603, 2.40, 0.229, 222, 205, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1992, 3dy42, 0.8603, 1.57, 0.265, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1993, 3dy3N, 0.8603, 1.57, 0.265, 196, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1994, 3dy32, 0.8603, 2.40, 0.229, 222, 205, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1995, 2fhhE, 0.8603, 2.40, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1996, 1g652, 0.8603, 1.59, 0.260, 196, 196, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1997, 5nifV, 0.8602, 1.59, 0.260, 196, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1998, 2fhhT, 0.8602, 1.58, 0.265, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
1999, 2fhhL, 0.8602, 1.58, 0.265, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2000, 5tryJ, 0.8601, 2.41, 0.229, 222, 205, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
2001, 3mkaH, 0.8601, 1.57, 0.265, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2002, 2fhhJ, 0.8601, 1.58, 0.265, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2003, 2fhh2, 0.8601, 2.41, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2004, 2fhgZ, 0.8601, 2.41, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2005, 2fhgX, 0.8601, 2.41, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2006, 3mkaG, 0.8600, 2.39, 0.229, 249, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2007, 2fhhV, 0.8600, 2.41, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
2008, 2fhgP, 0.8600, 2.41, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2009, 4g4sH, 0.8599, 2.42, 0.229, 222, 205, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2010, 3okjN, 0.8599, 2.42, 0.229, 222, 205, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2011, 3bdm1, 0.8599, 2.40, 0.229, 251, 205, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2012, 2fhgV, 0.8599, 2.41, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2013, 2fhgN, 0.8599, 2.42, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2014, 2fhgH, 0.8599, 1.59, 0.260, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2015, 2fhgG, 0.8599, 1.58, 0.265, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2016, 2fhgC, 0.8599, 1.59, 0.260, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2017, 2fhg2, 0.8599, 2.42, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2018, 3mka2, 0.8598, 2.42, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2019, 3bdmN, 0.8598, 2.42, 0.229, 222, 205, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2020, 2fhgL, 0.8598, 2.42, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2021, 2fhgJ, 0.8598, 2.42, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2022, 5bxlV, 0.8597, 2.42, 0.229, 222, 205, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2023, 5bxlH, 0.8597, 2.41, 0.229, 246, 205, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2024, 3mkaT, 0.8597, 1.59, 0.260, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2025, 3gpj2, 0.8597, 2.42, 0.229, 222, 205, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2026, 2fhgR, 0.8597, 2.42, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2027, 2fhgE, 0.8597, 1.57, 0.273, 222, 194, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2028, 3mkaN, 0.8596, 1.57, 0.273, 222, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2029, 3mfeP, 0.8596, 2.41, 0.229, 250, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2030, 3gpjN, 0.8596, 1.58, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2031, 2fhgT, 0.8596, 2.42, 0.229, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
2032, 5mpa2, 0.8594, 2.42, 0.229, 222, 205, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2033, 4v7oV, 0.8594, 2.47, 0.228, 252, 206, 
2034, 5mp9h, 0.8593, 2.40, 0.230, 221, 204, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2035, 4v7oPA, 0.8592, 1.59, 0.265, 196, 196, 
2036, 4v7oDB, 0.8592, 2.42, 0.229, 222, 205, 
2037, 4v7oH, 0.8591, 1.39, 0.280, 226, 193, 
2038, 5vfoo, 0.8590, 1.59, 0.255, 196, 196, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2039, 5vfpGA, 0.8589, 1.58, 0.260, 196, 196, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2040, 2zcy1, 0.8589, 1.59, 0.255, 196, 196, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2041, 2zcyN, 0.8588, 1.59, 0.255, 196, 196, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2042, 3jcpRA, 0.8587, 0.38, 0.991, 212, 212, 
2043, 3jcpD, 0.8587, 1.59, 0.255, 196, 196, 
2044, 3d292, 0.8587, 1.36, 0.255, 220, 192, PROTEASOME INHIBITION BY FELLUTAMIDE B
2045, 3d29N, 0.8586, 1.35, 0.255, 220, 192, PROTEASOME INHIBITION BY FELLUTAMIDE B
2046, 5vfoO, 0.8585, 1.60, 0.265, 196, 196, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2047, 5mp91, 0.8585, 1.60, 0.265, 196, 196, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2048, 3mkaJ, 0.8584, 1.41, 0.280, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2049, 5vfqHA, 0.8583, 1.41, 0.280, 222, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2050, 5mpcI, 0.8583, 1.60, 0.265, 196, 196, 
2051, 3mkaC, 0.8583, 1.60, 0.265, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2052, 5vfqI, 0.8581, 1.37, 0.255, 220, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2053, 5vfpI, 0.8580, 1.60, 0.260, 196, 196, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2054, 1fntV, 0.8580, 2.42, 0.229, 252, 205, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2055, 3mfeH, 0.8579, 1.36, 0.255, 220, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2056, 1fntH, 0.8579, 1.42, 0.280, 226, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2057, 3mfeC, 0.8577, 2.42, 0.229, 250, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2058, 5vfro, 0.8568, 1.37, 0.255, 220, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2059, 3mfeG, 0.8565, 2.05, 0.210, 204, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2060, 3jcpC, 0.8565, 1.37, 0.255, 220, 192, 
2061, 3jcpQA, 0.8563, 2.03, 0.179, 199, 196, 
2062, 5vfrO, 0.8562, 1.61, 0.260, 196, 196, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2063, 5a5b2, 0.8562, 2.39, 0.230, 221, 204, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2064, 4cr32, 0.8562, 1.61, 0.260, 196, 196, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2065, 5mpah, 0.8558, 2.41, 0.230, 221, 204, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2066, 5mpbH, 0.8557, 1.39, 0.255, 220, 192, 
2067, 3mfeV, 0.8557, 2.44, 0.234, 222, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2068, 5ln35, 0.8554, 1.61, 0.265, 205, 196, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
2069, 3okj2, 0.8552, 1.61, 0.265, 205, 196, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2070, 5mpa1, 0.8548, 1.40, 0.255, 220, 192, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2071, 5mpbV, 0.8534, 1.51, 0.280, 223, 193, 
2072, 2h6jK, 0.8531, 1.51, 0.280, 223, 193, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2073, 2h6jM, 0.8530, 1.63, 0.260, 196, 196, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2074, 2h6jJ, 0.8528, 1.62, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2075, 3jcoC, 0.8526, 2.55, 0.232, 224, 207, 
2076, 3jcoQA, 0.8524, 1.70, 0.660, 195, 194, 
2077, 2h6jH, 0.8523, 1.58, 0.267, 195, 195, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2078, 5t0jO, 0.8522, 1.65, 0.260, 196, 196, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2079, 2h6jL, 0.8522, 1.64, 0.265, 196, 196, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2080, 2h6jI, 0.8522, 2.10, 0.255, 242, 200, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2081, 5mpcV, 0.8521, 2.10, 0.255, 242, 200, 
2082, 3mfeT, 0.8521, 2.10, 0.255, 242, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2083, 6avoW, 0.8519, 1.66, 0.265, 205, 196, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2084, 6avoa, 0.8519, 1.66, 0.265, 205, 196, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2085, 2h6jN, 0.8519, 2.21, 0.264, 242, 201, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2086, 4cr42, 0.8518, 1.71, 0.258, 220, 194, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2087, 3jcoRA, 0.8516, 2.22, 0.264, 242, 201, 
2088, 3jcoD, 0.8516, 2.22, 0.264, 242, 201, 
2089, 3mkaZ, 0.8510, 1.69, 0.265, 196, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2090, 3mfe2, 0.8508, 2.43, 0.225, 221, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2091, 3mkaX, 0.8503, 2.06, 0.239, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2092, 3mfeR, 0.8501, 2.06, 0.239, 216, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2093, 3mfeZ, 0.8500, 2.22, 0.264, 242, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2094, 3mfeJ, 0.8500, 1.53, 0.280, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2095, 1q5rM, 0.8500, 1.52, 0.280, 222, 193, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2096, 1q5rI, 0.8500, 1.52, 0.280, 222, 193, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2097, 1q5rH, 0.8500, 2.48, 0.224, 245, 205, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2098, 5m32M, 0.8499, 2.46, 0.230, 221, 204, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2099, 1q5rN, 0.8499, 2.49, 0.224, 249, 205, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2100, 1q5rL, 0.8499, 2.46, 0.230, 221, 204, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2101, 1q5rK, 0.8499, 2.47, 0.230, 221, 204, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2102, 1q5rJ, 0.8499, 2.47, 0.230, 221, 204, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2103, 3mfeN, 0.8497, 2.34, 0.262, 251, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2104, 5fmgZ, 0.8496, 2.34, 0.262, 251, 202, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
2105, 5fmgL, 0.8496, 2.34, 0.262, 251, 202, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
2106, 4cr22, 0.8496, 2.08, 0.239, 216, 201, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2107, 5m32a, 0.8495, 2.34, 0.262, 251, 202, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2108, 3mfeX, 0.8495, 2.34, 0.262, 251, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2109, 3mfeE, 0.8495, 2.34, 0.262, 251, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2110, 5mpcW, 0.8494, 2.34, 0.262, 251, 202, 
2111, 5vfon, 0.8489, 2.46, 0.230, 221, 204, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2112, 5mpcH, 0.8487, 1.28, 0.471, 189, 189, 
2113, 3mfeL, 0.8487, 1.28, 0.471, 189, 189, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
2114, 5vfsN, 0.8486, 1.61, 0.280, 223, 193, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2115, 5l4gK, 0.8484, 2.08, 0.239, 216, 201, 
2116, 5gjqu, 0.8484, 2.47, 0.230, 221, 204, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2117, 5vfuEA, 0.8483, 2.47, 0.230, 221, 204, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2118, 5vftT, 0.8483, 1.55, 0.280, 226, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2119, 5wvkA, 0.8482, 1.40, 0.277, 191, 191, 
2120, 5vfoT, 0.8481, 1.74, 0.265, 196, 196, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2121, 5l4gY, 0.8481, 2.47, 0.230, 221, 204, 
2122, 5vfuSA, 0.8480, 2.13, 0.239, 215, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2123, 5vftt, 0.8480, 2.12, 0.239, 217, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2124, 5vfpN, 0.8479, 2.12, 0.239, 217, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2125, 5gjqg, 0.8479, 1.98, 0.240, 215, 200, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2126, 5vfoN, 0.8477, 1.98, 0.240, 215, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2127, 5vfpFA, 0.8476, 1.73, 0.260, 196, 196, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2128, 5mp9n, 0.8474, 2.14, 0.239, 215, 201, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2129, 5a0qW, 0.8474, 1.98, 0.240, 217, 200, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2130, 5a0qI, 0.8474, 2.13, 0.239, 215, 201, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2131, 5wvkH, 0.8472, 2.13, 0.239, 215, 201, 
2132, 5vfqGA, 0.8471, 2.14, 0.239, 215, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2133, 5gjrTA, 0.8470, 2.12, 0.239, 216, 201, 
2134, 5gjrFA, 0.8469, 1.42, 0.277, 191, 191, 
2135, 5vfsMA, 0.8468, 1.42, 0.277, 191, 191, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2136, 5vfqH, 0.8468, 2.27, 0.182, 232, 203, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2137, 3unfM, 0.8466, 1.53, 0.260, 198, 192, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2138, 3unfa, 0.8466, 1.53, 0.260, 198, 192, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2139, 5vfpLA, 0.8465, 1.77, 0.260, 196, 196, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2140, 5vfot, 0.8464, 1.43, 0.277, 191, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2141, 3unhM, 0.8464, 2.13, 0.239, 217, 201, MOUSE 20S IMMUNOPROTEASOME
2142, 3unha, 0.8464, 2.13, 0.239, 216, 201, MOUSE 20S IMMUNOPROTEASOME
2143, 5le5a, 0.8462, 2.00, 0.240, 215, 200, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2144, 5vfpH, 0.8461, 1.36, 0.255, 220, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2145, 4g4sN, 0.8461, 1.44, 0.277, 191, 191, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2146, 3unea, 0.8459, 2.13, 0.239, 216, 201, MOUSE CONSTITUTIVE 20S PROTEASOME
2147, 5vfuY, 0.8458, 2.13, 0.239, 216, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2148, 5vftN, 0.8458, 2.00, 0.240, 215, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2149, 3sdkM, 0.8458, 2.00, 0.240, 215, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2150, 5mpa7, 0.8457, 2.14, 0.239, 216, 201, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2151, 5lf7a, 0.8457, 2.14, 0.239, 216, 201, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2152, 5le5M, 0.8457, 2.14, 0.239, 216, 201, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2153, 5vfsH, 0.8456, 1.45, 0.277, 191, 191, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2154, 5t0hO, 0.8455, 2.05, 0.210, 204, 195, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2155, 5wvkI, 0.8454, 2.27, 0.182, 233, 203, 
2156, 5lf4a, 0.8454, 2.15, 0.239, 216, 201, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2157, 5lf3a, 0.8454, 1.45, 0.277, 191, 191, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2158, 4r3oN, 0.8454, 1.45, 0.277, 191, 191, HUMAN CONSTITUTIVE 20S PROTEASOME
2159, 4r3o2, 0.8454, 2.29, 0.182, 233, 203, HUMAN CONSTITUTIVE 20S PROTEASOME
2160, 5leya, 0.8453, 2.28, 0.182, 229, 203, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2161, 3sdk1, 0.8453, 2.14, 0.239, 216, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2162, 3mg41, 0.8453, 2.14, 0.239, 216, 201, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2163, 5vfrn, 0.8452, 1.33, 0.254, 220, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2164, 5leyM, 0.8452, 1.45, 0.277, 191, 191, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2165, 5wviFA, 0.8451, 1.80, 0.258, 220, 194, 
2166, 5lf7M, 0.8451, 1.58, 0.280, 223, 193, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2167, 5vfqMA, 0.8450, 2.14, 0.239, 216, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2168, 5lf4M, 0.8450, 2.14, 0.239, 216, 201, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2169, 5fggM, 0.8450, 2.15, 0.239, 217, 201, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2170, 5fgga, 0.8450, 2.15, 0.239, 217, 201, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2171, 4r67p, 0.8450, 2.15, 0.239, 216, 201, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2172, 4r67N, 0.8450, 2.29, 0.182, 233, 203, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2173, 4r67b, 0.8450, 2.28, 0.182, 233, 203, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2174, 4r672, 0.8450, 1.46, 0.277, 191, 191, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2175, 5vfrT, 0.8449, 2.15, 0.239, 216, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2176, 1ryp2, 0.8449, 1.58, 0.280, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2177, 5vfrN, 0.8448, 2.15, 0.239, 216, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2178, 5l5uM, 0.8448, 2.02, 0.240, 215, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2179, 5l5ua, 0.8448, 2.15, 0.239, 216, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2180, 5l5rM, 0.8448, 2.28, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2181, 5l5ra, 0.8448, 2.28, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2182, 4eu22, 0.8448, 2.15, 0.239, 217, 201, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2183, 3une3, 0.8448, 2.15, 0.239, 217, 201, MOUSE CONSTITUTIVE 20S PROTEASOME
2184, 3unb3, 0.8448, 2.15, 0.239, 217, 201, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2185, 3mg61, 0.8448, 2.15, 0.239, 217, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2186, 5lf6M, 0.8447, 2.02, 0.240, 215, 200, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2187, 5lf6a, 0.8447, 2.28, 0.182, 233, 203, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2188, 5lf1a, 0.8447, 1.47, 0.277, 191, 191, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2189, 4qvnM, 0.8447, 2.29, 0.182, 233, 203, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2190, 4qvna, 0.8447, 2.29, 0.182, 233, 203, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2191, 2fakM, 0.8447, 2.29, 0.182, 233, 203, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2192, 2fak1, 0.8447, 2.29, 0.182, 233, 203, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2193, 1rypN, 0.8447, 2.28, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2194, 5vfuMA, 0.8446, 2.16, 0.239, 216, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2195, 5vftn, 0.8446, 2.15, 0.239, 216, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2196, 5lf3M, 0.8446, 2.30, 0.182, 233, 203, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2197, 5bxnM, 0.8446, 2.16, 0.239, 216, 201, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2198, 5bxna, 0.8446, 2.16, 0.239, 216, 201, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2199, 4qwuM, 0.8446, 2.15, 0.239, 216, 201, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2200, 4qwua, 0.8446, 2.29, 0.182, 233, 203, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2201, 3mg71, 0.8446, 2.29, 0.182, 233, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2202, 5lf0a, 0.8445, 2.29, 0.182, 233, 203, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2203, 5l5bM, 0.8445, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2204, 5l5ba, 0.8445, 2.28, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2205, 5ahjM, 0.8445, 1.46, 0.277, 191, 191, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2206, 5ahja, 0.8445, 1.46, 0.277, 191, 191, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2207, 4q1sa, 0.8445, 2.15, 0.239, 216, 201, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2208, 5vfqN, 0.8444, 2.29, 0.182, 233, 203, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2209, 5ln32, 0.8444, 2.29, 0.182, 233, 203, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
2210, 5lf1M, 0.8444, 2.28, 0.182, 233, 203, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2211, 5l5yM, 0.8444, 2.28, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2212, 5l5ya, 0.8444, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2213, 5cggM, 0.8444, 2.15, 0.239, 216, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2214, 5cgga, 0.8444, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2215, 4ya4a, 0.8444, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2216, 4y8ga, 0.8444, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2217, 4qlta, 0.8444, 2.29, 0.182, 233, 203, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2218, 5mpbW, 0.8443, 2.30, 0.182, 233, 203, 
2219, 5l66M, 0.8443, 2.03, 0.240, 215, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2220, 5l66a, 0.8443, 1.81, 0.258, 222, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2221, 5l61M, 0.8443, 2.16, 0.239, 216, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2222, 5l61a, 0.8443, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2223, 4ya4M, 0.8443, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2224, 4y8gM, 0.8443, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2225, 4r18M, 0.8443, 2.29, 0.182, 233, 203, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2226, 4r18a, 0.8443, 2.30, 0.182, 232, 203, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2227, 4qltM, 0.8443, 2.29, 0.182, 233, 203, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2228, 3dy31, 0.8443, 2.28, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2229, 2zcyM, 0.8443, 1.60, 0.280, 226, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2230, 2zcy0, 0.8443, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2231, 5l6aM, 0.8442, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2232, 5l6aa, 0.8442, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2233, 5l65M, 0.8442, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2234, 5l65a, 0.8442, 2.30, 0.182, 229, 203, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2235, 5l63M, 0.8442, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2236, 5l63a, 0.8442, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2237, 5l5tM, 0.8442, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2238, 5l5ta, 0.8442, 2.28, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2239, 5l5sM, 0.8442, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2240, 5l5sa, 0.8442, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2241, 5bxlM, 0.8442, 2.28, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2242, 5bxla, 0.8442, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2243, 4y8ha, 0.8442, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2244, 4qz7M, 0.8442, 2.30, 0.182, 233, 203, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2245, 4qz7a, 0.8442, 2.30, 0.182, 233, 203, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2246, 4qz0M, 0.8442, 2.30, 0.182, 233, 203, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2247, 4qz0a, 0.8442, 2.30, 0.182, 233, 203, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2248, 3mg81, 0.8442, 2.30, 0.182, 233, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2249, 3gpjM, 0.8442, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2250, 3gpj1, 0.8442, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2251, 3dy3M, 0.8442, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2252, 5vfrt, 0.8441, 2.30, 0.182, 229, 203, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2253, 5m2bM, 0.8441, 2.30, 0.182, 232, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2254, 5m2ba, 0.8441, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2255, 5l6ba, 0.8441, 2.30, 0.182, 232, 203, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2256, 5l62M, 0.8441, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2257, 5l62a, 0.8441, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2258, 5l5zM, 0.8441, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2259, 5l5za, 0.8441, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2260, 5l5wM, 0.8441, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2261, 5l5da, 0.8441, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2262, 5l54M, 0.8441, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2263, 5l54a, 0.8441, 2.03, 0.240, 215, 200, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2264, 5jhsM, 0.8441, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2265, 5jhsa, 0.8441, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2266, 5d0sM, 0.8441, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2267, 5d0sa, 0.8441, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2268, 4y8hM, 0.8441, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2269, 4qwfM, 0.8441, 2.29, 0.182, 233, 203, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2270, 4qwfa, 0.8441, 2.29, 0.182, 233, 203, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2271, 4qw6M, 0.8441, 2.30, 0.182, 233, 203, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2272, 4qw6a, 0.8441, 2.31, 0.182, 233, 203, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2273, 3mg7M, 0.8441, 2.29, 0.182, 233, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2274, 1jd2T, 0.8441, 2.29, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2275, 1g0u1, 0.8441, 2.29, 0.182, 233, 203, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2276, 5lf0M, 0.8440, 2.29, 0.182, 233, 203, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2277, 5lezM, 0.8440, 2.29, 0.182, 233, 203, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2278, 5lexM, 0.8440, 2.29, 0.182, 233, 203, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2279, 5lajM, 0.8440, 2.29, 0.182, 233, 203, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2280, 5laja, 0.8440, 2.29, 0.182, 233, 203, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2281, 5l6cM, 0.8440, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2282, 5l6ca, 0.8440, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2283, 5l6bM, 0.8440, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2284, 5l5wa, 0.8440, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2285, 5l5pM, 0.8440, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2286, 5l5pa, 0.8440, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2287, 5l5oa, 0.8440, 2.16, 0.239, 216, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2288, 5l5dM, 0.8440, 2.16, 0.239, 216, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2289, 5l52M, 0.8440, 2.16, 0.239, 216, 201, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2290, 5l52a, 0.8440, 2.30, 0.182, 228, 203, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2291, 5d0wM, 0.8440, 2.30, 0.182, 231, 203, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2292, 5d0wa, 0.8440, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2293, 4r17M, 0.8440, 2.31, 0.182, 233, 203, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2294, 4r17a, 0.8440, 2.31, 0.182, 233, 203, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2295, 4qwlM, 0.8440, 2.30, 0.182, 233, 203, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2296, 4qwla, 0.8440, 2.31, 0.182, 233, 203, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2297, 4qv5M, 0.8440, 2.31, 0.182, 233, 203, YCP BETA5-M45I MUTANT
2298, 4qv5a, 0.8440, 2.31, 0.182, 233, 203, YCP BETA5-M45I MUTANT
2299, 3unba, 0.8440, 2.31, 0.182, 233, 203, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2300, 3oev1, 0.8440, 2.29, 0.182, 225, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2301, 3gpwM, 0.8440, 2.29, 0.182, 225, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2302, 3gpw1, 0.8440, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2303, 5lexa, 0.8439, 2.30, 0.182, 233, 203, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2304, 5l64M, 0.8439, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2305, 5l64a, 0.8439, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2306, 5l5oM, 0.8439, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2307, 5l5jM, 0.8439, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2308, 5l5ja, 0.8439, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2309, 5l5hM, 0.8439, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2310, 5l5ha, 0.8439, 2.16, 0.239, 216, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2311, 5l55M, 0.8439, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2312, 5fgfa, 0.8439, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2313, 5czaM, 0.8439, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2314, 5czaa, 0.8439, 2.16, 0.239, 216, 201, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2315, 5cz9a, 0.8439, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2316, 4qv0M, 0.8439, 2.31, 0.182, 233, 203, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2317, 4qv0a, 0.8439, 2.31, 0.182, 233, 203, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2318, 4quyM, 0.8439, 2.31, 0.182, 233, 203, YCP BETA5-A49S-MUTANT
2319, 4quya, 0.8439, 2.31, 0.182, 233, 203, YCP BETA5-A49S-MUTANT
2320, 4no8M, 0.8439, 2.31, 0.182, 233, 203, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2321, 4fzgM, 0.8439, 2.31, 0.182, 233, 203, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2322, 4fzga, 0.8439, 2.30, 0.182, 228, 203, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2323, 3sdi1, 0.8439, 2.29, 0.182, 233, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2324, 5wviC, 0.8438, 2.31, 0.182, 229, 203, 
2325, 5l67M, 0.8438, 2.31, 0.182, 232, 203, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2326, 5l55a, 0.8438, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2327, 5fhsM, 0.8438, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2328, 5fhsa, 0.8438, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2329, 5fgiM, 0.8438, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2330, 5fgia, 0.8438, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2331, 5fgfM, 0.8438, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2332, 5fgeM, 0.8438, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2333, 5fgea, 0.8438, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2334, 5d0ta, 0.8438, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2335, 5cz9M, 0.8438, 1.59, 0.280, 222, 193, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2336, 5cghM, 0.8438, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2337, 5cgha, 0.8438, 2.30, 0.182, 229, 203, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2338, 5a5b1, 0.8438, 2.30, 0.182, 233, 203, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2339, 4ya9M, 0.8438, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2340, 4ya2M, 0.8438, 2.30, 0.182, 232, 203, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2341, 4ya2a, 0.8438, 2.30, 0.182, 232, 203, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2342, 4qw7a, 0.8438, 2.29, 0.182, 233, 203, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2343, 4qw5M, 0.8438, 2.30, 0.182, 233, 203, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2344, 4qw5a, 0.8438, 2.30, 0.182, 233, 203, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2345, 4qw1M, 0.8438, 2.30, 0.182, 233, 203, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2346, 4qw1a, 0.8438, 2.30, 0.182, 233, 203, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2347, 4qvqM, 0.8438, 2.30, 0.182, 233, 203, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2348, 4qvqa, 0.8438, 2.30, 0.182, 233, 203, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2349, 4qvpM, 0.8438, 1.78, 0.265, 205, 196, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2350, 4qvpa, 0.8438, 2.29, 0.182, 233, 203, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2351, 4qvlM, 0.8438, 2.29, 0.182, 233, 203, YCP IN COMPLEX WITH BORTEZOMIB
2352, 4qvla, 0.8438, 2.29, 0.182, 233, 203, YCP IN COMPLEX WITH BORTEZOMIB
2353, 4qv9M, 0.8438, 2.29, 0.182, 233, 203, YCP BETA5-C63F MUTANT
2354, 4qv9a, 0.8438, 2.29, 0.182, 233, 203, YCP BETA5-C63F MUTANT
2355, 4qv6a, 0.8438, 2.29, 0.182, 233, 203, YCP BETA5-A49V MUTANT
2356, 4no8a, 0.8438, 2.29, 0.182, 233, 203, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2357, 4inta, 0.8438, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2358, 4cr31, 0.8438, 2.30, 0.182, 233, 203, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2359, 3hye1, 0.8438, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2360, 1jd2M, 0.8438, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2361, 6gopa, 0.8437, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2362, 5vfsGA, 0.8437, 2.30, 0.182, 233, 203, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2363, 5l69M, 0.8437, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2364, 5l67a, 0.8437, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2365, 5l60M, 0.8437, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2366, 5l60a, 0.8437, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2367, 5l5vM, 0.8437, 2.29, 0.182, 233, 203,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2368, 5l5va, 0.8437, 2.30, 0.182, 233, 203,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2369, 5l5qM, 0.8437, 1.78, 0.265, 205, 196, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2370, 5l5qa, 0.8437, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2371, 5fgdM, 0.8437, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2372, 5fgda, 0.8437, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2373, 5fgaM, 0.8437, 1.48, 0.277, 191, 191, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2374, 5fgaa, 0.8437, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2375, 5dkjM, 0.8437, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2376, 5dkja, 0.8437, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2377, 5d0tM, 0.8437, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2378, 4ya9a, 0.8437, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2379, 4y84M, 0.8437, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2380, 4y84a, 0.8437, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2381, 4r02M, 0.8437, 2.31, 0.182, 233, 203, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2382, 4qz1M, 0.8437, 2.30, 0.182, 233, 203, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2383, 4qz1a, 0.8437, 2.30, 0.182, 233, 203, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2384, 4qw7M, 0.8437, 2.30, 0.182, 233, 203, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2385, 4qv6M, 0.8437, 2.30, 0.182, 232, 203, YCP BETA5-A49V MUTANT
2386, 4qv3M, 0.8437, 2.30, 0.182, 233, 203, YCP BETA5-M45V MUTANT
2387, 4qv3a, 0.8437, 2.30, 0.182, 233, 203, YCP BETA5-M45V MUTANT
2388, 3wxr2, 0.8437, 2.30, 0.182, 231, 203, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2389, 3uneM, 0.8437, 2.29, 0.182, 233, 203, MOUSE CONSTITUTIVE 20S PROTEASOME
2390, 3mg8M, 0.8437, 2.29, 0.182, 233, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2391, 3mg4M, 0.8437, 2.29, 0.182, 233, 203, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2392, 3hyeM, 0.8437, 2.31, 0.182, 233, 203, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2393, 6gopM, 0.8436, 2.29, 0.182, 231, 203, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2394, 5laia, 0.8436, 2.29, 0.182, 233, 203, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2395, 5l69a, 0.8436, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2396, 5l68M, 0.8436, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2397, 5l68a, 0.8436, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2398, 5l5fa, 0.8436, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2399, 5jhrM, 0.8436, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2400, 5jhra, 0.8436, 2.18, 0.239, 216, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2401, 5d0zM, 0.8436, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2402, 5d0za, 0.8436, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2403, 5d0vM, 0.8436, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2404, 5d0va, 0.8436, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2405, 4y8tM, 0.8436, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2406, 4y8ta, 0.8436, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2407, 4y8rM, 0.8436, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2408, 4y8ra, 0.8436, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2409, 4qv7M, 0.8436, 2.31, 0.182, 233, 203, YCP BETA5-A50V MUTANT
2410, 4qv7a, 0.8436, 2.30, 0.182, 233, 203, YCP BETA5-A50V MUTANT
2411, 4qv4M, 0.8436, 2.30, 0.182, 233, 203, YCP BETA5-M45T MUTANT
2412, 4qv4a, 0.8436, 2.29, 0.182, 233, 203, YCP BETA5-M45T MUTANT
2413, 4qv1M, 0.8436, 2.29, 0.182, 233, 203, YCP BETA5-M45A MUTANT
2414, 4qv1a, 0.8436, 2.29, 0.182, 233, 203, YCP BETA5-M45A MUTANT
2415, 4qluM, 0.8436, 2.29, 0.182, 233, 203, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2416, 4qlua, 0.8436, 2.30, 0.182, 233, 203, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2417, 4qlsM, 0.8436, 2.30, 0.182, 233, 203, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2418, 4qlsa, 0.8436, 2.30, 0.182, 233, 203, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2419, 4eu2N, 0.8436, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2420, 3nzjM, 0.8436, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2421, 3nzj1, 0.8436, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2422, 3bdm0, 0.8436, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2423, 1g0uM, 0.8436, 2.30, 0.182, 233, 203, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2424, 5laiM, 0.8435, 2.30, 0.182, 233, 203, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2425, 5l5xM, 0.8435, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2426, 5l5xa, 0.8435, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2427, 5l5iM, 0.8435, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2428, 5l5ia, 0.8435, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2429, 5l5fM, 0.8435, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2430, 5fg7M, 0.8435, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2431, 5fg7a, 0.8435, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2432, 5cgia, 0.8435, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2433, 5cgfM, 0.8435, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2434, 5cgfa, 0.8435, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2435, 4y75M, 0.8435, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2436, 4y75a, 0.8435, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2437, 4r02a, 0.8435, 2.31, 0.182, 233, 203, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2438, 4qzza, 0.8435, 2.31, 0.182, 233, 203, YCP IN COMPLEX WITH OMURALIDE
2439, 4qz4M, 0.8435, 2.31, 0.182, 233, 203, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2440, 4qz4a, 0.8435, 2.31, 0.182, 233, 203, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2441, 4qw4M, 0.8435, 2.31, 0.182, 233, 203, YCP IN COMPLEX WITH CARFILZOMIB
2442, 4qw4a, 0.8435, 2.31, 0.182, 233, 203, YCP IN COMPLEX WITH CARFILZOMIB
2443, 4ltcM, 0.8435, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2444, 4intM, 0.8435, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2445, 4inra, 0.8435, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2446, 3oeu1, 0.8435, 2.30, 0.182, 224, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2447, 3bdmM, 0.8435, 2.30, 0.182, 224, 203, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2448, 5ltta, 0.8434, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2449, 5leza, 0.8434, 2.31, 0.182, 233, 203, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2450, 5cz7M, 0.8434, 2.29, 0.182, 225, 203, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2451, 5cz7a, 0.8434, 2.29, 0.182, 225, 203, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2452, 5cgiM, 0.8434, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2453, 4y8kM, 0.8434, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2454, 4y8ka, 0.8434, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2455, 4qzzM, 0.8434, 2.31, 0.182, 233, 203, YCP IN COMPLEX WITH OMURALIDE
2456, 4qvwM, 0.8434, 2.30, 0.182, 233, 203, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2457, 4qvwa, 0.8434, 2.32, 0.182, 233, 203, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2458, 4qvmM, 0.8434, 2.31, 0.182, 233, 203, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2459, 4qvma, 0.8434, 2.31, 0.182, 233, 203, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2460, 4qlva, 0.8434, 2.17, 0.239, 216, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2461, 4q1sM, 0.8434, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2462, 4no6M, 0.8434, 2.31, 0.182, 233, 203, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2463, 4ltca, 0.8434, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2464, 3unbM, 0.8434, 2.30, 0.182, 230, 203, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2465, 3shjM, 0.8434, 2.30, 0.182, 233, 203, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2466, 3shj1, 0.8434, 2.31, 0.182, 233, 203, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2467, 3nzwM, 0.8434, 2.31, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2468, 3nzw1, 0.8434, 2.31, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2469, 3mg01, 0.8434, 2.30, 0.182, 233, 203, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2470, 3e47M, 0.8434, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2471, 3e471, 0.8434, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2472, 3d29M, 0.8434, 2.32, 0.182, 233, 203, PROTEASOME INHIBITION BY FELLUTAMIDE B
2473, 5lttM, 0.8433, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2474, 5cz8a, 0.8433, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2475, 4ya1M, 0.8433, 2.17, 0.239, 216, 201, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2476, 4ya1a, 0.8433, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2477, 4y9yM, 0.8433, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2478, 4y9ya, 0.8433, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2479, 4y77M, 0.8433, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2480, 4x6zN, 0.8433, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2481, 4x6z2, 0.8433, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2482, 4qz6M, 0.8433, 2.31, 0.182, 233, 203, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2483, 4qz6a, 0.8433, 2.29, 0.182, 233, 203, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2484, 4qz2a, 0.8433, 2.31, 0.182, 233, 203, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2485, 4qv8M, 0.8433, 2.29, 0.182, 233, 203, YCP BETA5-C52F MUTANT
2486, 4qv8a, 0.8433, 2.32, 0.182, 233, 203, YCP BETA5-C52F MUTANT
2487, 4qlvM, 0.8433, 2.32, 0.182, 233, 203, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2488, 4no6a, 0.8433, 2.31, 0.182, 233, 203, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2489, 4nnwa, 0.8433, 2.31, 0.182, 233, 203, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2490, 4lqiM, 0.8433, 2.30, 0.182, 224, 203, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2491, 4lqia, 0.8433, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2492, 4inrM, 0.8433, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2493, 3unbo, 0.8433, 2.30, 0.182, 233, 203, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2494, 3okjM, 0.8433, 2.30, 0.182, 233, 203, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2495, 3d291, 0.8433, 2.30, 0.182, 233, 203, PROTEASOME INHIBITION BY FELLUTAMIDE B
2496, 5l5aa, 0.8432, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2497, 5fghM, 0.8432, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2498, 5fgha, 0.8432, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2499, 5cz8M, 0.8432, 2.29, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2500, 5bouM, 0.8432, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2501, 5boua, 0.8432, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2502, 4qz2M, 0.8432, 2.31, 0.182, 233, 203, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2503, 4qwrM, 0.8432, 2.31, 0.182, 233, 203, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2504, 4qwra, 0.8432, 2.18, 0.239, 216, 201, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2505, 4qlqM, 0.8432, 2.30, 0.182, 233, 203, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2506, 4qlqa, 0.8432, 2.29, 0.182, 233, 203, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2507, 4nnwM, 0.8432, 2.31, 0.182, 233, 203, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2508, 3sdiM, 0.8432, 2.30, 0.182, 233, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2509, 3oevM, 0.8432, 2.30, 0.182, 233, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2510, 3gptM, 0.8432, 2.29, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2511, 3gpt1, 0.8432, 2.32, 0.182, 229, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2512, 2f16M, 0.8432, 2.32, 0.182, 232, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2513, 2f161, 0.8432, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2514, 5l5eM, 0.8431, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2515, 5l5ea, 0.8431, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2516, 5l5aM, 0.8431, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2517, 5cz6M, 0.8431, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2518, 5cz6a, 0.8431, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2519, 4ya7M, 0.8431, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2520, 4ya7a, 0.8431, 2.33, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2521, 4qvyM, 0.8431, 2.30, 0.182, 233, 203, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2522, 4qvya, 0.8431, 2.30, 0.182, 233, 203, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2523, 4nnna, 0.8431, 2.30, 0.182, 233, 203, YCP IN COMPLEX WITH MG132
2524, 4j70a, 0.8431, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2525, 3wxrN, 0.8431, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2526, 3un4M, 0.8431, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2527, 3un4a, 0.8431, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2528, 3oeuM, 0.8431, 2.32, 0.182, 233, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2529, 3mg6M, 0.8431, 2.32, 0.182, 233, 203, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2530, 5mpan, 0.8430, 2.30, 0.182, 233, 203, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2531, 4y8lM, 0.8430, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2532, 4y8la, 0.8430, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2533, 4r00a, 0.8430, 2.31, 0.182, 233, 203, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2534, 4qz3M, 0.8430, 2.30, 0.182, 233, 203, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2535, 4qz3a, 0.8430, 2.32, 0.182, 233, 203, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2536, 4qwxM, 0.8430, 2.32, 0.182, 233, 203, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2537, 4qwxa, 0.8430, 2.31, 0.182, 233, 203, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2538, 4quxM, 0.8430, 2.31, 0.182, 233, 203, YCP BETA5-A49T-MUTANT
2539, 4quxa, 0.8430, 2.32, 0.182, 233, 203, YCP BETA5-A49T-MUTANT
2540, 4nnnM, 0.8430, 2.33, 0.182, 233, 203, YCP IN COMPLEX WITH MG132
2541, 4hrda, 0.8430, 2.20, 0.183, 232, 202, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2542, 4cr41, 0.8430, 2.30, 0.182, 230, 203, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2543, 3uneo, 0.8430, 2.30, 0.182, 233, 203, MOUSE CONSTITUTIVE 20S PROTEASOME
2544, 3un8M, 0.8430, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2545, 3tddM, 0.8430, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2546, 3tdd1, 0.8430, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2547, 3nzxM, 0.8430, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2548, 3nzx1, 0.8430, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2549, 5mpbI, 0.8429, 2.32, 0.182, 233, 203, 
2550, 5cz5a, 0.8429, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2551, 4y9zM, 0.8429, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2552, 4y9za, 0.8429, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2553, 4r00M, 0.8429, 1.78, 0.260, 205, 196, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2554, 4qz5a, 0.8429, 2.18, 0.239, 216, 201, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2555, 4no1a, 0.8429, 2.31, 0.182, 233, 203, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2556, 4j70M, 0.8429, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2557, 4inua, 0.8429, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2558, 4hnpa, 0.8429, 2.31, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2559, 3un8a, 0.8429, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2560, 3mg0M, 0.8429, 1.82, 0.278, 226, 194, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2561, 3h6fR, 0.8429, 2.31, 0.182, 233, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
2562, 1g65M, 0.8429, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2563, 5nif2, 0.8428, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2564, 5fg9M, 0.8428, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2565, 5fg9a, 0.8428, 2.30, 0.182, 225, 203, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2566, 5cz5M, 0.8428, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2567, 4zzg2, 0.8428, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2568, 4z1lM, 0.8428, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2569, 4z1la, 0.8428, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2570, 4y8ua, 0.8428, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2571, 4y82M, 0.8428, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2572, 4y82a, 0.8428, 2.85, 0.222, 222, 207, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2573, 4y6aM, 0.8428, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2574, 4y6aa, 0.8428, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2575, 4qz5M, 0.8428, 2.32, 0.182, 233, 203, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2576, 4qwkM, 0.8428, 2.32, 0.182, 233, 203, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2577, 4qwka, 0.8428, 2.31, 0.182, 233, 203, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2578, 4qwia, 0.8428, 2.30, 0.182, 233, 203, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2579, 4qw3M, 0.8428, 2.32, 0.182, 229, 203, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2580, 4qw3a, 0.8428, 2.32, 0.182, 232, 203, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2581, 4qbyM, 0.8428, 2.32, 0.182, 233, 203, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2582, 4qbya, 0.8428, 2.31, 0.182, 230, 203, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2583, 4no9a, 0.8428, 2.31, 0.182, 232, 203, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2584, 4no1M, 0.8428, 2.32, 0.182, 233, 203, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2585, 4jsqM, 0.8428, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2586, 4jsqa, 0.8428, 2.30, 0.182, 225, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2587, 5dkia, 0.8427, 2.31, 0.182, 230, 203, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2588, 4y8uM, 0.8427, 2.31, 0.182, 230, 203, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2589, 4y8iM, 0.8427, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2590, 4y8ia, 0.8427, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2591, 4y81a, 0.8427, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2592, 4y6vM, 0.8427, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2593, 4y6va, 0.8427, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2594, 4y69M, 0.8427, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2595, 4y69a, 0.8427, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2596, 4rurM, 0.8427, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2597, 4rura, 0.8427, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2598, 4qwiM, 0.8427, 2.31, 0.182, 233, 203, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2599, 4no9M, 0.8427, 2.32, 0.182, 233, 203, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2600, 4inuM, 0.8427, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2601, 4hrca, 0.8427, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2602, 1g651, 0.8427, 2.31, 0.182, 233, 203, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2603, 5dkiM, 0.8426, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2604, 4y81M, 0.8426, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2605, 4qzwM, 0.8426, 2.32, 0.182, 233, 203, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2606, 4qzwa, 0.8426, 2.32, 0.182, 233, 203, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2607, 4hrdM, 0.8426, 2.32, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2608, 3dy4M, 0.8426, 2.32, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2609, 3dy41, 0.8426, 2.30, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2610, 1iruN, 0.8426, 2.31, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2611, 1iru2, 0.8426, 2.31, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2612, 4y7xa, 0.8425, 2.30, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2613, 4y77a, 0.8425, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2614, 4y74M, 0.8425, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2615, 4y74a, 0.8425, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2616, 4qw0a, 0.8425, 2.31, 0.182, 233, 203, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2617, 4fzcM, 0.8425, 2.31, 0.182, 233, 203, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2618, 4fzca, 0.8425, 2.30, 0.182, 233, 203, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2619, 5d0xM, 0.8424, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2620, 5d0xa, 0.8424, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2621, 4y8sM, 0.8424, 2.17, 0.239, 217, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2622, 4y8sa, 0.8424, 2.17, 0.239, 217, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2623, 4y7xM, 0.8424, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2624, 4y6zM, 0.8424, 2.22, 0.178, 223, 202, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2625, 4y6za, 0.8424, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2626, 4qwsM, 0.8424, 2.31, 0.182, 233, 203, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2627, 4qwsa, 0.8424, 2.32, 0.182, 233, 203, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2628, 4qw0M, 0.8424, 2.32, 0.182, 233, 203, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2629, 4gk7M, 0.8424, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2630, 4gk7a, 0.8424, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2631, 5wvkB, 0.8423, 2.31, 0.182, 233, 203, 
2632, 4jsua, 0.8423, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2633, 3h6iR, 0.8423, 2.31, 0.182, 233, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
2634, 5nifN, 0.8422, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2635, 4y8nM, 0.8422, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2636, 4y8jM, 0.8422, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2637, 4y8ja, 0.8422, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2638, 4y80M, 0.8422, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2639, 4y80a, 0.8422, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2640, 4jsuM, 0.8422, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2641, 4hnpM, 0.8422, 2.31, 0.182, 233, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2642, 4ya5M, 0.8421, 1.76, 0.278, 223, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2643, 4ya5a, 0.8421, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2644, 4qzxM, 0.8421, 2.85, 0.222, 222, 207, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2645, 4qzxa, 0.8421, 2.31, 0.182, 232, 203, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2646, 4qxjM, 0.8421, 2.34, 0.182, 224, 203, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2647, 4qxja, 0.8421, 2.31, 0.182, 230, 203, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2648, 4y7wM, 0.8420, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2649, 4y7wa, 0.8420, 2.31, 0.182, 232, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2650, 4y70M, 0.8420, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2651, 4y70a, 0.8420, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2652, 4qwjM, 0.8420, 2.32, 0.182, 233, 203, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2653, 4qwja, 0.8420, 2.33, 0.182, 233, 203, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2654, 4qwgM, 0.8420, 2.33, 0.182, 233, 203, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2655, 4qwga, 0.8420, 2.32, 0.182, 231, 203, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2656, 4jt0M, 0.8420, 2.32, 0.182, 232, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2657, 4jt0a, 0.8420, 2.31, 0.182, 228, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2658, 2gpl1, 0.8420, 2.31, 0.182, 226, 203, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2659, 4zzgN, 0.8419, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2660, 2gplM, 0.8419, 2.31, 0.182, 233, 203, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2661, 4y7yM, 0.8417, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2662, 4y7ya, 0.8417, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2663, 4y78M, 0.8417, 2.31, 0.182, 230, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2664, 4y78a, 0.8417, 2.31, 0.182, 228, 203, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2665, 5cz4M, 0.8416, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2666, 5cz4a, 0.8416, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2667, 4qvvM, 0.8415, 2.32, 0.182, 233, 203, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2668, 4qvva, 0.8415, 2.32, 0.182, 233, 203, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2669, 4y8mM, 0.8414, 2.33, 0.182, 233, 203, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2670, 4y8na, 0.8413, 2.32, 0.182, 232, 203, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2671, 4cr21, 0.8413, 2.33, 0.182, 233, 203, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2672, 4ya3M, 0.8412, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2673, 4ya3a, 0.8412, 2.31, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2674, 4ya0M, 0.8411, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2675, 4ya0a, 0.8411, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2676, 4y8ma, 0.8411, 2.33, 0.182, 229, 203, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2677, 4hrcM, 0.8410, 2.33, 0.182, 232, 203, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2678, 4y8pM, 0.8408, 2.33, 0.182, 233, 203, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2679, 5mp97, 0.8405, 2.33, 0.182, 233, 203, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2680, 4y8oM, 0.8405, 2.07, 0.180, 222, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2681, 1z7qN, 0.8405, 2.28, 0.178, 223, 202, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2682, 1z7qb, 0.8405, 1.84, 0.265, 205, 196, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2683, 4y8qM, 0.8404, 2.34, 0.182, 233, 203, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2684, 4y8qa, 0.8404, 2.34, 0.182, 233, 203, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2685, 4y8oa, 0.8401, 2.33, 0.182, 233, 203, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2686, 1fntN, 0.8400, 2.33, 0.182, 233, 203, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2687, 1fntb, 0.8400, 2.15, 0.179, 222, 201, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2688, 4y8pa, 0.8398, 2.32, 0.182, 233, 203, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2689, 5t0cLB, 0.8397, 2.11, 0.180, 224, 200, 
2690, 5t0cFA, 0.8397, 2.36, 0.182, 229, 203, 
2691, 5t0cZ, 0.8383, 2.07, 0.180, 222, 200, 
2692, 5t0cFB, 0.8383, 2.36, 0.182, 233, 203, 
2693, 5l5wZ, 0.8382, 2.36, 0.182, 233, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2694, 5l5wL, 0.8382, 2.16, 0.179, 222, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2695, 4y8uZ, 0.8382, 2.16, 0.179, 222, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2696, 4y8uL, 0.8382, 2.16, 0.179, 222, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2697, 3h6fV, 0.8382, 2.36, 0.182, 233, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
2698, 4y8tZ, 0.8380, 2.36, 0.182, 233, 203, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2699, 4y8tL, 0.8380, 2.20, 0.179, 224, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2700, 3h6iV, 0.8380, 2.21, 0.239, 215, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
2701, 5lajZ, 0.8379, 2.21, 0.239, 215, 201, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2702, 5lajL, 0.8379, 1.56, 0.277, 191, 191, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2703, 5fgfZ, 0.8378, 1.56, 0.277, 191, 191, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2704, 5fgfL, 0.8378, 2.01, 0.190, 222, 195, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2705, 5fgdZ, 0.8377, 2.01, 0.190, 222, 195, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2706, 5fgdL, 0.8377, 2.01, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2707, 4z1lZ, 0.8377, 2.01, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2708, 4z1lL, 0.8377, 2.85, 0.218, 221, 206, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2709, 4y6aZ, 0.8377, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2710, 4y6aL, 0.8377, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2711, 4y69Z, 0.8377, 2.86, 0.223, 220, 206, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2712, 4y69L, 0.8377, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2713, 5l5bZ, 0.8376, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2714, 5l5bL, 0.8376, 2.01, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2715, 4ya3Z, 0.8376, 2.01, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2716, 5l5aZ, 0.8375, 2.01, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2717, 5l5aL, 0.8375, 2.01, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2718, 5cgfZ, 0.8375, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2719, 5bouZ, 0.8375, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2720, 5bouL, 0.8375, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2721, 4ya3L, 0.8375, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2722, 4ya0Z, 0.8375, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2723, 4ya0L, 0.8375, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2724, 3hf9e, 0.8375, 2.02, 0.190, 222, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2725, 5m2bZ, 0.8374, 2.02, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2726, 5l5eZ, 0.8374, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2727, 5l5eL, 0.8374, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2728, 5cz7L, 0.8374, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2729, 5cgfL, 0.8374, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2730, 4ya5Z, 0.8374, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2731, 4ya5L, 0.8374, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2732, 5m2bL, 0.8373, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2733, 5l5rZ, 0.8373, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2734, 5l5rL, 0.8373, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2735, 5cz7Z, 0.8373, 2.53, 0.228, 216, 202, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2736, 3hf9r, 0.8373, 2.02, 0.190, 222, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2737, 5wviEA, 0.8372, 2.02, 0.190, 222, 195, 
2738, 5l6cZ, 0.8371, 2.02, 0.190, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2739, 5l6cL, 0.8371, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2740, 5l6bZ, 0.8371, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2741, 5l6bL, 0.8371, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2742, 4y8rZ, 0.8371, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2743, 4y8rL, 0.8371, 2.02, 0.190, 222, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2744, 4y8nZ, 0.8371, 2.02, 0.190, 222, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2745, 4y8nL, 0.8371, 2.02, 0.190, 222, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2746, 3hf9P, 0.8371, 2.02, 0.195, 222, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2747, 5l67Z, 0.8370, 2.55, 0.228, 216, 202, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2748, 5fgaZ, 0.8370, 1.87, 0.260, 205, 196, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2749, 5fgaL, 0.8370, 2.03, 0.190, 222, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2750, 5fg9Z, 0.8370, 2.03, 0.190, 222, 195, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2751, 5fg9L, 0.8370, 2.02, 0.190, 222, 195, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2752, 5cz4Z, 0.8370, 2.02, 0.190, 222, 195, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2753, 4zzg1, 0.8370, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2754, 4ya1Z, 0.8370, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2755, 4ya1L, 0.8370, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2756, 4qv9Z, 0.8370, 2.03, 0.195, 222, 195, YCP BETA5-C63F MUTANT
2757, 4qv9L, 0.8370, 2.55, 0.228, 216, 202, YCP BETA5-C63F MUTANT
2758, 4qv7Z, 0.8370, 2.03, 0.190, 222, 195, YCP BETA5-A50V MUTANT
2759, 3hf9X, 0.8370, 2.02, 0.195, 222, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2760, 3hf9n, 0.8370, 2.02, 0.195, 222, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2761, 3hf9l, 0.8370, 2.03, 0.195, 222, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2762, 5l67L, 0.8369, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2763, 5fg7Z, 0.8369, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2764, 5fg7L, 0.8369, 2.01, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2765, 5cz4L, 0.8369, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2766, 4y6vL, 0.8369, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2767, 4qv7L, 0.8369, 2.02, 0.195, 222, 195, YCP BETA5-A50V MUTANT
2768, 3hf9H, 0.8369, 2.02, 0.195, 222, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2769, 1z7qM, 0.8369, 2.03, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2770, 5wviQA, 0.8368, 2.54, 0.228, 216, 202, 
2771, 5nif1, 0.8368, 2.54, 0.228, 216, 202, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2772, 5laiZ, 0.8368, 2.54, 0.228, 216, 202, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2773, 5laiL, 0.8368, 2.03, 0.190, 222, 195, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2774, 5l5fZ, 0.8368, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2775, 5l5fL, 0.8368, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2776, 4y8mZ, 0.8368, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2777, 4y8mL, 0.8368, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2778, 4y6vZ, 0.8368, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2779, 3hf9z, 0.8368, 2.54, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2780, 3hf9v, 0.8368, 2.01, 0.195, 222, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2781, 3hf9G, 0.8368, 1.87, 0.260, 205, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2782, 3hf94, 0.8368, 2.02, 0.195, 222, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2783, 1z7qa, 0.8368, 2.03, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2784, 1rypM, 0.8368, 2.03, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2785, 5l65Z, 0.8367, 2.03, 0.190, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2786, 5l65L, 0.8367, 2.03, 0.190, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2787, 5czaZ, 0.8367, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2788, 5czaL, 0.8367, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2789, 4r00Z, 0.8367, 2.03, 0.195, 222, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2790, 4r00L, 0.8367, 2.54, 0.228, 216, 202, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2791, 4quyZ, 0.8367, 2.67, 0.225, 218, 204, YCP BETA5-A49S-MUTANT
2792, 4quyL, 0.8367, 2.54, 0.228, 216, 202, YCP BETA5-A49S-MUTANT
2793, 4quxZ, 0.8367, 2.56, 0.228, 216, 202, YCP BETA5-A49T-MUTANT
2794, 4quxL, 0.8367, 2.02, 0.195, 222, 195, YCP BETA5-A49T-MUTANT
2795, 3hf9Z, 0.8367, 2.03, 0.195, 222, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2796, 3hf9x, 0.8367, 1.86, 0.191, 222, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2797, 3hf9t, 0.8367, 1.87, 0.191, 222, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2798, 5l5zZ, 0.8366, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2799, 5l5zL, 0.8366, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2800, 5fgeZ, 0.8366, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2801, 5fgeL, 0.8366, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2802, 4y9yZ, 0.8366, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2803, 4y9yL, 0.8366, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2804, 4j70Z, 0.8366, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2805, 3wxrM, 0.8366, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2806, 3hf9J, 0.8366, 2.55, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2807, 1ryp1, 0.8366, 2.55, 0.228, 216, 202, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2808, 4zzgM, 0.8365, 2.55, 0.228, 216, 202, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2809, 4ya4Z, 0.8365, 2.03, 0.190, 222, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2810, 4ya4L, 0.8365, 2.03, 0.190, 222, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2811, 4qv3Z, 0.8365, 2.02, 0.195, 222, 195, YCP BETA5-M45V MUTANT
2812, 4qv3L, 0.8365, 2.02, 0.195, 222, 195, YCP BETA5-M45V MUTANT
2813, 3hf9p, 0.8365, 2.03, 0.195, 222, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2814, 5l6aZ, 0.8364, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2815, 5l66Z, 0.8364, 1.88, 0.196, 222, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2816, 5l66L, 0.8364, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2817, 4qw0Z, 0.8364, 2.54, 0.228, 216, 202, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2818, 4qv4Z, 0.8364, 2.03, 0.195, 222, 195, YCP BETA5-M45T MUTANT
2819, 4qv4L, 0.8364, 2.02, 0.195, 222, 195, YCP BETA5-M45T MUTANT
2820, 4j70L, 0.8364, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2821, 5l6aL, 0.8363, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2822, 5d0wZ, 0.8363, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2823, 5d0wL, 0.8363, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2824, 4rurZ, 0.8363, 2.55, 0.228, 216, 202, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2825, 4qzzZ, 0.8363, 2.03, 0.190, 222, 195, YCP IN COMPLEX WITH OMURALIDE
2826, 4qzzL, 0.8363, 1.87, 0.191, 222, 194, YCP IN COMPLEX WITH OMURALIDE
2827, 4qwuZ, 0.8363, 1.87, 0.191, 222, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2828, 4qw0L, 0.8363, 2.04, 0.195, 222, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2829, 5l5uL, 0.8362, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2830, 4rurL, 0.8362, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2831, 4r18Z, 0.8362, 1.88, 0.196, 222, 194, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2832, 4r18L, 0.8362, 2.03, 0.190, 222, 195, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2833, 4r17Z, 0.8362, 2.03, 0.195, 222, 195, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2834, 4r17L, 0.8362, 2.03, 0.195, 222, 195, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2835, 4qwuL, 0.8362, 2.04, 0.195, 222, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2836, 4qv8Z, 0.8362, 2.03, 0.195, 222, 195, YCP BETA5-C52F MUTANT
2837, 4qv8L, 0.8362, 2.03, 0.195, 222, 195, YCP BETA5-C52F MUTANT
2838, 4qv5Z, 0.8362, 2.03, 0.195, 222, 195, YCP BETA5-M45I MUTANT
2839, 4qv5L, 0.8362, 2.04, 0.195, 222, 195, YCP BETA5-M45I MUTANT
2840, 4qv1Z, 0.8362, 2.04, 0.190, 222, 195, YCP BETA5-M45A MUTANT
2841, 4qv1L, 0.8362, 2.04, 0.195, 222, 195, YCP BETA5-M45A MUTANT
2842, 3hf9R, 0.8362, 1.87, 0.196, 222, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2843, 3hf9N, 0.8362, 1.87, 0.196, 222, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2844, 3hf9L, 0.8362, 2.03, 0.195, 222, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2845, 3hf9j, 0.8362, 2.03, 0.195, 222, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2846, 3hf9g, 0.8362, 2.03, 0.195, 222, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2847, 3hf92, 0.8362, 2.03, 0.195, 222, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2848, 5t0gT, 0.8361, 2.03, 0.195, 222, 195, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2849, 5l5uZ, 0.8361, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2850, 5l5dL, 0.8361, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2851, 5bxlZ, 0.8361, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2852, 5bxlL, 0.8361, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2853, 4qvyZ, 0.8361, 2.55, 0.228, 216, 202, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2854, 4qvyL, 0.8361, 2.55, 0.228, 216, 202, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2855, 3hf9C, 0.8361, 2.55, 0.228, 216, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2856, 5l64Z, 0.8360, 2.55, 0.228, 216, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2857, 5l64L, 0.8360, 2.55, 0.228, 216, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2858, 5fghZ, 0.8359, 2.55, 0.228, 216, 202, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2859, 5fghL, 0.8359, 2.25, 0.239, 215, 201, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2860, 5cz6Z, 0.8359, 2.03, 0.190, 222, 195, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2861, 5cz6L, 0.8359, 2.04, 0.190, 222, 195, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2862, 4qv0Z, 0.8359, 2.03, 0.195, 222, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2863, 4qv0L, 0.8359, 2.03, 0.195, 222, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2864, 4lqiL, 0.8359, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2865, 3wxr1, 0.8359, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2866, 1fntM, 0.8359, 2.56, 0.228, 216, 202, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2867, 5d0xZ, 0.8358, 2.04, 0.190, 222, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2868, 5d0xL, 0.8358, 2.04, 0.190, 222, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2869, 4qvvZ, 0.8358, 2.04, 0.195, 222, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2870, 4qvvL, 0.8358, 2.04, 0.195, 222, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2871, 3dy4L, 0.8358, 2.04, 0.195, 222, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2872, 1fnta, 0.8358, 2.04, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2873, 6gopZ, 0.8357, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2874, 5fhsZ, 0.8357, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2875, 4qvwZ, 0.8357, 2.04, 0.195, 222, 195, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2876, 4qvwL, 0.8357, 1.87, 0.196, 222, 194, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2877, 4q1sZ, 0.8357, 2.00, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2878, 3hf9T, 0.8357, 2.04, 0.195, 222, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2879, 6gopL, 0.8356, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2880, 5l5iL, 0.8356, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2881, 5fhsL, 0.8356, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2882, 4q1sL, 0.8356, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2883, 5l68Z, 0.8355, 2.00, 0.195, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2884, 5l68L, 0.8355, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2885, 5l5vZ, 0.8355, 2.03, 0.195, 222, 195,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2886, 5l5vL, 0.8355, 2.04, 0.195, 222, 195,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2887, 5l5pZ, 0.8355, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2888, 5l5pL, 0.8355, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2889, 4qvlL, 0.8355, 2.55, 0.228, 216, 202, YCP IN COMPLEX WITH BORTEZOMIB
2890, 5nifM, 0.8354, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2891, 4qw3Z, 0.8354, 2.04, 0.190, 222, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2892, 5lttZ, 0.8353, 2.03, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2893, 5lttL, 0.8353, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2894, 5l5xL, 0.8353, 1.88, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2895, 5l5oZ, 0.8353, 1.88, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2896, 5l5oL, 0.8353, 2.04, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2897, 5l5dZ, 0.8353, 2.04, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2898, 4qw3L, 0.8353, 1.88, 0.191, 222, 194, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2899, 5mp96, 0.8352, 1.88, 0.191, 222, 194, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2900, 5l5jZ, 0.8352, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2901, 5l5jL, 0.8352, 1.87, 0.196, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2902, 5fmgV, 0.8352, 2.05, 0.195, 222, 195, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
2903, 5fmgH, 0.8352, 2.05, 0.195, 222, 195, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
2904, 4x6zM, 0.8352, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2905, 4x6z1, 0.8352, 2.04, 0.190, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2906, 4qvmZ, 0.8352, 1.88, 0.191, 222, 194, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2907, 3hyeL, 0.8352, 1.88, 0.191, 222, 194, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2908, 3gptZ, 0.8352, 1.88, 0.191, 222, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2909, 5l5tZ, 0.8351, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2910, 5l5tL, 0.8351, 2.01, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2911, 4qvmL, 0.8351, 1.87, 0.191, 222, 194, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2912, 5ln37, 0.8350, 1.87, 0.191, 222, 194, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
2913, 5l5sZ, 0.8350, 1.49, 0.206, 191, 189, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2914, 5l5sL, 0.8350, 1.49, 0.206, 191, 189, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2915, 5d0tZ, 0.8350, 1.88, 0.196, 222, 194, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2916, 4lqiZ, 0.8350, 1.88, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2917, 3un8Z, 0.8350, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2918, 3dy4Z, 0.8350, 2.05, 0.195, 222, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2919, 1z7qX, 0.8350, 2.05, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2920, 5lf6W, 0.8349, 1.88, 0.191, 222, 194, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2921, 5lf6I, 0.8349, 1.88, 0.191, 222, 194, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2922, 5l64I, 0.8349, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2923, 5l62Z, 0.8349, 2.40, 0.228, 218, 202, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2924, 5l62L, 0.8349, 2.05, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2925, 5d0tL, 0.8349, 2.05, 0.190, 222, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2926, 3hf9V, 0.8349, 2.05, 0.195, 222, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2927, 1z7qJ, 0.8349, 1.89, 0.196, 222, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2928, 5l64W, 0.8348, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2929, 5l61Z, 0.8348, 1.88, 0.196, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2930, 5l61L, 0.8348, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2931, 5l60Z, 0.8348, 2.02, 0.210, 204, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2932, 5l60L, 0.8348, 2.03, 0.210, 204, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2933, 3hf9E, 0.8348, 1.94, 0.196, 204, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
2934, 5l69Z, 0.8347, 1.88, 0.191, 222, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2935, 5l69L, 0.8347, 1.88, 0.191, 222, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2936, 5l63W, 0.8347, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2937, 5l63I, 0.8347, 2.62, 0.232, 217, 203, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2938, 5l5vW, 0.8347, 1.95, 0.196, 204, 194,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2939, 5l5vI, 0.8347, 1.94, 0.196, 204, 194,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2940, 5l5qL, 0.8347, 1.88, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2941, 5l5iZ, 0.8347, 1.88, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2942, 5fggZ, 0.8347, 1.89, 0.191, 222, 194, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2943, 4qwrZ, 0.8347, 1.89, 0.191, 222, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2944, 4qwrL, 0.8347, 2.58, 0.228, 216, 202, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2945, 5t0iT, 0.8346, 1.89, 0.191, 222, 194, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2946, 5l63Z, 0.8346, 1.89, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2947, 5l63L, 0.8346, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2948, 5l61W, 0.8346, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2949, 5l61I, 0.8346, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2950, 5l5hL, 0.8346, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2951, 5fggL, 0.8346, 2.05, 0.190, 222, 195, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2952, 5dkiZ, 0.8346, 1.89, 0.191, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2953, 5dkiL, 0.8346, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2954, 5cz9Z, 0.8346, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2955, 5cz9L, 0.8346, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2956, 4qvlZ, 0.8346, 2.26, 0.239, 215, 201, YCP IN COMPLEX WITH BORTEZOMIB
2957, 5mp9m, 0.8345, 1.89, 0.191, 222, 194, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2958, 5l62W, 0.8345, 1.89, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2959, 5l62I, 0.8345, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2960, 5l5xZ, 0.8345, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2961, 5l5hZ, 0.8345, 2.05, 0.190, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2962, 4qvqZ, 0.8345, 2.04, 0.195, 222, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2963, 3e47Z, 0.8345, 2.05, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2964, 5m2bW, 0.8344, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2965, 5m2bI, 0.8344, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2966, 5l67W, 0.8344, 2.04, 0.195, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2967, 5l67I, 0.8344, 1.89, 0.196, 222, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2968, 5dkjZ, 0.8344, 2.02, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2969, 4y7xZ, 0.8344, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2970, 4qvqL, 0.8344, 1.94, 0.196, 204, 194, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2971, 4qvpZ, 0.8344, 1.89, 0.191, 222, 194, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2972, 4qvpL, 0.8344, 2.05, 0.190, 222, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2973, 3un8L, 0.8344, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2974, 3tddZ, 0.8344, 1.90, 0.196, 222, 194, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2975, 3tddL, 0.8344, 1.95, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2976, 3e47L, 0.8344, 1.95, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2977, 5l5yW, 0.8343, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2978, 5l5yI, 0.8343, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2979, 5l5qW, 0.8343, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2980, 5l5qI, 0.8343, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2981, 5l5oI, 0.8343, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2982, 5dkjL, 0.8343, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2983, 4y7xL, 0.8343, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2984, 4eu21, 0.8343, 2.06, 0.195, 222, 195, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2985, 3hyeZ, 0.8343, 1.90, 0.196, 222, 194, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2986, 3gpwZ, 0.8343, 1.90, 0.196, 222, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2987, 3gpwL, 0.8343, 1.90, 0.196, 222, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2988, 3gptL, 0.8343, 1.94, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2989, 2gplZ, 0.8343, 1.94, 0.196, 204, 194, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2990, 2gplL, 0.8343, 1.94, 0.196, 204, 194, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2991, 5l5wW, 0.8342, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2992, 5l5wI, 0.8342, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2993, 5l5oW, 0.8342, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2994, 5cghZ, 0.8342, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2995, 5cghL, 0.8342, 1.89, 0.196, 222, 194, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2996, 1g0uZ, 0.8342, 1.89, 0.196, 222, 194, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2997, 5l6cW, 0.8341, 1.90, 0.196, 222, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2998, 5l6cI, 0.8341, 1.90, 0.196, 222, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2999, 5l60W, 0.8341, 1.89, 0.196, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3000, 5l60I, 0.8341, 1.90, 0.196, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3001, 5l5yZ, 0.8341, 1.90, 0.196, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3002, 5l5yL, 0.8341, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3003, 5l5tW, 0.8341, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3004, 5l5tI, 0.8341, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3005, 5l5hW, 0.8341, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3006, 5l5hI, 0.8341, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3007, 4qzwZ, 0.8341, 1.89, 0.196, 222, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3008, 4qzwL, 0.8341, 1.95, 0.196, 204, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3009, 5l6aW, 0.8340, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3010, 5l6aI, 0.8340, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3011, 5l5uW, 0.8340, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3012, 5l5uI, 0.8340, 1.89, 0.191, 222, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3013, 5cz5Z, 0.8340, 1.89, 0.191, 222, 194, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3014, 5cz5L, 0.8340, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3015, 5bxnZ, 0.8340, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3016, 4qw1L, 0.8340, 1.94, 0.196, 204, 194, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3017, 4qvnL, 0.8340, 1.94, 0.196, 204, 194, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3018, 4qlvL, 0.8340, 2.05, 0.195, 222, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3019, 4qlsZ, 0.8340, 2.05, 0.195, 222, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3020, 3oevL, 0.8340, 1.94, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3021, 5lttW, 0.8339, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3022, 5l5rW, 0.8339, 1.94, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3023, 5l5pW, 0.8339, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3024, 5l5pI, 0.8339, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3025, 5bxnL, 0.8339, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3026, 4qw1Z, 0.8339, 1.89, 0.196, 222, 194, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3027, 4qlvZ, 0.8339, 1.90, 0.196, 222, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3028, 4qlsL, 0.8339, 2.06, 0.195, 222, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3029, 4eu2M, 0.8339, 2.05, 0.195, 222, 195, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3030, 5lttI, 0.8338, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3031, 5l5sW, 0.8338, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3032, 5l5sI, 0.8338, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3033, 5l5rI, 0.8338, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3034, 5l5qZ, 0.8338, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3035, 5l5bI, 0.8338, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3036, 5jhsZ, 0.8338, 1.90, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3037, 5fgiZ, 0.8338, 1.90, 0.196, 222, 194, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3038, 5fgiL, 0.8338, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3039, 5d0vZ, 0.8338, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3040, 5d0sZ, 0.8338, 1.89, 0.196, 222, 194, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3041, 5cz8Z, 0.8338, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3042, 5cz8L, 0.8338, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3043, 4qwjZ, 0.8338, 1.95, 0.196, 204, 194, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3044, 4qwjL, 0.8338, 1.95, 0.196, 204, 194, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3045, 3dy3Z, 0.8338, 1.90, 0.191, 222, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3046, 2zcyZ, 0.8338, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3047, 2zcyL, 0.8338, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3048, 5vfsM, 0.8337, 2.05, 0.195, 222, 195, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3049, 5l66W, 0.8337, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3050, 5l66I, 0.8337, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3051, 5l5xW, 0.8337, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3052, 5l5xI, 0.8337, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3053, 5l5jW, 0.8337, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3054, 5l5jI, 0.8337, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3055, 5l5bW, 0.8337, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3056, 5jhsL, 0.8337, 1.90, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3057, 5d0zZ, 0.8337, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3058, 5d0zL, 0.8337, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3059, 5d0vL, 0.8337, 2.00, 0.240, 215, 200, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3060, 5d0sL, 0.8337, 2.01, 0.200, 213, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3061, 4y8kZ, 0.8337, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3062, 4y8kL, 0.8337, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3063, 4qwsZ, 0.8337, 1.95, 0.196, 204, 194, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3064, 4qwsL, 0.8337, 1.95, 0.196, 204, 194, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3065, 4qluZ, 0.8337, 1.95, 0.196, 204, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3066, 4qluL, 0.8337, 1.95, 0.196, 204, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3067, 3oevZ, 0.8337, 1.95, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3068, 3dy3L, 0.8337, 2.05, 0.195, 222, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3069, 5vfuDA, 0.8336, 2.05, 0.195, 222, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3070, 5vftS, 0.8336, 2.05, 0.195, 222, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3071, 5vfrs, 0.8336, 2.05, 0.195, 222, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3072, 5lf3W, 0.8336, 2.05, 0.195, 222, 195, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3073, 5le5I, 0.8336, 1.89, 0.196, 222, 194, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3074, 5l69W, 0.8336, 1.89, 0.196, 222, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3075, 5l69I, 0.8336, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3076, 5l5zW, 0.8336, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3077, 5l5zI, 0.8336, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3078, 5cggZ, 0.8336, 2.05, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3079, 5cggL, 0.8336, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3080, 4y8sZ, 0.8336, 1.90, 0.196, 222, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3081, 4y8sL, 0.8336, 2.05, 0.200, 213, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3082, 4y8qZ, 0.8336, 2.05, 0.200, 213, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3083, 4y8qL, 0.8336, 2.04, 0.200, 213, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3084, 4qv6Z, 0.8336, 2.04, 0.210, 204, 195, YCP BETA5-A49V MUTANT
3085, 3nzjZ, 0.8336, 2.04, 0.210, 204, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3086, 3nzjL, 0.8336, 1.95, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3087, 2fakZ, 0.8336, 1.95, 0.196, 204, 194, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3088, 2fakL, 0.8336, 1.95, 0.196, 204, 194, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3089, 5lf7W, 0.8335, 1.95, 0.196, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3090, 5leyW, 0.8335, 2.05, 0.195, 222, 195, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3091, 5leyI, 0.8335, 2.05, 0.195, 222, 195, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3092, 5fmgW, 0.8335, 1.89, 0.196, 222, 194, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3093, 5fmgI, 0.8335, 1.89, 0.196, 222, 194, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3094, 4r18W, 0.8335, 2.05, 0.195, 222, 195, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3095, 4r18I, 0.8335, 2.05, 0.195, 222, 195, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3096, 4r02Z, 0.8335, 1.90, 0.196, 222, 194, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3097, 4r02L, 0.8335, 2.06, 0.195, 222, 195, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3098, 4qz6Z, 0.8335, 2.06, 0.195, 222, 195, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3099, 4qwkZ, 0.8335, 1.90, 0.196, 222, 194, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3100, 4qwkL, 0.8335, 1.90, 0.196, 222, 194, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3101, 4qwiZ, 0.8335, 2.04, 0.210, 204, 195, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3102, 4qwiL, 0.8335, 2.03, 0.210, 204, 195, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3103, 4qv6L, 0.8335, 2.04, 0.210, 204, 195, YCP BETA5-A49V MUTANT
3104, 3mg7Z, 0.8335, 1.30, 0.253, 186, 186, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3105, 5l68W, 0.8334, 1.30, 0.253, 186, 186, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3106, 5l68I, 0.8334, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3107, 5l65I, 0.8334, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3108, 4qz6L, 0.8334, 1.89, 0.196, 222, 194, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3109, 4qw7Z, 0.8334, 1.89, 0.196, 222, 194, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3110, 4qw6Z, 0.8334, 2.06, 0.195, 222, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3111, 4qw6L, 0.8334, 2.06, 0.195, 222, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3112, 4qw5Z, 0.8334, 2.06, 0.195, 222, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3113, 4qw5L, 0.8334, 2.06, 0.195, 222, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3114, 4no8W, 0.8334, 2.06, 0.195, 222, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3115, 4no8I, 0.8334, 1.90, 0.196, 222, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3116, 1g0uL, 0.8334, 2.05, 0.195, 222, 195, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3117, 5lf3I, 0.8333, 1.96, 0.196, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3118, 5lezI, 0.8333, 1.96, 0.196, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3119, 5lexI, 0.8333, 1.95, 0.196, 204, 194, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3120, 5lajI, 0.8333, 2.06, 0.195, 222, 195, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3121, 5l6bW, 0.8333, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3122, 5l6bI, 0.8333, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3123, 5l65W, 0.8333, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3124, 5l5fW, 0.8333, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3125, 5l54Z, 0.8333, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3126, 4qw7L, 0.8333, 1.95, 0.196, 204, 194, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3127, 3unek, 0.8333, 1.95, 0.196, 204, 194, MOUSE CONSTITUTIVE 20S PROTEASOME
3128, 5lf1W, 0.8332, 1.91, 0.196, 222, 194, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3129, 5lf1I, 0.8332, 2.05, 0.210, 204, 195, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3130, 5lexW, 0.8332, 2.04, 0.210, 204, 195, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3131, 5le5W, 0.8332, 2.04, 0.210, 204, 195, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3132, 5lajW, 0.8332, 1.95, 0.196, 204, 194, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3133, 5l5fI, 0.8332, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3134, 5l55W, 0.8332, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3135, 5l55I, 0.8332, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3136, 5l54L, 0.8332, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3137, 5fggW, 0.8332, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3138, 5fggI, 0.8332, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3139, 4qv3W, 0.8332, 2.06, 0.215, 204, 195, YCP BETA5-M45V MUTANT
3140, 4qv3I, 0.8332, 2.04, 0.210, 204, 195, YCP BETA5-M45V MUTANT
3141, 4inrZ, 0.8332, 2.04, 0.210, 204, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3142, 4inrL, 0.8332, 2.04, 0.210, 204, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3143, 5l5dW, 0.8331, 2.04, 0.210, 204, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3144, 5l5dI, 0.8331, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3145, 5l54W, 0.8331, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3146, 4r02W, 0.8331, 1.94, 0.196, 204, 194, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3147, 4r02I, 0.8331, 1.95, 0.196, 204, 194, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3148, 4qzzW, 0.8331, 2.06, 0.195, 222, 195, YCP IN COMPLEX WITH OMURALIDE
3149, 4qzzI, 0.8331, 1.95, 0.196, 204, 194, YCP IN COMPLEX WITH OMURALIDE
3150, 4qwgZ, 0.8331, 1.95, 0.196, 204, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3151, 4qwgL, 0.8331, 1.95, 0.196, 204, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3152, 4qwfZ, 0.8331, 1.95, 0.196, 204, 194, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3153, 4qwfL, 0.8331, 2.07, 0.195, 222, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3154, 4qvnZ, 0.8331, 2.07, 0.195, 222, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3155, 4qv7I, 0.8331, 1.96, 0.196, 204, 194, YCP BETA5-A50V MUTANT
3156, 4q1sW, 0.8331, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3157, 4jt0Z, 0.8331, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3158, 4jt0L, 0.8331, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3159, 3oeuZ, 0.8331, 1.96, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3160, 3oeuL, 0.8331, 1.95, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3161, 3h6iJ, 0.8331, 1.96, 0.196, 204, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3162, 5lezW, 0.8330, 2.06, 0.195, 222, 195, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3163, 5l5iW, 0.8330, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3164, 5l5eW, 0.8330, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3165, 5l5eI, 0.8330, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3166, 5jhrZ, 0.8330, 1.90, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3167, 5jhrL, 0.8330, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3168, 5fgfW, 0.8330, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3169, 5fgfI, 0.8330, 1.91, 0.196, 222, 194, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3170, 5fgdW, 0.8330, 1.91, 0.196, 222, 194, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3171, 5fgdI, 0.8330, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3172, 5d0tW, 0.8330, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3173, 5d0tI, 0.8330, 2.53, 0.224, 215, 201, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3174, 4x6zX, 0.8330, 2.04, 0.210, 204, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3175, 4qv7W, 0.8330, 1.96, 0.196, 204, 194, YCP BETA5-A50V MUTANT
3176, 4qv4W, 0.8330, 1.96, 0.196, 204, 194, YCP BETA5-M45T MUTANT
3177, 4qv4I, 0.8330, 1.96, 0.196, 204, 194, YCP BETA5-M45T MUTANT
3178, 3mg0Z, 0.8330, 2.06, 0.195, 222, 195, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3179, 3gpjZ, 0.8330, 2.06, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3180, 3gpjL, 0.8330, 1.96, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3181, 5l5iI, 0.8329, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3182, 5jhrW, 0.8329, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3183, 5jhrI, 0.8329, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3184, 5fgeW, 0.8329, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3185, 5fgeI, 0.8329, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3186, 4y82Z, 0.8329, 1.93, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3187, 4y82L, 0.8329, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3188, 4qvnW, 0.8329, 1.96, 0.196, 204, 194, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3189, 4g4sM, 0.8329, 1.96, 0.196, 204, 194, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3190, 3sdkZ, 0.8329, 2.06, 0.195, 222, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3191, 3mg0L, 0.8329, 2.07, 0.195, 222, 195, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3192, 5lf7I, 0.8328, 2.07, 0.195, 222, 195, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3193, 5l54I, 0.8328, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3194, 5l52W, 0.8328, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3195, 5l52I, 0.8328, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3196, 5bxnW, 0.8328, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3197, 5bxnI, 0.8328, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3198, 4y8lL, 0.8328, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3199, 4qz7Z, 0.8328, 2.06, 0.195, 222, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3200, 4qz7L, 0.8328, 1.95, 0.196, 204, 194, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3201, 4qwlZ, 0.8328, 2.06, 0.195, 222, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3202, 4qwlL, 0.8328, 2.06, 0.195, 222, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3203, 4qw4Z, 0.8328, 2.07, 0.195, 222, 195, YCP IN COMPLEX WITH CARFILZOMIB
3204, 4qw4L, 0.8328, 2.05, 0.210, 204, 195, YCP IN COMPLEX WITH CARFILZOMIB
3205, 4qvnI, 0.8328, 1.95, 0.196, 204, 194, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3206, 4qv5W, 0.8328, 1.95, 0.196, 204, 194, YCP BETA5-M45I MUTANT
3207, 4qv5I, 0.8328, 1.95, 0.196, 204, 194, YCP BETA5-M45I MUTANT
3208, 4qv1W, 0.8328, 1.96, 0.196, 204, 194, YCP BETA5-M45A MUTANT
3209, 4qv1I, 0.8328, 1.96, 0.196, 204, 194, YCP BETA5-M45A MUTANT
3210, 4qlsW, 0.8328, 2.06, 0.195, 222, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3211, 4qlsI, 0.8328, 2.06, 0.195, 222, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3212, 4nnwW, 0.8328, 2.06, 0.195, 222, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3213, 4nnwI, 0.8328, 2.06, 0.195, 222, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3214, 4fzcZ, 0.8328, 2.06, 0.195, 222, 195, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3215, 3nzjI, 0.8328, 2.06, 0.195, 222, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3216, 3h6fJ, 0.8328, 2.06, 0.195, 222, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3217, 5fgaW, 0.8327, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3218, 5fgaI, 0.8327, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3219, 5fg7W, 0.8327, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3220, 5fg7I, 0.8327, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3221, 5cggW, 0.8327, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3222, 5cggI, 0.8327, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3223, 4ya2Z, 0.8327, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3224, 4ya2L, 0.8327, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3225, 4y8pZ, 0.8327, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3226, 4y8lZ, 0.8327, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3227, 4y81Z, 0.8327, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3228, 4y7yZ, 0.8327, 2.55, 0.229, 215, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3229, 4y7yL, 0.8327, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3230, 4qz7W, 0.8327, 1.96, 0.196, 204, 194, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3231, 4qz7I, 0.8327, 1.96, 0.196, 204, 194, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3232, 4qv9W, 0.8327, 1.96, 0.196, 204, 194, YCP BETA5-C63F MUTANT
3233, 4qv9I, 0.8327, 1.95, 0.196, 204, 194, YCP BETA5-C63F MUTANT
3234, 4fzcL, 0.8327, 1.95, 0.196, 204, 194, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3235, 3shjZ, 0.8327, 1.90, 0.196, 222, 194, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3236, 3nzjW, 0.8327, 1.90, 0.196, 222, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3237, 6avoX, 0.8326, 2.07, 0.195, 222, 195, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3238, 6avoS, 0.8326, 2.06, 0.195, 222, 195, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3239, 5lf4W, 0.8326, 2.06, 0.195, 222, 195, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3240, 5fhsW, 0.8326, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3241, 5fhsI, 0.8326, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3242, 5fgiW, 0.8326, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3243, 5fgiI, 0.8326, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3244, 5cgfW, 0.8326, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3245, 5cgfI, 0.8326, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3246, 5bouW, 0.8326, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3247, 5bouI, 0.8326, 1.92, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3248, 4ya1I, 0.8326, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3249, 4y8pL, 0.8326, 1.90, 0.201, 213, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3250, 4y8mW, 0.8326, 1.90, 0.201, 213, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3251, 4y8mI, 0.8326, 2.04, 0.210, 204, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3252, 4y81L, 0.8326, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3253, 4y75W, 0.8326, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3254, 4y75I, 0.8326, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3255, 4qzxZ, 0.8326, 1.95, 0.196, 204, 194, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3256, 4qzxL, 0.8326, 1.96, 0.196, 204, 194, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3257, 4qv6W, 0.8326, 1.96, 0.196, 204, 194, YCP BETA5-A49V MUTANT
3258, 4qv6I, 0.8326, 1.96, 0.196, 204, 194, YCP BETA5-A49V MUTANT
3259, 4quyW, 0.8326, 1.96, 0.196, 204, 194, YCP BETA5-A49S-MUTANT
3260, 4q1sI, 0.8326, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3261, 4no1I, 0.8326, 2.07, 0.195, 222, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3262, 4nnnW, 0.8326, 1.97, 0.196, 204, 194, YCP IN COMPLEX WITH MG132
3263, 4nnnI, 0.8326, 1.97, 0.196, 204, 194, YCP IN COMPLEX WITH MG132
3264, 3unbI, 0.8326, 2.06, 0.195, 222, 195, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3265, 3shjL, 0.8326, 1.95, 0.196, 204, 194, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3266, 3h6fT, 0.8326, 1.95, 0.196, 204, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3267, 3h6fE, 0.8326, 2.07, 0.195, 222, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3268, 3bdmZ, 0.8326, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3269, 3bdmL, 0.8326, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3270, 5vfqM, 0.8325, 1.96, 0.196, 204, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3271, 5lf4I, 0.8325, 1.96, 0.196, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3272, 5lf0W, 0.8325, 1.96, 0.196, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3273, 5lf0I, 0.8325, 1.96, 0.196, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3274, 5l5aW, 0.8325, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3275, 5l5aI, 0.8325, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3276, 5l52Z, 0.8325, 2.05, 0.215, 204, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3277, 5l52L, 0.8325, 1.92, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3278, 5jhsI, 0.8325, 2.53, 0.224, 215, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3279, 5d0sW, 0.8325, 2.54, 0.229, 215, 201, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3280, 5d0sI, 0.8325, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3281, 5cghW, 0.8325, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3282, 5cghI, 0.8325, 2.02, 0.240, 215, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3283, 5bxlW, 0.8325, 2.05, 0.200, 213, 195, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3284, 5bxlI, 0.8325, 2.05, 0.210, 204, 195, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3285, 5ahjW, 0.8325, 2.05, 0.210, 204, 195, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3286, 4ya1W, 0.8325, 2.05, 0.210, 204, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3287, 4y8tW, 0.8325, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3288, 4y8tI, 0.8325, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3289, 4y80Z, 0.8325, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3290, 4y80L, 0.8325, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3291, 4r00W, 0.8325, 1.95, 0.196, 204, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3292, 4r00I, 0.8325, 1.95, 0.196, 204, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3293, 4qv8W, 0.8325, 1.95, 0.196, 204, 194, YCP BETA5-C52F MUTANT
3294, 4qv8I, 0.8325, 1.95, 0.196, 204, 194, YCP BETA5-C52F MUTANT
3295, 4qv0I, 0.8325, 1.95, 0.196, 204, 194, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3296, 4quyI, 0.8325, 1.96, 0.196, 204, 194, YCP BETA5-A49S-MUTANT
3297, 4qltZ, 0.8325, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3298, 4qltL, 0.8325, 1.95, 0.196, 204, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3299, 4no1W, 0.8325, 1.97, 0.196, 204, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3300, 3mg4Z, 0.8325, 1.96, 0.196, 204, 194, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3301, 3h6iE, 0.8325, 1.96, 0.196, 204, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3302, 5vfpM, 0.8324, 2.07, 0.195, 222, 195, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3303, 5jhsW, 0.8324, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3304, 5d0wW, 0.8324, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3305, 5czaW, 0.8324, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3306, 5czaI, 0.8324, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3307, 5ahjI, 0.8324, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3308, 4y8kW, 0.8324, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3309, 4y8kI, 0.8324, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3310, 4y8iL, 0.8324, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3311, 4y8hI, 0.8324, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3312, 4qz0L, 0.8324, 1.96, 0.196, 204, 194, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3313, 4qv0W, 0.8324, 1.92, 0.196, 222, 194, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3314, 3tddW, 0.8324, 2.53, 0.229, 215, 201, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3315, 3tddI, 0.8324, 2.05, 0.200, 213, 195, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3316, 3h6iT, 0.8324, 1.96, 0.196, 204, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3317, 3h6fL, 0.8324, 1.96, 0.196, 204, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3318, 3h6fG, 0.8324, 1.96, 0.196, 204, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3319, 3e47I, 0.8324, 1.96, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3320, 3dy4W, 0.8324, 1.95, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3321, 3dy4I, 0.8324, 1.96, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3322, 2fakW, 0.8324, 1.96, 0.196, 204, 194, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3323, 6avoU, 0.8323, 2.07, 0.195, 222, 195, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3324, 5vfsLA, 0.8323, 1.95, 0.196, 204, 194, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3325, 5vfos, 0.8323, 2.07, 0.195, 222, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3326, 5ln31, 0.8323, 1.96, 0.196, 204, 194, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3327, 5laiW, 0.8323, 1.97, 0.196, 204, 194, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3328, 5laiI, 0.8323, 1.97, 0.196, 204, 194, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3329, 5fg9I, 0.8323, 2.54, 0.224, 215, 201, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3330, 5d0wI, 0.8323, 2.54, 0.224, 215, 201, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3331, 5cz9W, 0.8323, 2.56, 0.229, 215, 201, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3332, 5cz9I, 0.8323, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3333, 5cz7W, 0.8323, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3334, 5cz7I, 0.8323, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3335, 4ya4I, 0.8323, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3336, 4y9zZ, 0.8323, 2.04, 0.210, 204, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3337, 4y8jZ, 0.8323, 2.03, 0.200, 213, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3338, 4y8jL, 0.8323, 2.06, 0.200, 213, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3339, 4y8iZ, 0.8323, 2.20, 0.268, 214, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3340, 4y8hW, 0.8323, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3341, 4y78Z, 0.8323, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3342, 4y78L, 0.8323, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3343, 4y77Z, 0.8323, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3344, 4y77L, 0.8323, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3345, 4y6aW, 0.8323, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3346, 4qz3Z, 0.8323, 1.96, 0.196, 204, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3347, 4qz3L, 0.8323, 1.96, 0.196, 204, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3348, 4qvpW, 0.8323, 1.97, 0.196, 204, 194, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3349, 4qvpI, 0.8323, 2.07, 0.195, 222, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3350, 4qlvI, 0.8323, 2.07, 0.195, 222, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3351, 4no1Z, 0.8323, 2.07, 0.195, 222, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3352, 4no1L, 0.8323, 2.07, 0.195, 222, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3353, 4intZ, 0.8323, 1.95, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3354, 3uneI, 0.8323, 1.91, 0.196, 222, 194, MOUSE CONSTITUTIVE 20S PROTEASOME
3355, 3sdkL, 0.8323, 1.91, 0.196, 222, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3356, 3mg7L, 0.8323, 2.07, 0.195, 222, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3357, 3h6iP, 0.8323, 2.07, 0.195, 222, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3358, 3e47W, 0.8323, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3359, 2fakI, 0.8323, 2.07, 0.195, 222, 195, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3360, 1iruX, 0.8323, 2.07, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3361, 1iruJ, 0.8323, 1.96, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3362, 6gopW, 0.8322, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3363, 6gopI, 0.8322, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3364, 5vfoS, 0.8322, 1.90, 0.196, 222, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3365, 5fg9W, 0.8322, 1.90, 0.196, 222, 194, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3366, 5dkjW, 0.8322, 2.08, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3367, 5dkjI, 0.8322, 2.06, 0.215, 204, 195, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3368, 5d0zW, 0.8322, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3369, 5d0zI, 0.8322, 2.06, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3370, 5cgiW, 0.8322, 2.54, 0.229, 215, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3371, 5cgiI, 0.8322, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3372, 5ahjZ, 0.8322, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3373, 5ahjL, 0.8322, 2.07, 0.210, 204, 195, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3374, 4z1lI, 0.8322, 2.07, 0.210, 204, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3375, 4ya4W, 0.8322, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3376, 4y9zL, 0.8322, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3377, 4y8uI, 0.8322, 2.05, 0.200, 213, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3378, 4y74I, 0.8322, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3379, 4y6aI, 0.8322, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3380, 4qz5Z, 0.8322, 1.96, 0.196, 204, 194, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3381, 4qz5L, 0.8322, 1.96, 0.196, 204, 194, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3382, 4qz0W, 0.8322, 1.96, 0.196, 204, 194, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3383, 4qz0I, 0.8322, 1.96, 0.196, 204, 194, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3384, 4qxjZ, 0.8322, 1.96, 0.196, 204, 194, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3385, 4qxjL, 0.8322, 2.07, 0.195, 222, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3386, 4qlvW, 0.8322, 2.07, 0.195, 222, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3387, 4qluW, 0.8322, 1.97, 0.196, 204, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3388, 4qluI, 0.8322, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3389, 4inrI, 0.8322, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3390, 3uneW, 0.8322, 1.97, 0.196, 204, 194, MOUSE CONSTITUTIVE 20S PROTEASOME
3391, 3un8I, 0.8322, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3392, 3h6iG, 0.8322, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3393, 5gjqc, 0.8321, 2.07, 0.195, 222, 195, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3394, 5cgiZ, 0.8321, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3395, 4z1lW, 0.8321, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3396, 4y8uW, 0.8321, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3397, 4y8oZ, 0.8321, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3398, 4y8oL, 0.8321, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3399, 4y8gW, 0.8321, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3400, 4y8gI, 0.8321, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3401, 4y7xW, 0.8321, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3402, 4y7xI, 0.8321, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3403, 4y7wZ, 0.8321, 2.06, 0.215, 204, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3404, 4y7wL, 0.8321, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3405, 4y6zL, 0.8321, 2.55, 0.229, 215, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3406, 4qz5W, 0.8321, 2.06, 0.210, 204, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3407, 4qwlW, 0.8321, 1.91, 0.196, 222, 194, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3408, 4qwlI, 0.8321, 1.97, 0.196, 204, 194, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3409, 4quxW, 0.8321, 1.97, 0.196, 204, 194, YCP BETA5-A49T-MUTANT
3410, 4quxI, 0.8321, 2.07, 0.195, 222, 195, YCP BETA5-A49T-MUTANT
3411, 4qlqW, 0.8321, 2.07, 0.195, 222, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3412, 4qlqI, 0.8321, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3413, 4j70I, 0.8321, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3414, 4inrW, 0.8321, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3415, 3unbk, 0.8321, 1.97, 0.196, 204, 194, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3416, 3mg7I, 0.8321, 2.07, 0.195, 222, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3417, 3h6iX, 0.8321, 2.07, 0.195, 222, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3418, 5l55Z, 0.8320, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3419, 5l55L, 0.8320, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3420, 5cgiL, 0.8320, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3421, 4y8rW, 0.8320, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3422, 4y8qW, 0.8320, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3423, 4y77I, 0.8320, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3424, 4y74W, 0.8320, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3425, 4y6zW, 0.8320, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3426, 4r67z, 0.8320, 1.98, 0.196, 204, 194, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3427, 4qz6W, 0.8320, 1.97, 0.196, 204, 194, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3428, 4qz5I, 0.8320, 2.06, 0.215, 204, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3429, 4qwxW, 0.8320, 1.97, 0.196, 204, 194, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3430, 4qwxI, 0.8320, 2.55, 0.229, 215, 201, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3431, 4qw7I, 0.8320, 2.07, 0.195, 222, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3432, 4qvqW, 0.8320, 2.07, 0.195, 222, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3433, 4qvqI, 0.8320, 1.91, 0.196, 222, 194, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3434, 4qvlW, 0.8320, 1.97, 0.196, 204, 194, YCP IN COMPLEX WITH BORTEZOMIB
3435, 4qvlI, 0.8320, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH BORTEZOMIB
3436, 4no8Z, 0.8320, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3437, 4no8L, 0.8320, 1.97, 0.196, 204, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3438, 3okjL, 0.8320, 1.97, 0.196, 204, 194, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3439, 3h6iL, 0.8320, 2.07, 0.210, 204, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3440, 3dy3W, 0.8320, 1.96, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3441, 3dy3I, 0.8320, 1.96, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3442, 6epc5, 0.8319, 1.96, 0.196, 204, 194, GROUND STATE 26S PROTEASOME (GS2)
3443, 6avoY, 0.8319, 1.96, 0.196, 204, 194, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3444, 5fghW, 0.8319, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3445, 5fghI, 0.8319, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3446, 4ya7W, 0.8319, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3447, 4ya7I, 0.8319, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3448, 4ya2W, 0.8319, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3449, 4ya2I, 0.8319, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3450, 4y8rI, 0.8319, 2.07, 0.195, 222, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3451, 4y8qI, 0.8319, 1.92, 0.196, 222, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3452, 4y8pW, 0.8319, 2.54, 0.224, 215, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3453, 4y8pI, 0.8319, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3454, 4y8nI, 0.8319, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3455, 4y8hZ, 0.8319, 2.05, 0.080, 201, 199, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3456, 4y8hL, 0.8319, 2.05, 0.210, 204, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3457, 4y82I, 0.8319, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3458, 4y77W, 0.8319, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3459, 4y70L, 0.8319, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3460, 4y6zI, 0.8319, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3461, 4rurW, 0.8319, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3462, 4rurI, 0.8319, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3463, 4r67X, 0.8319, 1.97, 0.196, 204, 194, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3464, 4r67l, 0.8319, 1.96, 0.196, 204, 194, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3465, 4r67J, 0.8319, 1.96, 0.196, 204, 194, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3466, 4qz6I, 0.8319, 1.96, 0.196, 204, 194, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3467, 4qz3W, 0.8319, 1.97, 0.196, 204, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3468, 4qw7W, 0.8319, 2.07, 0.195, 222, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3469, 4qltW, 0.8319, 2.07, 0.195, 222, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3470, 4qltI, 0.8319, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3471, 4no6W, 0.8319, 1.96, 0.196, 204, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3472, 4no6I, 0.8319, 2.07, 0.195, 222, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3473, 4j70W, 0.8319, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3474, 4g4sJ, 0.8319, 1.97, 0.196, 204, 194, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3475, 4cr26, 0.8319, 1.97, 0.196, 204, 194, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3476, 3shjW, 0.8319, 2.07, 0.210, 204, 195, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3477, 3shjI, 0.8319, 2.07, 0.210, 204, 195, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3478, 5d0vW, 0.8318, 2.07, 0.210, 204, 195, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3479, 5d0vI, 0.8318, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3480, 4y82W, 0.8318, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3481, 4y70W, 0.8318, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3482, 4r17W, 0.8318, 1.96, 0.196, 204, 194, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3483, 4r17I, 0.8318, 1.96, 0.196, 204, 194, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3484, 4qz3I, 0.8318, 1.97, 0.196, 204, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3485, 4qw6I, 0.8318, 1.97, 0.196, 204, 194, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3486, 4fzgZ, 0.8318, 1.98, 0.196, 204, 194, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3487, 3un8W, 0.8318, 1.97, 0.196, 203, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3488, 5t0iO, 0.8317, 1.90, 0.196, 222, 194, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3489, 5cz6W, 0.8317, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3490, 5cz6I, 0.8317, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3491, 5cz5I, 0.8317, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3492, 4y9yW, 0.8317, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3493, 4y8nW, 0.8317, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3494, 4y7wW, 0.8317, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3495, 4y7wI, 0.8317, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3496, 4y75Z, 0.8317, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3497, 4y75L, 0.8317, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3498, 4y70I, 0.8317, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3499, 4qzwW, 0.8317, 1.92, 0.196, 222, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3500, 4qz4W, 0.8317, 1.97, 0.196, 204, 194, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3501, 4qz4I, 0.8317, 1.79, 0.254, 220, 193, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3502, 4qwrW, 0.8317, 1.97, 0.196, 204, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3503, 4qwrI, 0.8317, 1.97, 0.196, 204, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3504, 4qw6W, 0.8317, 1.97, 0.196, 204, 194, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3505, 4qw5W, 0.8317, 1.97, 0.196, 204, 194, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3506, 4qw5I, 0.8317, 1.97, 0.196, 204, 194, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3507, 4no9W, 0.8317, 1.97, 0.196, 204, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3508, 4fzgL, 0.8317, 1.97, 0.196, 204, 194, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3509, 3oevI, 0.8317, 2.08, 0.195, 222, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3510, 3h6fX, 0.8317, 2.08, 0.195, 222, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3511, 5vfqLA, 0.8316, 1.97, 0.196, 204, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3512, 5t0gP, 0.8316, 1.96, 0.196, 204, 194, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3513, 5cz5W, 0.8316, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3514, 4ya9I, 0.8316, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3515, 4y9zI, 0.8316, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3516, 4y9yI, 0.8316, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3517, 4y8sW, 0.8316, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3518, 4y8sI, 0.8316, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3519, 4y8lW, 0.8316, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3520, 4y84W, 0.8316, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3521, 4y84I, 0.8316, 1.92, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3522, 4y80W, 0.8316, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3523, 4y80I, 0.8316, 2.56, 0.229, 215, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3524, 4qzxW, 0.8316, 2.06, 0.200, 213, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3525, 4qzxI, 0.8316, 2.10, 0.210, 204, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3526, 4qzwI, 0.8316, 1.97, 0.196, 204, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3527, 4qz1W, 0.8316, 1.97, 0.196, 204, 194, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3528, 4qvyW, 0.8316, 1.97, 0.196, 204, 194, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3529, 4qvyI, 0.8316, 1.97, 0.196, 204, 194, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3530, 4qvmI, 0.8316, 1.97, 0.196, 204, 194, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3531, 4no9I, 0.8316, 1.97, 0.196, 204, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3532, 4jt0W, 0.8316, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3533, 4jt0I, 0.8316, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3534, 3okjW, 0.8316, 1.97, 0.196, 204, 194, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3535, 3okjI, 0.8316, 1.97, 0.196, 204, 194, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3536, 3oeuI, 0.8316, 1.97, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3537, 3hyeW, 0.8316, 1.96, 0.196, 204, 194, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3538, 3hyeI, 0.8316, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3539, 3gptW, 0.8316, 1.96, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3540, 2f16W, 0.8316, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3541, 2f16I, 0.8316, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3542, 1fntX, 0.8316, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3543, 1fntJ, 0.8316, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3544, 4y9zW, 0.8315, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3545, 4y8lI, 0.8315, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3546, 4y6vI, 0.8315, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3547, 4x6zJ, 0.8315, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3548, 4qz1I, 0.8315, 1.97, 0.196, 204, 194, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3549, 4qz0Z, 0.8315, 1.97, 0.196, 204, 194, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3550, 4qwuI, 0.8315, 1.98, 0.196, 204, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3551, 4qwfW, 0.8315, 1.98, 0.196, 204, 194, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3552, 4qwfI, 0.8315, 1.98, 0.196, 204, 194, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3553, 4qw1W, 0.8315, 1.98, 0.196, 204, 194, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3554, 4qw1I, 0.8315, 1.98, 0.196, 204, 194, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3555, 4qvmW, 0.8315, 1.98, 0.196, 204, 194, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3556, 4ltcW, 0.8315, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3557, 4ltcI, 0.8315, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3558, 4intL, 0.8315, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3559, 4eu2J, 0.8315, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3560, 3uney, 0.8315, 1.81, 0.197, 204, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3561, 3sdkI, 0.8315, 1.97, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3562, 3nzwW, 0.8315, 1.92, 0.196, 222, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3563, 3nzwI, 0.8315, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3564, 3mg8I, 0.8315, 1.97, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3565, 3mg4W, 0.8315, 1.97, 0.196, 204, 194, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3566, 3gptI, 0.8315, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3567, 3d29W, 0.8315, 1.97, 0.196, 204, 194, PROTEASOME INHIBITION BY FELLUTAMIDE B
3568, 3d29I, 0.8315, 1.97, 0.196, 204, 194, PROTEASOME INHIBITION BY FELLUTAMIDE B
3569, 5vfoP, 0.8314, 1.97, 0.196, 204, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3570, 5nifJ, 0.8314, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3571, 4ya9Z, 0.8314, 1.93, 0.196, 222, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3572, 4ya9W, 0.8314, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3573, 4ya9L, 0.8314, 2.07, 0.215, 204, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3574, 4y8jW, 0.8314, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3575, 4y8jI, 0.8314, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3576, 4y8gZ, 0.8314, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3577, 4y8gL, 0.8314, 1.96, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3578, 4y84Z, 0.8314, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3579, 4y84L, 0.8314, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3580, 4y6vW, 0.8314, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3581, 4y69W, 0.8314, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3582, 4y69I, 0.8314, 2.05, 0.210, 204, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3583, 4qz2Z, 0.8314, 1.97, 0.196, 204, 194, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3584, 4qwuW, 0.8314, 1.92, 0.196, 222, 194, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3585, 4lqiW, 0.8314, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3586, 4lqiI, 0.8314, 1.92, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3587, 4inuZ, 0.8314, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3588, 3oevW, 0.8314, 1.97, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3589, 3mg6I, 0.8314, 2.08, 0.195, 222, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3590, 3h6fP, 0.8314, 2.08, 0.195, 222, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3591, 3gpwW, 0.8314, 2.08, 0.195, 222, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3592, 5vfsIA, 0.8313, 2.08, 0.195, 222, 195, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3593, 5t0gN, 0.8313, 1.98, 0.196, 204, 194, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3594, 5t0cHB, 0.8313, 1.98, 0.196, 204, 194, 
3595, 5t0cBA, 0.8313, 1.97, 0.196, 204, 194, 
3596, 4ya7Z, 0.8313, 1.92, 0.196, 222, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3597, 4y7yW, 0.8313, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3598, 4y6zZ, 0.8313, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3599, 4qz2W, 0.8313, 1.98, 0.196, 204, 194, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3600, 4qz2L, 0.8313, 2.09, 0.195, 222, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3601, 4qz2I, 0.8313, 1.97, 0.196, 204, 194, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3602, 4qw3W, 0.8313, 1.97, 0.196, 204, 194, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3603, 4qw3I, 0.8313, 2.56, 0.224, 215, 201, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3604, 4qw0W, 0.8313, 1.98, 0.196, 204, 194, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3605, 4qw0I, 0.8313, 2.06, 0.210, 204, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3606, 4qvwW, 0.8313, 1.66, 0.277, 191, 191, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3607, 4qvwI, 0.8313, 2.06, 0.210, 204, 195, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3608, 4nnnZ, 0.8313, 2.06, 0.210, 204, 195, YCP IN COMPLEX WITH MG132
3609, 4nnnL, 0.8313, 1.92, 0.196, 222, 194, YCP IN COMPLEX WITH MG132
3610, 4jsuZ, 0.8313, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3611, 4jsuL, 0.8313, 1.92, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3612, 4inuW, 0.8313, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3613, 3unbW, 0.8313, 1.92, 0.196, 222, 194, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3614, 3sdiL, 0.8313, 1.97, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3615, 3oeuW, 0.8313, 1.97, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3616, 3nzxW, 0.8313, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3617, 3nzxI, 0.8313, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3618, 3gpwI, 0.8313, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3619, 3d29Z, 0.8313, 1.97, 0.196, 204, 194, PROTEASOME INHIBITION BY FELLUTAMIDE B
3620, 5vfqIA, 0.8312, 1.97, 0.196, 204, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3621, 5mpa6, 0.8312, 2.08, 0.195, 222, 195, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3622, 5gjrPA, 0.8312, 2.08, 0.195, 222, 195, 
3623, 5d0xW, 0.8312, 1.93, 0.196, 222, 194, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3624, 5d0xI, 0.8312, 1.93, 0.196, 222, 194, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3625, 5cz8W, 0.8312, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3626, 5cz8I, 0.8312, 2.08, 0.215, 204, 195, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3627, 4zzgJ, 0.8312, 2.08, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3628, 4ya7L, 0.8312, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3629, 4ya5W, 0.8312, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3630, 4ya5I, 0.8312, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3631, 4y81I, 0.8312, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3632, 4y7yI, 0.8312, 2.09, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3633, 4r3oJ, 0.8312, 2.05, 0.210, 204, 195, HUMAN CONSTITUTIVE 20S PROTEASOME
3634, 4qwkW, 0.8312, 2.03, 0.195, 222, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3635, 4qbyW, 0.8312, 2.08, 0.210, 204, 195, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3636, 4qbyI, 0.8312, 1.98, 0.196, 204, 194, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3637, 4jsqZ, 0.8312, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3638, 4jsqW, 0.8312, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3639, 4jsqL, 0.8312, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3640, 4jsqI, 0.8312, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3641, 4inuL, 0.8312, 1.92, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3642, 4intI, 0.8312, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3643, 4hnpZ, 0.8312, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3644, 4hnpW, 0.8312, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3645, 3sdkW, 0.8312, 1.97, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3646, 3nzxZ, 0.8312, 2.08, 0.210, 204, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3647, 3nzxL, 0.8312, 1.97, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3648, 3nzwZ, 0.8312, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3649, 3nzwL, 0.8312, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3650, 3mg4I, 0.8312, 1.93, 0.196, 222, 194, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3651, 3gpjW, 0.8312, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3652, 3gpjI, 0.8312, 1.93, 0.196, 222, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3653, 2f16L, 0.8312, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3654, 5vfrP, 0.8311, 2.09, 0.195, 222, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3655, 5mpam, 0.8311, 1.98, 0.196, 204, 194, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3656, 4y8oW, 0.8311, 1.92, 0.196, 222, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3657, 4y8oI, 0.8311, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3658, 4y81W, 0.8311, 1.97, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3659, 4y78I, 0.8311, 2.09, 0.195, 222, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3660, 4r3oX, 0.8311, 2.09, 0.195, 222, 195, HUMAN CONSTITUTIVE 20S PROTEASOME
3661, 4qxjW, 0.8311, 1.93, 0.196, 222, 194, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3662, 4qxjI, 0.8311, 1.93, 0.196, 222, 194, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3663, 4qwkI, 0.8311, 1.98, 0.196, 204, 194, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3664, 4qwiW, 0.8311, 1.98, 0.196, 204, 194, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3665, 4qwiI, 0.8311, 1.98, 0.196, 204, 194, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3666, 4qw4I, 0.8311, 2.09, 0.195, 222, 195, YCP IN COMPLEX WITH CARFILZOMIB
3667, 4intW, 0.8311, 2.07, 0.210, 204, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3668, 4cr27, 0.8311, 2.03, 0.195, 222, 195, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3669, 3mg6L, 0.8311, 1.98, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3670, 3bdmW, 0.8311, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3671, 5vfqJ, 0.8310, 1.97, 0.196, 204, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3672, 5dkiW, 0.8310, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3673, 5dkiI, 0.8310, 2.08, 0.210, 204, 195, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3674, 4ya3I, 0.8310, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3675, 4y70Z, 0.8310, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3676, 4qwsW, 0.8310, 1.97, 0.196, 204, 194, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3677, 4qwsI, 0.8310, 1.97, 0.196, 204, 194, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3678, 4qw4W, 0.8310, 1.97, 0.196, 204, 194, YCP IN COMPLEX WITH CARFILZOMIB
3679, 3mg4L, 0.8310, 1.97, 0.196, 204, 194, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3680, 3mg0I, 0.8310, 1.98, 0.196, 204, 194, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3681, 3bdmI, 0.8310, 2.37, 0.182, 233, 203, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3682, 2zcyW, 0.8310, 2.08, 0.195, 222, 195, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3683, 2zcyI, 0.8310, 1.99, 0.196, 204, 194, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3684, 5vfsJ, 0.8309, 2.06, 0.210, 204, 195, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3685, 5vfrS, 0.8309, 2.03, 0.179, 199, 196, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3686, 5cz4W, 0.8309, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3687, 5cz4I, 0.8309, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3688, 4ya3W, 0.8309, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3689, 4y78W, 0.8309, 1.92, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3690, 4qwjW, 0.8309, 1.98, 0.196, 204, 194, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3691, 4qwgW, 0.8309, 1.98, 0.196, 204, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3692, 4qwgI, 0.8309, 1.97, 0.196, 204, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3693, 4inuI, 0.8309, 1.94, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3694, 4eu2X, 0.8309, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3695, 3wxrJ, 0.8309, 1.99, 0.196, 204, 194, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3696, 3unhW, 0.8309, 1.99, 0.196, 204, 194, MOUSE 20S IMMUNOPROTEASOME
3697, 3unhI, 0.8309, 1.99, 0.196, 204, 194, MOUSE 20S IMMUNOPROTEASOME
3698, 3un4W, 0.8309, 2.07, 0.210, 204, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3699, 3un4I, 0.8309, 2.14, 0.179, 199, 196, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3700, 3sdiI, 0.8309, 2.06, 0.200, 213, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3701, 3mg0W, 0.8309, 1.99, 0.196, 204, 194, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3702, 5vfrp, 0.8308, 1.99, 0.196, 204, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3703, 4qz1Z, 0.8308, 1.98, 0.196, 204, 194, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3704, 4qz1L, 0.8308, 1.98, 0.196, 204, 194, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3705, 4qwjI, 0.8308, 1.98, 0.196, 204, 194, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3706, 4fzgW, 0.8308, 1.98, 0.196, 204, 194, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3707, 4fzgI, 0.8308, 1.98, 0.196, 204, 194, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3708, 4fzcW, 0.8308, 1.98, 0.196, 204, 194, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3709, 4fzcI, 0.8308, 1.99, 0.196, 204, 194, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3710, 3unfW, 0.8308, 1.99, 0.196, 204, 194, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3711, 3unfI, 0.8308, 2.06, 0.215, 204, 195, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3712, 3un4Z, 0.8308, 2.06, 0.215, 204, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3713, 3un4L, 0.8308, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3714, 5vfop, 0.8307, 1.98, 0.196, 204, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3715, 4y8iW, 0.8307, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3716, 4y8iI, 0.8307, 1.98, 0.201, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3717, 4qwxZ, 0.8307, 2.06, 0.210, 204, 195, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3718, 4qwxL, 0.8307, 1.92, 0.196, 222, 194, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3719, 4nnwZ, 0.8307, 1.92, 0.196, 222, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3720, 4ltcZ, 0.8307, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3721, 4hrcZ, 0.8307, 1.99, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3722, 3mg7W, 0.8307, 1.99, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3723, 5gjrSA, 0.8306, 1.99, 0.196, 204, 194, 
3724, 5gjrEA, 0.8306, 1.99, 0.196, 204, 194, 
3725, 4qz4Z, 0.8306, 2.06, 0.215, 204, 195, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3726, 4qlqZ, 0.8306, 2.06, 0.215, 204, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3727, 4qlqL, 0.8306, 1.93, 0.196, 222, 194, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3728, 4no9Z, 0.8306, 1.93, 0.196, 222, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3729, 4no9L, 0.8306, 2.06, 0.210, 204, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3730, 4nnwL, 0.8306, 1.98, 0.196, 204, 194, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3731, 4ltcL, 0.8306, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3732, 4hnpI, 0.8306, 1.93, 0.196, 222, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3733, 3sdiZ, 0.8306, 1.93, 0.196, 222, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3734, 2gplW, 0.8306, 1.93, 0.196, 222, 194, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3735, 2gplI, 0.8306, 1.93, 0.196, 222, 194, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3736, 1jd2P, 0.8306, 1.93, 0.196, 222, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3737, 1iruM, 0.8306, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3738, 1iru1, 0.8306, 1.94, 0.201, 213, 194, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3739, 1g65Z, 0.8306, 1.94, 0.201, 213, 194, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3740, 1g65L, 0.8306, 1.93, 0.196, 222, 194, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3741, 5vfpHA, 0.8305, 1.93, 0.196, 222, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3742, 4y74Z, 0.8305, 1.93, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3743, 4y74L, 0.8305, 1.93, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3744, 4qz4L, 0.8305, 1.93, 0.196, 222, 194, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3745, 4qbyZ, 0.8305, 1.93, 0.196, 222, 194, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3746, 4qbyL, 0.8305, 1.94, 0.196, 222, 194, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3747, 3wxrX, 0.8305, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3748, 3mg8W, 0.8305, 2.09, 0.195, 222, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3749, 3mg6Z, 0.8305, 2.00, 0.196, 204, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3750, 6epf1, 0.8304, 2.00, 0.196, 204, 194, GROUND STATE 26S PROTEASOME (GS1)
3751, 5nifX, 0.8304, 1.99, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3752, 5gjrBA, 0.8304, 1.93, 0.201, 213, 194, 
3753, 4jsuW, 0.8304, 1.93, 0.201, 213, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3754, 4jsuI, 0.8304, 1.93, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3755, 4hnpL, 0.8304, 1.93, 0.196, 222, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3756, 3sdiW, 0.8304, 2.05, 0.210, 204, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3757, 3d29L, 0.8304, 1.93, 0.196, 222, 194, PROTEASOME INHIBITION BY FELLUTAMIDE B
3758, 2f16Z, 0.8304, 1.93, 0.196, 222, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3759, 1jd2I, 0.8304, 1.93, 0.196, 222, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3760, 4qvvW, 0.8303, 1.93, 0.196, 222, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3761, 4qvvI, 0.8303, 1.93, 0.196, 222, 194, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3762, 3mg6W, 0.8303, 1.83, 0.197, 204, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3763, 1g0uW, 0.8303, 1.97, 0.196, 204, 194, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3764, 4no6Z, 0.8302, 2.09, 0.195, 222, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3765, 4no6L, 0.8302, 2.27, 0.080, 202, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3766, 4hrdZ, 0.8302, 1.99, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3767, 4gk7Z, 0.8302, 1.93, 0.211, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3768, 5vfuOA, 0.8301, 1.99, 0.196, 204, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3769, 5vftp, 0.8301, 1.99, 0.196, 204, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3770, 4ya0W, 0.8301, 1.93, 0.196, 222, 194, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3771, 4ya0I, 0.8301, 1.98, 0.196, 204, 194, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3772, 4gk7L, 0.8301, 1.93, 0.196, 222, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3773, 3mg8Z, 0.8301, 1.94, 0.196, 222, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3774, 5vfpJ, 0.8300, 1.98, 0.196, 204, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3775, 4zzgX, 0.8300, 1.99, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3776, 4hrdI, 0.8300, 1.99, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3777, 4hrcI, 0.8300, 1.98, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3778, 4gk7I, 0.8300, 1.99, 0.196, 204, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3779, 1rypX, 0.8300, 1.93, 0.196, 222, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3780, 1rypJ, 0.8300, 1.93, 0.196, 222, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3781, 5vfuRA, 0.8299, 1.93, 0.196, 222, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3782, 5vfts, 0.8299, 1.94, 0.196, 222, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3783, 4gk7W, 0.8299, 2.07, 0.210, 204, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3784, 3mg8L, 0.8299, 2.07, 0.210, 204, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3785, 4r3oM, 0.8298, 1.99, 0.196, 204, 194, HUMAN CONSTITUTIVE 20S PROTEASOME
3786, 3hf9c, 0.8298, 1.99, 0.196, 204, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
3787, 1g0uI, 0.8298, 1.94, 0.196, 222, 194, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3788, 5l4gV, 0.8297, 1.93, 0.196, 222, 194, 
3789, 1jd2S, 0.8297, 0.77, 0.657, 201, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3790, 4r3o1, 0.8296, 2.07, 0.210, 204, 195, HUMAN CONSTITUTIVE 20S PROTEASOME
3791, 1g65W, 0.8295, 1.99, 0.196, 204, 194, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3792, 5vfpKA, 0.8294, 1.99, 0.196, 204, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3793, 5gjqt, 0.8293, 1.99, 0.196, 204, 194, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3794, 4hrdL, 0.8293, 1.99, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3795, 5gjqq, 0.8292, 1.99, 0.196, 204, 194, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3796, 4hrcW, 0.8292, 1.99, 0.196, 204, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3797, 3unby, 0.8292, 2.05, 0.200, 213, 195, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3798, 5gjqr, 0.8291, 2.05, 0.200, 213, 195, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3799, 5gjqf, 0.8291, 1.99, 0.196, 204, 194, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3800, 3okj1, 0.8291, 1.94, 0.196, 222, 194, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3801, 1jd2L, 0.8291, 1.95, 0.201, 213, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3802, 5vfuAA, 0.8290, 2.54, 0.225, 214, 200, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3803, 5vftP, 0.8290, 1.99, 0.196, 204, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3804, 5l4gH, 0.8289, 2.08, 0.200, 213, 195, 
3805, 4hrdW, 0.8289, 2.10, 0.195, 222, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3806, 3uneL, 0.8289, 1.96, 0.201, 213, 194, MOUSE CONSTITUTIVE 20S PROTEASOME
3807, 3unen, 0.8288, 1.98, 0.196, 204, 194, MOUSE CONSTITUTIVE 20S PROTEASOME
3808, 3h6f2, 0.8288, 1.93, 0.201, 213, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3809, 3okjZ, 0.8287, 1.95, 0.201, 213, 194, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3810, 3h6i2, 0.8287, 1.94, 0.196, 222, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3811, 1g65I, 0.8287, 2.11, 0.210, 204, 195, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3812, 5t0jT, 0.8286, 2.00, 0.196, 204, 194, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3813, 5gjqd, 0.8285, 2.11, 0.215, 204, 195, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3814, 4hrcL, 0.8285, 2.05, 0.179, 199, 196, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3815, 3h6iC, 0.8282, 1.96, 0.201, 213, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3816, 3une2, 0.8281, 2.32, 0.180, 228, 200, MOUSE CONSTITUTIVE 20S PROTEASOME
3817, 5gjrQA, 0.8278, 2.10, 0.195, 222, 195, 
3818, 5l4gW, 0.8277, 2.10, 0.210, 204, 195, 
3819, 5gjrCA, 0.8277, 2.10, 0.210, 204, 195, 
3820, 3h6iZ, 0.8275, 2.10, 0.200, 213, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3821, 3h6fZ, 0.8275, 2.01, 0.196, 204, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3822, 5fmgY, 0.8274, 1.96, 0.196, 213, 194, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3823, 5fmgK, 0.8274, 1.97, 0.196, 213, 194, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3824, 3uneZ, 0.8273, 2.53, 0.230, 214, 200, MOUSE CONSTITUTIVE 20S PROTEASOME
3825, 3h6fC, 0.8273, 1.98, 0.196, 221, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3826, 5mp93, 0.8272, 2.53, 0.225, 214, 200, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3827, 3hf9h, 0.8272, 1.99, 0.196, 204, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
3828, 5t0cKB, 0.8270, 2.30, 0.239, 215, 201, 
3829, 5t0cEA, 0.8270, 2.05, 0.179, 199, 196, 
3830, 4r3oK, 0.8270, 1.95, 0.196, 222, 194, HUMAN CONSTITUTIVE 20S PROTEASOME
3831, 4r3oY, 0.8269, 2.54, 0.220, 214, 200, HUMAN CONSTITUTIVE 20S PROTEASOME
3832, 5mp9j, 0.8268, 1.97, 0.196, 213, 194, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3833, 5t0iN, 0.8266, 1.92, 0.179, 199, 195, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3834, 5l4gJ, 0.8266, 2.06, 0.179, 199, 196, 
3835, 4r67o, 0.8266, 1.92, 0.179, 199, 195, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3836, 4r67M, 0.8266, 2.54, 0.225, 214, 200, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3837, 4r67a, 0.8266, 2.56, 0.230, 214, 200, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3838, 4r671, 0.8266, 1.76, 0.156, 194, 192, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3839, 5lf6Z, 0.8262, 1.76, 0.156, 194, 192, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3840, 5le5Z, 0.8261, 1.97, 0.196, 213, 194, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3841, 3unbZ, 0.8261, 2.56, 0.225, 214, 200, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3842, 5lf6L, 0.8260, 2.01, 0.196, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3843, 3unb2, 0.8259, 2.52, 0.226, 213, 199, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3844, 5l4gI, 0.8258, 1.98, 0.201, 213, 194, 
3845, 3unbL, 0.8257, 1.98, 0.201, 213, 194, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3846, 5le5L, 0.8256, 1.93, 0.179, 199, 195, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3847, 5lexZ, 0.8255, 1.93, 0.179, 199, 195, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3848, 5lexL, 0.8255, 2.00, 0.196, 204, 194, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3849, 5l4gX, 0.8255, 1.71, 0.277, 191, 191, 
3850, 5t0hT, 0.8254, 2.09, 0.210, 204, 195, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3851, 5lf1Z, 0.8254, 1.99, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3852, 3unhZ, 0.8254, 1.99, 0.201, 213, 194, MOUSE 20S IMMUNOPROTEASOME
3853, 3unhL, 0.8254, 1.99, 0.201, 213, 194, MOUSE 20S IMMUNOPROTEASOME
3854, 3unbn, 0.8254, 1.99, 0.201, 213, 194, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3855, 5lf1L, 0.8253, 1.99, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3856, 5lf7Z, 0.8246, 1.99, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3857, 5leyZ, 0.8246, 1.99, 0.196, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3858, 5lf4Z, 0.8245, 1.99, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3859, 5t0gS, 0.8244, 2.00, 0.196, 213, 194, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3860, 5lf0Z, 0.8243, 2.07, 0.179, 199, 196, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3861, 5leyL, 0.8243, 2.00, 0.196, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3862, 5lf4L, 0.8242, 2.00, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3863, 5lf3Z, 0.8242, 2.00, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3864, 3unfL, 0.8242, 2.00, 0.201, 213, 194, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3865, 6avoT, 0.8241, 2.13, 0.210, 204, 195, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3866, 3unfZ, 0.8241, 2.35, 0.239, 215, 201, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3867, 6avoV, 0.8240, 2.00, 0.201, 213, 194, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3868, 5lf3L, 0.8240, 2.00, 0.196, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3869, 5lf0L, 0.8240, 2.00, 0.196, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3870, 5lezZ, 0.8240, 2.00, 0.196, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3871, 5lezL, 0.8240, 2.00, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3872, 5lf7L, 0.8238, 2.01, 0.201, 213, 194, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3873, 5vfoQ, 0.8235, 2.01, 0.201, 213, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3874, 5vfoq, 0.8234, 2.01, 0.201, 213, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3875, 5m32Z, 0.8234, 2.01, 0.201, 213, 194, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3876, 5m32L, 0.8234, 2.01, 0.201, 213, 194, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3877, 4r67Y, 0.8234, 2.01, 0.201, 213, 194, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3878, 4r67m, 0.8234, 2.01, 0.201, 213, 194, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3879, 4r67K, 0.8234, 2.01, 0.201, 213, 194, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3880, 4r670, 0.8234, 2.01, 0.196, 213, 194, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3881, 5vfrQ, 0.8232, 1.84, 0.181, 196, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3882, 5mpa3, 0.8230, 2.01, 0.196, 213, 194, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3883, 4cr46, 0.8227, 1.84, 0.181, 196, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3884, 5vfuBA, 0.8223, 2.01, 0.201, 213, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3885, 5vftQ, 0.8223, 2.01, 0.201, 213, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3886, 3h6fN, 0.8220, 2.01, 0.201, 213, 194, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3887, 5vfpIA, 0.8219, 2.01, 0.201, 213, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3888, 1iruY, 0.8219, 2.02, 0.201, 213, 194, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3889, 1iruK, 0.8219, 2.01, 0.179, 199, 196, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3890, 3h6iN, 0.8217, 2.01, 0.179, 199, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3891, 5vfqJA, 0.8216, 1.98, 0.201, 213, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3892, 5vfpK, 0.8215, 1.98, 0.201, 213, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3893, 5m32W, 0.8215, 1.97, 0.179, 199, 195, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3894, 5m32I, 0.8215, 1.97, 0.179, 199, 195, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3895, 5t0jN, 0.8210, 1.97, 0.179, 199, 195, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3896, 3h6fH, 0.8209, 1.97, 0.179, 199, 195, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
3897, 5vfuPA, 0.8208, 2.01, 0.179, 199, 196, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3898, 5vftq, 0.8208, 2.05, 0.196, 204, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3899, 4cr47, 0.8208, 2.08, 0.195, 222, 195, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3900, 3h6iH, 0.8208, 2.08, 0.179, 199, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
3901, 5t0iP, 0.8205, 2.08, 0.179, 199, 196, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3902, 5vfqK, 0.8203, 2.53, 0.227, 212, 198, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3903, 3unez, 0.8203, 2.03, 0.179, 199, 196, MOUSE CONSTITUTIVE 20S PROTEASOME
3904, 5vfrq, 0.8201, 1.99, 0.179, 199, 195, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3905, 5mpaj, 0.8199, 1.99, 0.179, 199, 195, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3906, 5fmgM, 0.8198, 2.53, 0.227, 212, 198, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3907, 5fmga, 0.8198, 2.03, 0.179, 199, 196, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3908, 5a5bG, 0.8198, 1.93, 0.201, 213, 194, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3909, 4cr3G, 0.8198, 2.03, 0.179, 199, 196, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3910, 5t0hN, 0.8197, 2.15, 0.210, 204, 195, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3911, 3unhX, 0.8195, 2.15, 0.210, 204, 195, MOUSE 20S IMMUNOPROTEASOME
3912, 3unhJ, 0.8195, 1.82, 0.277, 191, 191, MOUSE 20S IMMUNOPROTEASOME
3913, 5gjqn, 0.8194, 2.55, 0.227, 212, 198, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3914, 5ln36, 0.8193, 2.10, 0.179, 199, 196, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3915, 5gjqX, 0.8193, 2.10, 0.179, 199, 196, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3916, 4r3oU, 0.8192, 2.42, 0.183, 233, 202, HUMAN CONSTITUTIVE 20S PROTEASOME
3917, 5vfsK, 0.8191, 2.54, 0.227, 212, 198, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3918, 3unfX, 0.8190, 2.08, 0.211, 204, 194, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3919, 3unfJ, 0.8190, 0.76, 0.657, 201, 201, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3920, 4r3oG, 0.8189, 2.04, 0.179, 199, 196, HUMAN CONSTITUTIVE 20S PROTEASOME
3921, 5vfsJA, 0.8188, 1.89, 0.187, 196, 193, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3922, 3uneJ, 0.8186, 2.05, 0.179, 199, 196, MOUSE CONSTITUTIVE 20S PROTEASOME
3923, 3uneX, 0.8185, 2.05, 0.196, 204, 194, MOUSE CONSTITUTIVE 20S PROTEASOME
3924, 5gjrY, 0.8183, 1.72, 0.190, 199, 189, 
3925, 5gjrMA, 0.8183, 1.72, 0.190, 199, 189, 
3926, 5t0hS, 0.8181, 2.78, 0.146, 245, 199, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3927, 5t0hP, 0.8181, 2.78, 0.146, 245, 199, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3928, 5nywM, 0.8180, 1.81, 0.277, 191, 191, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
3929, 5fmgX, 0.8177, 1.89, 0.187, 196, 193, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3930, 5fmgJ, 0.8177, 1.89, 0.187, 196, 193, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
3931, 5nygB, 0.8176, 2.69, 0.135, 243, 200, ANBU (GLY-1) MUTANT FROM HYPHOMICROBIUM SP. STRAIN MC1 - SG P2(1)2(1) 2(1)
3932, 3unel, 0.8176, 2.22, 0.200, 213, 195, MOUSE CONSTITUTIVE 20S PROTEASOME
3933, 5nyw1, 0.8174, 2.74, 0.135, 243, 200, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
3934, 5nygA, 0.8174, 2.74, 0.130, 245, 200, ANBU (GLY-1) MUTANT FROM HYPHOMICROBIUM SP. STRAIN MC1 - SG P2(1)2(1) 2(1)
3935, 5nygC, 0.8173, 0.78, 0.657, 201, 201, ANBU (GLY-1) MUTANT FROM HYPHOMICROBIUM SP. STRAIN MC1 - SG P2(1)2(1) 2(1)
3936, 5le5J, 0.8173, 2.13, 0.179, 199, 196, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3937, 5nywX, 0.8172, 1.90, 0.187, 196, 193, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
3938, 3unbl, 0.8172, 1.90, 0.187, 196, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3939, 5le5X, 0.8171, 2.74, 0.135, 245, 200, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3940, 3unbJ, 0.8170, 2.14, 0.179, 199, 196, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3941, 5t0jS, 0.8169, 1.91, 0.187, 196, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3942, 5nywP, 0.8169, 1.92, 0.187, 196, 193, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
3943, 4r67G, 0.8169, 2.72, 0.130, 243, 200, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3944, 3unbX, 0.8169, 2.62, 0.131, 243, 199, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3945, 5nywB, 0.8168, 2.08, 0.201, 213, 194, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
3946, 5lf0X, 0.8168, 2.10, 0.206, 204, 194, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3947, 4r67i, 0.8168, 3.04, 0.179, 233, 207, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3948, 5lf0J, 0.8167, 1.73, 0.201, 191, 189, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3949, 5lexX, 0.8167, 1.73, 0.201, 191, 189, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3950, 5lexJ, 0.8167, 2.75, 0.172, 231, 204, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3951, 5lf1J, 0.8166, 1.92, 0.187, 196, 193, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3952, 5leyX, 0.8166, 3.01, 0.179, 234, 207, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3953, 3unbz, 0.8166, 2.85, 0.166, 235, 205, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3954, 5lf7X, 0.8165, 2.76, 0.172, 231, 204, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3955, 5lf7J, 0.8165, 1.95, 0.181, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3956, 5lf1X, 0.8165, 3.01, 0.179, 236, 207, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3957, 4r67w, 0.8165, 1.93, 0.187, 196, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3958, 4r67U, 0.8165, 1.95, 0.181, 195, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3959, 5nygH, 0.8164, 1.93, 0.187, 196, 193, ANBU (GLY-1) MUTANT FROM HYPHOMICROBIUM SP. STRAIN MC1 - SG P2(1)2(1) 2(1)
3960, 5nywE, 0.8163, 2.09, 0.201, 213, 194, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
3961, 5nygE, 0.8163, 3.02, 0.179, 234, 207, ANBU (GLY-1) MUTANT FROM HYPHOMICROBIUM SP. STRAIN MC1 - SG P2(1)2(1) 2(1)
3962, 5lf4J, 0.8163, 2.76, 0.135, 245, 200, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3963, 5lf3X, 0.8163, 1.93, 0.187, 196, 193, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3964, 5lf4X, 0.8162, 3.03, 0.179, 233, 207, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3965, 5leyJ, 0.8162, 1.95, 0.181, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3966, 5nywQ, 0.8161, 2.66, 0.136, 245, 199, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
3967, 5nygD, 0.8161, 1.95, 0.181, 195, 193, ANBU (GLY-1) MUTANT FROM HYPHOMICROBIUM SP. STRAIN MC1 - SG P2(1)2(1) 2(1)
3968, 5lf3J, 0.8161, 1.95, 0.181, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3969, 5l4gG, 0.8161, 1.96, 0.181, 195, 193, 
3970, 5a5b6, 0.8161, 1.96, 0.181, 195, 193, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3971, 4cr36, 0.8161, 1.95, 0.181, 195, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3972, 5nywZ, 0.8160, 1.94, 0.187, 196, 193, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
3973, 5lezJ, 0.8160, 1.96, 0.181, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3974, 5m32J, 0.8159, 1.96, 0.181, 195, 193, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3975, 5lf6J, 0.8158, 1.96, 0.181, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3976, 5lezX, 0.8158, 2.66, 0.136, 245, 199, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3977, 5a5b7, 0.8158, 2.66, 0.136, 245, 199, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3978, 4cr37, 0.8158, 2.79, 0.172, 231, 204, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3979, 4cr2G, 0.8158, 3.01, 0.179, 233, 207, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3980, 5m32X, 0.8157, 2.89, 0.171, 227, 205, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3981, 4cr23, 0.8157, 1.96, 0.181, 195, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3982, 5nywJ, 0.8156, 1.96, 0.181, 195, 193, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
3983, 5nywC, 0.8156, 1.96, 0.181, 195, 193, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
3984, 5lf6X, 0.8156, 1.96, 0.181, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3985, 5nywH, 0.8155, 3.00, 0.179, 237, 207, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
3986, 5nywU, 0.8154, 2.77, 0.172, 231, 204, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
3987, 5nywG, 0.8154, 1.96, 0.181, 195, 193, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
3988, 5l4gU, 0.8153, 2.82, 0.130, 242, 200, 
3989, 6epe1, 0.8152, 2.06, 0.196, 222, 194, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3990, 5nywD, 0.8152, 2.06, 0.196, 222, 194, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
3991, 5nywY, 0.8151, 3.01, 0.179, 236, 207, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
3992, 5nywW, 0.8151, 1.96, 0.181, 195, 193, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
3993, 5t0cIB, 0.8150, 1.94, 0.187, 196, 193, 
3994, 5t0cCA, 0.8150, 1.96, 0.181, 195, 193, 
3995, 5nywL, 0.8150, 1.96, 0.181, 195, 193, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
3996, 5nywF, 0.8148, 2.47, 0.183, 233, 202, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
3997, 5nywS, 0.8147, 2.47, 0.183, 233, 202, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
3998, 5lf3F, 0.8146, 2.79, 0.146, 245, 199, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3999, 5nywV, 0.8145, 1.94, 0.187, 196, 193, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4000, 5leyF, 0.8145, 2.03, 0.197, 204, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4001, 5nywT, 0.8144, 3.02, 0.179, 235, 207, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4002, 5lf7F, 0.8144, 3.03, 0.179, 236, 207, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4003, 5nywK, 0.8143, 1.96, 0.181, 195, 193, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4004, 5lf6F, 0.8143, 3.02, 0.179, 234, 207, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4005, 5lf1F, 0.8143, 3.02, 0.179, 235, 207, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4006, 5lf0F, 0.8143, 3.05, 0.179, 234, 207, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4007, 5nywI, 0.8142, 2.77, 0.130, 241, 200, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4008, 5lexT, 0.8142, 2.38, 0.080, 202, 201, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4009, 5le5F, 0.8142, 3.03, 0.179, 234, 207, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4010, 5lf4F, 0.8140, 3.03, 0.179, 233, 207, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4011, 5lexF, 0.8140, 3.02, 0.179, 233, 207, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4012, 3sdkX, 0.8140, 2.17, 0.179, 199, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4013, 3mg8X, 0.8139, 2.17, 0.179, 199, 196, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4014, 5nywR, 0.8138, 3.02, 0.179, 237, 207, ANBU (ANCESTRAL BETA-SUBUNIT) FROM YERSINIA BERCOVIERI
4015, 3unhT, 0.8138, 3.05, 0.179, 234, 207, MOUSE 20S IMMUNOPROTEASOME
4016, 3unhF, 0.8138, 3.03, 0.179, 235, 207, MOUSE 20S IMMUNOPROTEASOME
4017, 3sdkJ, 0.8138, 2.73, 0.131, 239, 199, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4018, 4cr4E, 0.8136, 3.03, 0.179, 234, 207, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4019, 3mg7X, 0.8135, 2.73, 0.131, 239, 199, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4020, 3mg7J, 0.8135, 3.04, 0.179, 235, 207, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4021, 5vfuLA, 0.8134, 2.74, 0.131, 239, 199, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4022, 5vftm, 0.8134, 3.04, 0.179, 233, 207, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4023, 3unfT, 0.8134, 2.74, 0.131, 239, 199, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
4024, 3unfF, 0.8134, 2.74, 0.131, 239, 199, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
4025, 3unbh, 0.8134, 2.74, 0.131, 239, 199, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4026, 3oevJ, 0.8134, 3.05, 0.179, 233, 207, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4027, 1iruU, 0.8134, 2.73, 0.131, 240, 199, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
4028, 1iruG, 0.8134, 2.73, 0.131, 239, 199, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
4029, 4ltcJ, 0.8133, 2.74, 0.131, 239, 199, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4030, 4intX, 0.8133, 2.74, 0.131, 239, 199, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4031, 4cr43, 0.8133, 2.02, 0.227, 198, 194, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4032, 3uneT, 0.8133, 2.03, 0.227, 198, 194, MOUSE CONSTITUTIVE 20S PROTEASOME
4033, 3mg6X, 0.8133, 3.05, 0.179, 236, 207, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4034, 5m32T, 0.8132, 2.76, 0.136, 244, 199, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4035, 4jsqX, 0.8132, 2.76, 0.136, 244, 199, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4036, 4jsqJ, 0.8132, 2.05, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4037, 4intJ, 0.8132, 3.03, 0.207, 243, 203, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4038, 5lf6T, 0.8131, 2.03, 0.227, 198, 194, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4039, 5lf1T, 0.8131, 2.06, 0.227, 198, 194, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4040, 5lezT, 0.8131, 2.88, 0.140, 240, 200, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4041, 5lezF, 0.8131, 2.88, 0.140, 240, 200, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4042, 5lf3T, 0.8130, 2.76, 0.131, 244, 199, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4043, 5lf0T, 0.8130, 2.76, 0.131, 244, 199, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4044, 3mg8J, 0.8130, 2.65, 0.131, 244, 198, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4045, 5lf7T, 0.8129, 2.05, 0.227, 198, 194, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4046, 5leyT, 0.8129, 2.78, 0.135, 245, 200, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4047, 3oeuX, 0.8129, 2.78, 0.135, 245, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4048, 5lf4T, 0.8128, 2.07, 0.227, 198, 194, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4049, 3mg6J, 0.8128, 2.08, 0.227, 198, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4050, 5nygF, 0.8127, 2.05, 0.202, 204, 193, ANBU (GLY-1) MUTANT FROM HYPHOMICROBIUM SP. STRAIN MC1 - SG P2(1)2(1) 2(1)
4051, 4ltcX, 0.8127, 2.76, 0.136, 244, 199, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4052, 4gk7J, 0.8127, 2.03, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4053, 4fzgJ, 0.8127, 2.87, 0.130, 240, 200, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4054, 3unbv, 0.8127, 2.08, 0.227, 198, 194, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4055, 4gk7X, 0.8126, 2.08, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4056, 4fzgX, 0.8126, 2.08, 0.227, 198, 194, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4057, 3unbF, 0.8126, 2.75, 0.131, 240, 199, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4058, 3un8X, 0.8126, 2.75, 0.131, 240, 199, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4059, 4jsuJ, 0.8125, 2.75, 0.131, 240, 199, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4060, 4inuJ, 0.8125, 2.75, 0.131, 239, 199, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4061, 3unbT, 0.8125, 2.76, 0.131, 240, 199, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
4062, 3un8J, 0.8125, 2.76, 0.131, 240, 199, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4063, 3okjJ, 0.8125, 2.07, 0.227, 198, 194, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4064, 1rypY, 0.8125, 2.76, 0.131, 240, 199, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4065, 5le5T, 0.8124, 2.75, 0.131, 240, 199, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4066, 4jsuX, 0.8124, 2.04, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4067, 4inrJ, 0.8124, 2.75, 0.131, 240, 199, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4068, 3wxrY, 0.8124, 2.07, 0.227, 198, 194, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4069, 3tddX, 0.8124, 2.82, 0.167, 229, 204, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4070, 3tddJ, 0.8124, 2.07, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4071, 3uneh, 0.8123, 2.08, 0.227, 198, 194, MOUSE CONSTITUTIVE 20S PROTEASOME
4072, 3okjX, 0.8123, 2.08, 0.227, 198, 194, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4073, 3mg4J, 0.8123, 2.77, 0.131, 244, 199, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4074, 4lqiX, 0.8121, 2.08, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4075, 4lqiJ, 0.8121, 2.08, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4076, 4jt0X, 0.8121, 2.67, 0.131, 244, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4077, 4jt0J, 0.8121, 2.08, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4078, 4inrX, 0.8121, 2.09, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4079, 3unev, 0.8121, 2.09, 0.227, 198, 194, MOUSE CONSTITUTIVE 20S PROTEASOME
4080, 3uneF, 0.8121, 2.77, 0.136, 244, 199, MOUSE CONSTITUTIVE 20S PROTEASOME
4081, 3un4J, 0.8121, 2.09, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4082, 3oevX, 0.8121, 2.09, 0.227, 198, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4083, 3oeuJ, 0.8121, 2.09, 0.227, 198, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4084, 3nzxJ, 0.8121, 2.75, 0.131, 240, 199, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4085, 3gpjX, 0.8121, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4086, 3gpjJ, 0.8121, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4087, 5vfoM, 0.8120, 2.09, 0.227, 198, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4088, 4q1sX, 0.8120, 2.09, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4089, 3un4X, 0.8120, 2.09, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4090, 3nzxX, 0.8120, 2.77, 0.131, 244, 199, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4091, 3mg0X, 0.8120, 2.09, 0.227, 198, 194, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4092, 1rypK, 0.8120, 2.08, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4093, 3nzwX, 0.8119, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4094, 3nzwJ, 0.8119, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4095, 6avoQ, 0.8118, 2.09, 0.227, 198, 194, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4096, 6avoJ, 0.8118, 2.09, 0.227, 198, 194, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4097, 4inuX, 0.8118, 2.09, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4098, 2gplX, 0.8118, 2.77, 0.131, 244, 199, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4099, 5vfpG, 0.8117, 2.67, 0.136, 244, 198, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4100, 4hrdX, 0.8117, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4101, 4hrcX, 0.8117, 2.05, 0.227, 197, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4102, 4cr4G, 0.8117, 2.08, 0.227, 198, 194, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4103, 3nzjX, 0.8117, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4104, 3nzjJ, 0.8117, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4105, 3gptX, 0.8117, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4106, 3gptJ, 0.8117, 2.76, 0.145, 240, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4107, 3bdmJ, 0.8117, 2.08, 0.227, 198, 194, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4108, 2gplJ, 0.8117, 2.09, 0.227, 198, 194, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4109, 1jd2Q, 0.8117, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4110, 1jd2J, 0.8117, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4111, 4hrdJ, 0.8116, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4112, 4hnpJ, 0.8116, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4113, 3mg0J, 0.8116, 2.09, 0.227, 198, 194, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4114, 3bdmX, 0.8116, 2.74, 0.131, 239, 199, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4115, 2fakX, 0.8116, 2.74, 0.131, 239, 199, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4116, 2fakJ, 0.8116, 2.10, 0.227, 198, 194, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4117, 2f16X, 0.8116, 2.10, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4118, 2f16J, 0.8116, 1.35, 0.255, 220, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4119, 5nygG, 0.8115, 2.76, 0.145, 240, 200, ANBU (GLY-1) MUTANT FROM HYPHOMICROBIUM SP. STRAIN MC1 - SG P2(1)2(1) 2(1)
4120, 4fzcJ, 0.8115, 2.09, 0.227, 198, 194, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4121, 3sdiX, 0.8115, 2.08, 0.227, 198, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4122, 3hyeX, 0.8115, 2.76, 0.146, 245, 198, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4123, 3hyeJ, 0.8115, 2.09, 0.227, 198, 194, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4124, 4q1sJ, 0.8114, 2.09, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4125, 4hnpX, 0.8114, 2.10, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4126, 4fzcX, 0.8114, 2.10, 0.227, 198, 194, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4127, 3oevR, 0.8114, 2.10, 0.227, 198, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4128, 3gpwX, 0.8114, 2.10, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4129, 3d29J, 0.8114, 2.08, 0.227, 198, 194, PROTEASOME INHIBITION BY FELLUTAMIDE B
4130, 5vfrM, 0.8113, 2.08, 0.227, 198, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4131, 3wxrK, 0.8113, 2.10, 0.227, 198, 194, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4132, 3gpwJ, 0.8113, 2.08, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4133, 3d29X, 0.8113, 2.09, 0.227, 198, 194, PROTEASOME INHIBITION BY FELLUTAMIDE B
4134, 4hrcJ, 0.8112, 2.10, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4135, 3shjJ, 0.8112, 2.10, 0.227, 198, 194, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4136, 6epe5, 0.8111, 2.10, 0.227, 198, 194, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4137, 3shjX, 0.8111, 2.10, 0.227, 198, 194, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4138, 3e47X, 0.8110, 2.10, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4139, 3e47J, 0.8110, 2.80, 0.167, 228, 203, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4140, 5dsvF, 0.8109, 2.10, 0.227, 198, 194, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4141, 5vfuX, 0.8108, 2.09, 0.227, 198, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4142, 5vftM, 0.8108, 2.10, 0.227, 198, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4143, 1g65J, 0.8108, 2.10, 0.227, 198, 194, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4144, 5dsvL, 0.8107, 2.11, 0.227, 198, 194, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4145, 3sdiJ, 0.8107, 2.08, 0.227, 198, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4146, 5vfqG, 0.8106, 2.10, 0.227, 198, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4147, 5dsvB, 0.8106, 2.93, 0.204, 242, 201, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4148, 5vfsG, 0.8104, 2.10, 0.227, 198, 194, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4149, 4j70J, 0.8104, 2.10, 0.227, 198, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4150, 5vfqFA, 0.8103, 2.74, 0.145, 240, 200, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4151, 4j70X, 0.8103, 2.10, 0.227, 197, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4152, 1g65X, 0.8103, 2.10, 0.227, 198, 194, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4153, 1g0uR, 0.8103, 2.10, 0.227, 198, 194, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4154, 1g0uJ, 0.8103, 2.09, 0.227, 198, 194, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4155, 5vfom, 0.8102, 2.10, 0.227, 198, 194, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4156, 5dsvA, 0.8101, 2.35, 0.085, 201, 199, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4157, 3mg8R, 0.8101, 2.10, 0.227, 198, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4158, 5dsvN, 0.8100, 2.12, 0.227, 198, 194, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4159, 3mg7R, 0.8100, 2.12, 0.227, 198, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4160, 3mg7D, 0.8100, 2.66, 0.136, 244, 198, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4161, 3dy3X, 0.8100, 2.69, 0.141, 240, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4162, 2zcyX, 0.8100, 2.69, 0.141, 240, 198, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4163, 2zcyJ, 0.8100, 2.11, 0.227, 198, 194, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4164, 3mg6R, 0.8099, 2.66, 0.136, 245, 198, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4165, 3dy3J, 0.8099, 2.11, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4166, 3dy4J, 0.8098, 1.43, 0.277, 191, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4167, 5vfsFA, 0.8097, 2.77, 0.145, 240, 200, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4168, 5mpcU, 0.8097, 2.66, 0.136, 245, 198, 
4169, 5dsvE, 0.8097, 1.48, 0.277, 191, 191, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4170, 3mg4X, 0.8097, 2.82, 0.140, 240, 200, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4171, 3dy4X, 0.8097, 2.11, 0.227, 198, 194, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4172, 5dsvD, 0.8096, 2.77, 0.145, 240, 200, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4173, 1g0uX, 0.8096, 2.11, 0.227, 198, 194, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4174, 1g0uD, 0.8096, 2.12, 0.227, 198, 194, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4175, 3sdkR, 0.8095, 2.98, 0.204, 230, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4176, 5dsvG, 0.8094, 2.13, 0.227, 198, 194, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4177, 3oeuR, 0.8093, 2.78, 0.145, 240, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4178, 5mp9G, 0.8092, 2.66, 0.136, 244, 198, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4179, 3mg4R, 0.8089, 2.87, 0.205, 242, 200, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4180, 5mpaG, 0.8088, 2.67, 0.136, 244, 198, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4181, 3sdiR, 0.8088, 2.87, 0.205, 242, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4182, 1fntK, 0.8088, 2.96, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4183, 1z7qY, 0.8087, 2.12, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4184, 1z7qK, 0.8087, 2.11, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4185, 1fntY, 0.8087, 2.11, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4186, 5vfrm, 0.8086, 2.86, 0.205, 242, 200, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4187, 5vfpEA, 0.8086, 2.12, 0.227, 198, 194, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4188, 5t0gQ, 0.8086, 2.12, 0.227, 198, 194, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4189, 2f16R, 0.8085, 2.83, 0.140, 240, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4190, 2f16D, 0.8084, 2.77, 0.146, 243, 198, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4191, 3mg8D, 0.8083, 2.67, 0.136, 245, 198, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4192, 5t0cY, 0.8082, 2.10, 0.227, 198, 194, 
4193, 5t0cEB, 0.8082, 2.12, 0.227, 198, 194, 
4194, 5mp9g, 0.8081, 2.67, 0.136, 244, 198, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4195, 3oevD, 0.8081, 2.15, 0.227, 198, 194, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4196, 3oeuD, 0.8081, 3.00, 0.204, 230, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4197, 2gplR, 0.8081, 2.87, 0.205, 232, 200, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4198, 2gplD, 0.8081, 2.67, 0.136, 242, 198, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4199, 4x6zY, 0.8080, 2.95, 0.204, 236, 201, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
4200, 3tddR, 0.8080, 2.78, 0.146, 243, 198, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4201, 3tddD, 0.8080, 2.88, 0.205, 242, 200, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4202, 2fakR, 0.8080, 2.77, 0.146, 243, 198, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4203, 2fakD, 0.8080, 2.96, 0.205, 229, 200, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4204, 1z7qS, 0.8080, 2.15, 0.227, 198, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4205, 5mpag, 0.8079, 2.17, 0.227, 198, 194, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4206, 3okjR, 0.8079, 2.17, 0.227, 198, 194, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4207, 3okjD, 0.8079, 2.15, 0.227, 198, 194, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4208, 1z7qE, 0.8079, 2.79, 0.145, 240, 200, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4209, 5nifY, 0.8078, 2.79, 0.145, 240, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4210, 4zzgY, 0.8078, 2.24, 0.179, 199, 196, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4211, 4eu2K, 0.8077, 3.01, 0.204, 242, 201, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4212, 3mg4D, 0.8076, 3.01, 0.204, 242, 201, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4213, 5dsvK, 0.8075, 2.91, 0.205, 242, 200, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4214, 4inuR, 0.8075, 2.75, 0.146, 240, 199, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4215, 4hnpF, 0.8075, 2.75, 0.146, 240, 199, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4216, 3shjR, 0.8075, 2.81, 0.146, 243, 198, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4217, 3shjD, 0.8075, 2.96, 0.205, 242, 200, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4218, 4qlvR, 0.8074, 2.96, 0.205, 242, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4219, 4qlvD, 0.8074, 3.02, 0.204, 242, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4220, 4qlsR, 0.8074, 3.02, 0.204, 242, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4221, 4qlsD, 0.8074, 1.98, 0.229, 196, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4222, 3gptR, 0.8074, 3.02, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4223, 1rypS, 0.8074, 3.02, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4224, 4eu2G, 0.8073, 3.02, 0.204, 242, 201, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4225, 3gptD, 0.8073, 3.02, 0.204, 242, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4226, 3e47R, 0.8073, 2.92, 0.206, 245, 199, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4227, 5dsvI, 0.8072, 2.82, 0.146, 243, 198, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4228, 5cgiR, 0.8072, 2.96, 0.204, 242, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4229, 5cgiD, 0.8072, 2.96, 0.204, 242, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4230, 4zzgD, 0.8072, 2.92, 0.206, 245, 199, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4231, 4inuD, 0.8072, 2.00, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4232, 3mg6D, 0.8072, 2.00, 0.229, 196, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4233, 3e47D, 0.8072, 2.00, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4234, 1rypE, 0.8072, 2.97, 0.205, 242, 200, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4235, 5fggX, 0.8071, 2.66, 0.137, 244, 197, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4236, 5fggJ, 0.8071, 3.04, 0.204, 242, 201, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4237, 4r02R, 0.8071, 2.77, 0.152, 244, 197, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
4238, 4qz7R, 0.8071, 3.03, 0.204, 242, 201, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4239, 4qz7D, 0.8071, 3.03, 0.204, 242, 201, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4240, 4no8R, 0.8071, 2.95, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4241, 4no8D, 0.8071, 2.95, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4242, 5mpcG, 0.8070, 2.95, 0.205, 235, 200, 
4243, 4x6zK, 0.8070, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
4244, 2zcyQ, 0.8070, 3.03, 0.204, 242, 201, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4245, 2zcyC, 0.8070, 2.94, 0.205, 242, 200, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4246, 5lajR, 0.8069, 2.80, 0.146, 244, 198, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4247, 5cgfR, 0.8069, 3.03, 0.204, 242, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4248, 3bdmQ, 0.8069, 3.03, 0.204, 242, 201, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4249, 3bdmC, 0.8069, 2.66, 0.137, 244, 197, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4250, 5nifD, 0.8068, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4251, 5d0zR, 0.8068, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4252, 5d0zD, 0.8068, 2.97, 0.175, 241, 200, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4253, 5d0sR, 0.8068, 3.05, 0.204, 242, 201, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4254, 5d0sD, 0.8068, 2.96, 0.205, 242, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4255, 4ya7R, 0.8068, 3.03, 0.204, 242, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
4256, 4ya2R, 0.8068, 2.95, 0.205, 242, 200, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4257, 4ya2D, 0.8068, 1.94, 0.230, 195, 191, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4258, 4y9zR, 0.8068, 1.94, 0.230, 195, 191, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
4259, 4qzxR, 0.8068, 2.96, 0.205, 235, 200, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4260, 4qzxD, 0.8068, 2.95, 0.205, 235, 200, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4261, 4qz3R, 0.8068, 2.95, 0.205, 235, 200, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4262, 4qz3D, 0.8068, 2.90, 0.205, 235, 200, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4263, 4qw5R, 0.8068, 2.90, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4264, 4hrdR, 0.8068, 2.79, 0.146, 243, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4265, 3nzwR, 0.8068, 2.00, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4266, 3mg0R, 0.8068, 2.94, 0.175, 241, 200, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4267, 5nifK, 0.8067, 2.94, 0.175, 241, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4268, 5jhsR, 0.8067, 2.89, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
4269, 5jhsD, 0.8067, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
4270, 5jhrD, 0.8067, 2.95, 0.180, 241, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
4271, 5fgfR, 0.8067, 2.95, 0.180, 241, 200, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4272, 4zzgK, 0.8067, 2.98, 0.175, 241, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4273, 4ya7D, 0.8067, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
4274, 4y8jR, 0.8067, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
4275, 4y70R, 0.8067, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
4276, 4r17R, 0.8067, 2.90, 0.205, 235, 200, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4277, 4r17D, 0.8067, 2.90, 0.205, 235, 200, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4278, 4qz5R, 0.8067, 2.95, 0.205, 235, 200, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
4279, 4qxjR, 0.8067, 2.95, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4280, 4qxjD, 0.8067, 2.90, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4281, 4qbyR, 0.8067, 2.90, 0.205, 235, 200, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4282, 4qbyD, 0.8067, 2.91, 0.205, 235, 200, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4283, 4no9T, 0.8067, 2.90, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4284, 4no9F, 0.8067, 2.90, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4285, 4no6R, 0.8067, 2.90, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4286, 4no6D, 0.8067, 2.94, 0.205, 242, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4287, 3wxrS, 0.8067, 2.95, 0.205, 242, 200, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4288, 3nzwD, 0.8067, 2.96, 0.205, 242, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4289, 3gpwR, 0.8067, 2.02, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4290, 6epd5, 0.8066, 2.90, 0.205, 235, 200, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4291, 5lajD, 0.8066, 2.90, 0.205, 235, 200, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4292, 5l6bR, 0.8066, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4293, 5l6bD, 0.8066, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4294, 5jhrR, 0.8066, 2.02, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
4295, 5gjqm, 0.8066, 2.90, 0.205, 235, 200, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4296, 5bxnX, 0.8066, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4297, 5bxnJ, 0.8066, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4298, 4y7wR, 0.8066, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
4299, 4y7wD, 0.8066, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
4300, 4y70D, 0.8066, 2.88, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
4301, 4r18R, 0.8066, 2.91, 0.205, 235, 200, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4302, 4r18D, 0.8066, 2.91, 0.205, 235, 200, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4303, 4qz5D, 0.8066, 2.95, 0.205, 235, 200, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
4304, 4qz0R, 0.8066, 2.95, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4305, 4qz0D, 0.8066, 2.80, 0.146, 243, 198, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4306, 4qw7D, 0.8066, 2.80, 0.146, 243, 198, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4307, 4qv9R, 0.8066, 2.90, 0.205, 235, 200, YCP BETA5-C63F MUTANT
4308, 4qv9D, 0.8066, 2.90, 0.205, 235, 200, YCP BETA5-C63F MUTANT
4309, 4qltR, 0.8066, 2.88, 0.205, 238, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4310, 4qltD, 0.8066, 2.95, 0.205, 242, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4311, 4fzgR, 0.8066, 2.95, 0.205, 242, 200, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4312, 4fzgD, 0.8066, 2.30, 0.081, 201, 198, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4313, 3gpwD, 0.8066, 2.96, 0.205, 235, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4314, 5l65R, 0.8065, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4315, 5l65D, 0.8065, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4316, 5l63X, 0.8065, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4317, 5l63J, 0.8065, 2.97, 0.141, 238, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4318, 5l55R, 0.8065, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4319, 5l55D, 0.8065, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4320, 5l54R, 0.8065, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4321, 5l54D, 0.8065, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4322, 5l52R, 0.8065, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4323, 5l52D, 0.8065, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4324, 5ahjX, 0.8065, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4325, 5ahjJ, 0.8065, 2.88, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4326, 4ya4X, 0.8065, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4327, 4ya4J, 0.8065, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4328, 4y8lD, 0.8065, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4329, 4y7yR, 0.8065, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
4330, 4y7yD, 0.8065, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
4331, 4v7oG, 0.8065, 2.96, 0.205, 235, 200, 
4332, 4qz4R, 0.8065, 2.96, 0.205, 235, 200, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4333, 4qz4D, 0.8065, 2.97, 0.205, 242, 200, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4334, 4qwxR, 0.8065, 2.97, 0.205, 242, 200, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4335, 4qwxD, 0.8065, 2.95, 0.205, 242, 200, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4336, 4qwiR, 0.8065, 2.98, 0.205, 235, 200, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
4337, 4qwiD, 0.8065, 2.98, 0.205, 235, 200, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
4338, 4qw7R, 0.8065, 1.95, 0.230, 195, 191, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4339, 4qw1R, 0.8065, 1.95, 0.230, 195, 191, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4340, 4qw1D, 0.8065, 2.95, 0.205, 235, 200, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4341, 4qvnX, 0.8065, 2.95, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4342, 4qvnJ, 0.8065, 2.96, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4343, 4no9R, 0.8065, 2.96, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4344, 4no9D, 0.8065, 2.95, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4345, 4eu2Y, 0.8065, 2.95, 0.205, 235, 200, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4346, 3sdiT, 0.8065, 1.95, 0.230, 195, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4347, 3hyeR, 0.8065, 1.95, 0.230, 195, 191, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4348, 3hyeD, 0.8065, 1.95, 0.230, 195, 191, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4349, 3dy3C, 0.8065, 1.95, 0.230, 195, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4350, 5l68R, 0.8064, 2.91, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4351, 5l68D, 0.8064, 2.88, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4352, 5l5oR, 0.8064, 2.89, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4353, 5l5jT, 0.8064, 2.77, 0.146, 244, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4354, 5l5jR, 0.8064, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4355, 5l5jF, 0.8064, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4356, 5l5jD, 0.8064, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4357, 5l5eR, 0.8064, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4358, 5l5eD, 0.8064, 2.89, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4359, 5l5dR, 0.8064, 2.89, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4360, 5l5dD, 0.8064, 2.90, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4361, 5jhrX, 0.8064, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
4362, 5fggR, 0.8064, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4363, 5fggD, 0.8064, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4364, 5d0vX, 0.8064, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4365, 5d0vJ, 0.8064, 2.88, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4366, 5cz8R, 0.8064, 2.88, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
4367, 5cz8D, 0.8064, 2.01, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
4368, 5cz5R, 0.8064, 2.80, 0.146, 242, 198, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4369, 5cggD, 0.8064, 2.95, 0.205, 242, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
4370, 4ya1R, 0.8064, 2.95, 0.205, 242, 200, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4371, 4ya1D, 0.8064, 2.95, 0.180, 241, 200, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4372, 4y8tX, 0.8064, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4373, 4y8tJ, 0.8064, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4374, 4y8lR, 0.8064, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4375, 4y8jD, 0.8064, 2.80, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
4376, 4y80R, 0.8064, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
4377, 4y80D, 0.8064, 2.80, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
4378, 4v7oU, 0.8064, 2.98, 0.205, 235, 200, 
4379, 4v7oCB, 0.8064, 2.98, 0.205, 235, 200, 
4380, 4qz2R, 0.8064, 2.98, 0.205, 235, 200, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4381, 4qz2D, 0.8064, 2.97, 0.205, 235, 200, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4382, 4qwlR, 0.8064, 2.97, 0.205, 235, 200, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4383, 4qwlD, 0.8064, 1.96, 0.230, 195, 191, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4384, 4qwkT, 0.8064, 2.95, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4385, 4qwkF, 0.8064, 2.96, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4386, 4qwgT, 0.8064, 1.95, 0.230, 195, 191, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4387, 4qw1J, 0.8064, 1.95, 0.230, 195, 191, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4388, 4gk7R, 0.8064, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4389, 4gk7D, 0.8064, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4390, 3dy3Q, 0.8064, 2.89, 0.205, 235, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4391, 6gopX, 0.8063, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4392, 5laiR, 0.8063, 2.96, 0.205, 235, 200, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4393, 5laiD, 0.8063, 2.97, 0.205, 235, 200, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4394, 5l68F, 0.8063, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4395, 5l5tT, 0.8063, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4396, 5l5tR, 0.8063, 2.91, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4397, 5l5tF, 0.8063, 2.89, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4398, 5l5tD, 0.8063, 2.89, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4399, 5l5rD, 0.8063, 2.89, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4400, 5l5oD, 0.8063, 2.77, 0.146, 244, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4401, 5l5bR, 0.8063, 2.77, 0.146, 244, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4402, 5l5bD, 0.8063, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4403, 5jhrJ, 0.8063, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
4404, 5fgeJ, 0.8063, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4405, 5fgaJ, 0.8063, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
4406, 5d0wR, 0.8063, 2.83, 0.146, 243, 198, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4407, 5d0wD, 0.8063, 2.83, 0.146, 243, 198, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4408, 5cz5D, 0.8063, 2.82, 0.146, 243, 198, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4409, 5cggR, 0.8063, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
4410, 5cgfD, 0.8063, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4411, 4y9zD, 0.8063, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
4412, 4y9yR, 0.8063, 2.95, 0.180, 241, 200, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4413, 4y9yD, 0.8063, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4414, 4y8sR, 0.8063, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4415, 4y8sD, 0.8063, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4416, 4y8rR, 0.8063, 2.80, 0.146, 243, 198, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4417, 4y8rD, 0.8063, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4418, 4y8qR, 0.8063, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
4419, 4r02F, 0.8063, 2.81, 0.146, 243, 198, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
4420, 4qz6R, 0.8063, 2.98, 0.205, 235, 200, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4421, 4qz6D, 0.8063, 2.97, 0.205, 235, 200, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4422, 4qwlX, 0.8063, 2.97, 0.205, 235, 200, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4423, 4qwlJ, 0.8063, 2.97, 0.205, 235, 200, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4424, 4qwgF, 0.8063, 2.97, 0.205, 235, 200, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4425, 4qw1X, 0.8063, 1.96, 0.230, 195, 191, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4426, 4qvwR, 0.8063, 1.96, 0.230, 195, 191, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4427, 4qvwD, 0.8063, 1.96, 0.230, 195, 191, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4428, 4qv5X, 0.8063, 2.96, 0.205, 235, 200, YCP BETA5-M45I MUTANT
4429, 4qv5J, 0.8063, 2.96, 0.205, 235, 200, YCP BETA5-M45I MUTANT
4430, 4qv0R, 0.8063, 2.89, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT
4431, 4qv0D, 0.8063, 2.96, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT
4432, 4j70R, 0.8063, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4433, 4eu2E, 0.8063, 2.96, 0.205, 235, 200, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4434, 3un4R, 0.8063, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4435, 3un4D, 0.8063, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4436, 3gpjQ, 0.8063, 2.96, 0.205, 235, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4437, 3gpjC, 0.8063, 2.96, 0.205, 235, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4438, 3d29R, 0.8063, 2.96, 0.205, 235, 200, PROTEASOME INHIBITION BY FELLUTAMIDE B
4439, 3d29C, 0.8063, 2.96, 0.205, 235, 200, PROTEASOME INHIBITION BY FELLUTAMIDE B
4440, 6gopJ, 0.8062, 2.91, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4441, 5l6cR, 0.8062, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4442, 5l6cD, 0.8062, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4443, 5l6aR, 0.8062, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4444, 5l6aD, 0.8062, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4445, 5l68T, 0.8062, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4446, 5l67R, 0.8062, 2.82, 0.146, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4447, 5l67D, 0.8062, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4448, 5l60T, 0.8062, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4449, 5l60F, 0.8062, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4450, 5l5uR, 0.8062, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4451, 5l5rR, 0.8062, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4452, 5l5pR, 0.8062, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4453, 5l5pD, 0.8062, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4454, 5l5iR, 0.8062, 2.96, 0.205, 242, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4455, 5l5iD, 0.8062, 3.05, 0.204, 242, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4456, 5l5fR, 0.8062, 2.96, 0.205, 242, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4457, 5l5aR, 0.8062, 2.96, 0.205, 242, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
4458, 5l5aD, 0.8062, 2.95, 0.180, 241, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
4459, 5fgiF, 0.8062, 2.95, 0.180, 241, 200, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4460, 5fgeX, 0.8062, 3.04, 0.204, 242, 201, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4461, 5fg7R, 0.8062, 2.95, 0.180, 241, 200, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4462, 5fg7D, 0.8062, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4463, 5d0vR, 0.8062, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4464, 5d0vD, 0.8062, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4465, 5czaR, 0.8062, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT
4466, 5czaD, 0.8062, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT
4467, 5cz9R, 0.8062, 2.80, 0.146, 243, 198, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
4468, 5cz9D, 0.8062, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
4469, 5cz6R, 0.8062, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4470, 5cz6D, 0.8062, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4471, 5cggX, 0.8062, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
4472, 5cggJ, 0.8062, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
4473, 5bxnR, 0.8062, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4474, 5bxnD, 0.8062, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4475, 5ahjR, 0.8062, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4476, 5ahjD, 0.8062, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4477, 4z1lR, 0.8062, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4478, 4z1lD, 0.8062, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4479, 4ya4R, 0.8062, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4480, 4ya4D, 0.8062, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4481, 4v7oOA, 0.8062, 2.82, 0.146, 243, 198, 
4482, 4qwfR, 0.8062, 1.96, 0.230, 195, 191, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4483, 4qwfD, 0.8062, 2.97, 0.205, 235, 200, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4484, 4qw6R, 0.8062, 2.97, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4485, 4qw6D, 0.8062, 2.96, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4486, 4qw5D, 0.8062, 2.96, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4487, 4qvlR, 0.8062, 2.97, 0.205, 235, 200, YCP IN COMPLEX WITH BORTEZOMIB
4488, 4qvlJ, 0.8062, 2.97, 0.205, 235, 200, YCP IN COMPLEX WITH BORTEZOMIB
4489, 4qvlD, 0.8062, 2.96, 0.205, 235, 200, YCP IN COMPLEX WITH BORTEZOMIB
4490, 4qv7R, 0.8062, 2.96, 0.205, 235, 200, YCP BETA5-A50V MUTANT
4491, 4qv7D, 0.8062, 2.97, 0.205, 235, 200, YCP BETA5-A50V MUTANT
4492, 4qv5R, 0.8062, 2.97, 0.205, 235, 200, YCP BETA5-M45I MUTANT
4493, 4qv5D, 0.8062, 1.96, 0.230, 195, 191, YCP BETA5-M45I MUTANT
4494, 4qv3R, 0.8062, 1.96, 0.230, 195, 191, YCP BETA5-M45V MUTANT
4495, 4qv3D, 0.8062, 2.97, 0.205, 235, 200, YCP BETA5-M45V MUTANT
4496, 4qlqR, 0.8062, 2.97, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4497, 4nnwR, 0.8062, 2.95, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4498, 4lqiR, 0.8062, 2.95, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4499, 3nzxR, 0.8062, 2.97, 0.205, 235, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4500, 3d29Q, 0.8062, 2.97, 0.205, 235, 200, PROTEASOME INHIBITION BY FELLUTAMIDE B
4501, 3d29D, 0.8062, 2.96, 0.205, 235, 200, PROTEASOME INHIBITION BY FELLUTAMIDE B
4502, 5m2bR, 0.8061, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4503, 5m2bD, 0.8061, 2.77, 0.146, 244, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4504, 5lttD, 0.8061, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
4505, 5loyD, 0.8061, 2.97, 0.205, 235, 200, HELICAL ASSEMBLY OF A DESIGNED ANBU PROTEIN
4506, 5l66R, 0.8061, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4507, 5l66D, 0.8061, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4508, 5l5wX, 0.8061, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4509, 5l5wJ, 0.8061, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4510, 5l5uD, 0.8061, 1.95, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4511, 5l5fD, 0.8061, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4512, 5fgfD, 0.8061, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4513, 5fgdT, 0.8061, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4514, 5fgdF, 0.8061, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4515, 5fgaX, 0.8061, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
4516, 5fgaR, 0.8061, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
4517, 5fgaD, 0.8061, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
4518, 5fg9R, 0.8061, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4519, 5fg9D, 0.8061, 2.88, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4520, 5d0tR, 0.8061, 2.96, 0.205, 242, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
4521, 5d0tD, 0.8061, 2.95, 0.205, 242, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
4522, 5czaX, 0.8061, 2.96, 0.180, 241, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT
4523, 5czaJ, 0.8061, 3.04, 0.204, 242, 201, YEAST 20S PROTEASOME BETA5-D166N MUTANT
4524, 5bxlR, 0.8061, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4525, 5bxlD, 0.8061, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4526, 4zzgU, 0.8061, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4527, 4y8mR, 0.8061, 3.17, 0.189, 229, 206, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
4528, 4y8mD, 0.8061, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
4529, 4y75R, 0.8061, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4530, 4y75D, 0.8061, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4531, 4x6zS, 0.8061, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
4532, 4qz1R, 0.8061, 2.97, 0.205, 235, 200, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4533, 4qz1D, 0.8061, 2.98, 0.205, 235, 200, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4534, 4qvyR, 0.8061, 2.96, 0.205, 235, 200, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
4535, 4qvyD, 0.8061, 2.83, 0.146, 243, 198, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
4536, 4qvpR, 0.8061, 2.83, 0.146, 243, 198, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4537, 4qvpD, 0.8061, 1.96, 0.230, 195, 191, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4538, 4qvnR, 0.8061, 2.97, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4539, 4qvnD, 0.8061, 2.97, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4540, 4qvlX, 0.8061, 2.97, 0.205, 235, 200, YCP IN COMPLEX WITH BORTEZOMIB
4541, 4qv6X, 0.8061, 2.97, 0.205, 235, 200, YCP BETA5-A49V MUTANT
4542, 4qv6J, 0.8061, 2.97, 0.205, 235, 200, YCP BETA5-A49V MUTANT
4543, 4qv4R, 0.8061, 2.97, 0.205, 235, 200, YCP BETA5-M45T MUTANT
4544, 4qv4D, 0.8061, 1.96, 0.230, 195, 191, YCP BETA5-M45T MUTANT
4545, 4quyR, 0.8061, 1.96, 0.230, 195, 191, YCP BETA5-A49S-MUTANT
4546, 4quyD, 0.8061, 2.97, 0.205, 235, 200, YCP BETA5-A49S-MUTANT
4547, 4quxR, 0.8061, 2.97, 0.205, 235, 200, YCP BETA5-A49T-MUTANT
4548, 4qlqD, 0.8061, 2.67, 0.147, 244, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4549, 4no8X, 0.8061, 2.97, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4550, 4no8J, 0.8061, 2.97, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4551, 4no1X, 0.8061, 2.96, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4552, 4no1J, 0.8061, 2.96, 0.205, 235, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4553, 4nnwD, 0.8061, 2.91, 0.205, 242, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4554, 4lqiD, 0.8061, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4555, 4inrR, 0.8061, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4556, 3nzxD, 0.8061, 2.97, 0.205, 235, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4557, 3gpjR, 0.8061, 2.97, 0.205, 235, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4558, 3dy4Q, 0.8061, 2.97, 0.205, 235, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4559, 3dy4C, 0.8061, 2.97, 0.205, 235, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4560, 5lttR, 0.8060, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
4561, 5l69R, 0.8060, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4562, 5l69D, 0.8060, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4563, 5l63R, 0.8060, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4564, 5l62R, 0.8060, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4565, 5l62D, 0.8060, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4566, 5l61X, 0.8060, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4567, 5l61R, 0.8060, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4568, 5l61J, 0.8060, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4569, 5l61D, 0.8060, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4570, 5l5xR, 0.8060, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4571, 5l5xD, 0.8060, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4572, 5l5sR, 0.8060, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
4573, 5l5sD, 0.8060, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
4574, 5l5qR, 0.8060, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
4575, 5l5qD, 0.8060, 2.88, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
4576, 5l5oT, 0.8060, 2.96, 0.205, 242, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4577, 5l5oF, 0.8060, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4578, 5l5iT, 0.8060, 2.96, 0.205, 242, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4579, 5l5iF, 0.8060, 3.03, 0.204, 242, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4580, 5l5hR, 0.8060, 2.95, 0.180, 241, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4581, 5l5hD, 0.8060, 2.95, 0.180, 241, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4582, 5fhsR, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
4583, 5fhsD, 0.8060, 2.99, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
4584, 5fgiT, 0.8060, 2.99, 0.205, 235, 200, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4585, 5fghT, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
4586, 5d0xR, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
4587, 5d0xD, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
4588, 5cz7R, 0.8060, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4589, 5cz7D, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4590, 5cghR, 0.8060, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4591, 5cghD, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4592, 4ya9X, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4593, 4ya9J, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4594, 4y8pR, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4595, 4y8pD, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4596, 4y77R, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4597, 4y77D, 0.8060, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4598, 4y6vR, 0.8060, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4599, 4y6vD, 0.8060, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4600, 4rurR, 0.8060, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4601, 4qzzR, 0.8060, 2.81, 0.146, 243, 198, YCP IN COMPLEX WITH OMURALIDE
4602, 4qzwR, 0.8060, 2.98, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4603, 4qzwD, 0.8060, 2.98, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4604, 4qwuR, 0.8060, 2.96, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4605, 4qwuD, 0.8060, 2.96, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4606, 4qw4R, 0.8060, 2.82, 0.146, 243, 198, YCP IN COMPLEX WITH CARFILZOMIB
4607, 4qw4D, 0.8060, 2.82, 0.146, 243, 198, YCP IN COMPLEX WITH CARFILZOMIB
4608, 4qvmT, 0.8060, 2.98, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
4609, 4qvmF, 0.8060, 2.98, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
4610, 4qv1R, 0.8060, 2.98, 0.205, 235, 200, YCP BETA5-M45A MUTANT
4611, 4qv1D, 0.8060, 2.98, 0.205, 235, 200, YCP BETA5-M45A MUTANT
4612, 4quxD, 0.8060, 2.97, 0.205, 235, 200, YCP BETA5-A49T-MUTANT
4613, 4q1sR, 0.8060, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4614, 3gpjD, 0.8060, 1.96, 0.230, 195, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4615, 2zcyR, 0.8060, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4616, 2zcyD, 0.8060, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4617, 1g65R, 0.8060, 2.96, 0.205, 235, 200, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4618, 1g0uT, 0.8060, 2.96, 0.205, 235, 200, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4619, 1g0uF, 0.8060, 2.97, 0.205, 235, 200, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4620, 6gopR, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4621, 6gopD, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4622, 5ln3G, 0.8059, 2.98, 0.205, 235, 200, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4623, 5l63D, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4624, 5l5zR, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4625, 5l5zD, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4626, 5l5yR, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4627, 5l5yD, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4628, 5l5wR, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4629, 5l5wD, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4630, 5fghR, 0.8059, 2.82, 0.146, 243, 198, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
4631, 5fghD, 0.8059, 2.82, 0.146, 243, 198, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
4632, 5fgfX, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4633, 5fgfJ, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4634, 5fgeR, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4635, 5fgdR, 0.8059, 2.96, 0.205, 242, 200, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4636, 5fgdD, 0.8059, 3.03, 0.204, 242, 201, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4637, 5dkjR, 0.8059, 3.04, 0.204, 242, 201, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
4638, 5dkjD, 0.8059, 3.04, 0.204, 242, 201, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
4639, 5d0wX, 0.8059, 2.96, 0.205, 242, 200, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4640, 5d0wJ, 0.8059, 2.72, 0.147, 242, 197, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4641, 5bouT, 0.8059, 2.72, 0.147, 242, 197, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4642, 5bouR, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4643, 5bouF, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4644, 5bouD, 0.8059, 3.12, 0.134, 242, 202, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4645, 4ya9R, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4646, 4ya9D, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4647, 4ya5R, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4648, 4ya5D, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4649, 4y8tR, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4650, 4y8tD, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4651, 4y8oR, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4652, 4y8oD, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4653, 4y8nR, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4654, 4y8nD, 0.8059, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4655, 4y84R, 0.8059, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4656, 4y84D, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4657, 4y74R, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
4658, 4y74D, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
4659, 4rurT, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4660, 4rurF, 0.8059, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4661, 4rurD, 0.8059, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4662, 4qzzD, 0.8059, 1.96, 0.230, 195, 191, YCP IN COMPLEX WITH OMURALIDE
4663, 4qz7T, 0.8059, 2.81, 0.146, 243, 198, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4664, 4qz7F, 0.8059, 2.98, 0.205, 235, 200, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4665, 4qwrR, 0.8059, 2.81, 0.146, 243, 198, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4666, 4qwrD, 0.8059, 2.98, 0.205, 235, 200, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4667, 4qwkR, 0.8059, 2.97, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4668, 4qwkD, 0.8059, 2.97, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4669, 4qwjR, 0.8059, 2.98, 0.205, 235, 200, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
4670, 4qwjD, 0.8059, 2.98, 0.205, 235, 200, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
4671, 4qvmR, 0.8059, 2.96, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
4672, 4qvmD, 0.8059, 2.97, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
4673, 4qv8R, 0.8059, 2.97, 0.205, 235, 200, YCP BETA5-C52F MUTANT
4674, 4qv8D, 0.8059, 2.98, 0.205, 235, 200, YCP BETA5-C52F MUTANT
4675, 4qlvT, 0.8059, 2.98, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4676, 4qlvF, 0.8059, 2.98, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4677, 4nnnR, 0.8059, 2.97, 0.205, 235, 200, YCP IN COMPLEX WITH MG132
4678, 4nnnD, 0.8059, 2.97, 0.205, 235, 200, YCP IN COMPLEX WITH MG132
4679, 4inrD, 0.8059, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4680, 3sdiF, 0.8059, 2.97, 0.205, 235, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4681, 3nzjR, 0.8059, 2.81, 0.146, 243, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4682, 3mg8T, 0.8059, 2.81, 0.146, 243, 198, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4683, 3jcoMA, 0.8059, 2.98, 0.205, 235, 200, 
4684, 3jcoM, 0.8059, 2.97, 0.205, 235, 200, 
4685, 3dy3R, 0.8059, 2.71, 0.147, 243, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4686, 3dy3D, 0.8059, 2.71, 0.147, 243, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4687, 5laiT, 0.8058, 2.96, 0.205, 235, 200, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4688, 5laiF, 0.8058, 2.96, 0.205, 235, 200, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4689, 5l69F, 0.8058, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4690, 5l62X, 0.8058, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4691, 5l5vR, 0.8058, 2.97, 0.205, 235, 200,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4692, 5l5vD, 0.8058, 2.97, 0.205, 235, 200,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4693, 5fgiR, 0.8058, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4694, 5fgiD, 0.8058, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4695, 5fghF, 0.8058, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
4696, 5fgeD, 0.8058, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4697, 5d0sX, 0.8058, 2.80, 0.146, 243, 198, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4698, 5d0sJ, 0.8058, 2.80, 0.146, 243, 198, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4699, 5bxlX, 0.8058, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4700, 5bxlJ, 0.8058, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4701, 4y8uR, 0.8058, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4702, 4y8uD, 0.8058, 2.72, 0.147, 242, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4703, 4y8qD, 0.8058, 2.96, 0.205, 242, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
4704, 4y8kR, 0.8058, 2.81, 0.146, 237, 198, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
4705, 4y8kD, 0.8058, 2.97, 0.180, 241, 200, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
4706, 4y8iR, 0.8058, 2.97, 0.180, 241, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
4707, 4y8hR, 0.8058, 2.97, 0.180, 241, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4708, 4y8hD, 0.8058, 3.04, 0.204, 242, 201, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4709, 4y8gR, 0.8058, 3.04, 0.204, 242, 201, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4710, 4y8gD, 0.8058, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4711, 4y82R, 0.8058, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4712, 4y82D, 0.8058, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4713, 4y6vT, 0.8058, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4714, 4y6vF, 0.8058, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4715, 4y69R, 0.8058, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4716, 4y69D, 0.8058, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4717, 4x6zU, 0.8058, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
4718, 4r18T, 0.8058, 2.82, 0.146, 243, 198, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4719, 4r18F, 0.8058, 2.97, 0.205, 235, 200, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4720, 4r00R, 0.8058, 1.96, 0.230, 195, 191, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
4721, 4r00D, 0.8058, 1.96, 0.230, 195, 191, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
4722, 4qz1T, 0.8058, 1.96, 0.230, 195, 191, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4723, 4qz1F, 0.8058, 1.96, 0.230, 195, 191, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4724, 4qz0X, 0.8058, 2.98, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4725, 4qz0J, 0.8058, 2.98, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4726, 4qxjT, 0.8058, 2.97, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4727, 4qxjF, 0.8058, 2.97, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4728, 4qw6X, 0.8058, 2.97, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4729, 4qw6J, 0.8058, 2.97, 0.205, 235, 200, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4730, 4qw3T, 0.8058, 2.96, 0.205, 235, 200, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4731, 4qw3F, 0.8058, 2.96, 0.205, 235, 200, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4732, 4qw0T, 0.8058, 2.97, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
4733, 4qw0R, 0.8058, 2.97, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
4734, 4qw0F, 0.8058, 2.97, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
4735, 4qw0D, 0.8058, 2.97, 0.205, 235, 200, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
4736, 4qvwJ, 0.8058, 2.81, 0.146, 243, 198, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4737, 4qvvR, 0.8058, 2.81, 0.146, 243, 198, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
4738, 4qvvD, 0.8058, 2.98, 0.205, 235, 200, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
4739, 4qvqR, 0.8058, 2.98, 0.205, 235, 200, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
4740, 4qvqD, 0.8058, 2.71, 0.147, 244, 197, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
4741, 4qvpJ, 0.8058, 2.70, 0.147, 243, 197, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4742, 4qv9J, 0.8058, 2.70, 0.147, 243, 197, YCP BETA5-C63F MUTANT
4743, 4qv6R, 0.8058, 2.97, 0.205, 235, 200, YCP BETA5-A49V MUTANT
4744, 4qv6D, 0.8058, 2.97, 0.205, 235, 200, YCP BETA5-A49V MUTANT
4745, 4qv4J, 0.8058, 2.72, 0.147, 243, 197, YCP BETA5-M45T MUTANT
4746, 4qluR, 0.8058, 2.72, 0.147, 243, 197, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4747, 4qluD, 0.8058, 1.96, 0.230, 195, 191, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4748, 4qlsT, 0.8058, 1.96, 0.230, 195, 191, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4749, 4qlsF, 0.8058, 2.83, 0.146, 243, 198, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4750, 4no1R, 0.8058, 2.83, 0.146, 243, 198, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4751, 4j70D, 0.8058, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4752, 4hrdF, 0.8058, 1.96, 0.230, 195, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4753, 4hrcR, 0.8058, 2.83, 0.146, 243, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4754, 4g4sK, 0.8058, 2.83, 0.146, 243, 198, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
4755, 3nzjD, 0.8058, 2.82, 0.146, 243, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4756, 3dy4R, 0.8058, 2.98, 0.205, 235, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4757, 3dy4D, 0.8058, 2.82, 0.146, 243, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4758, 5nifE, 0.8057, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4759, 5l69T, 0.8057, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4760, 5l64R, 0.8057, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4761, 5l64D, 0.8057, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4762, 5l62J, 0.8057, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4763, 5dkiR, 0.8057, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
4764, 5dkiF, 0.8057, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
4765, 5dkiD, 0.8057, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
4766, 5cz4R, 0.8057, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4767, 5cz4D, 0.8057, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4768, 4zzgE, 0.8057, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4769, 4ya5T, 0.8057, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4770, 4ya5F, 0.8057, 2.96, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4771, 4y8rX, 0.8057, 2.79, 0.146, 243, 198, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4772, 4y8rJ, 0.8057, 2.79, 0.146, 243, 198, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4773, 4y8oT, 0.8057, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4774, 4y8oF, 0.8057, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4775, 4y8iD, 0.8057, 2.73, 0.147, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
4776, 4y81R, 0.8057, 2.95, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4777, 4y78R, 0.8057, 1.98, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
4778, 4y6zT, 0.8057, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4779, 4y6zF, 0.8057, 3.04, 0.204, 242, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4780, 4r18X, 0.8057, 3.04, 0.204, 242, 201, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4781, 4r18J, 0.8057, 2.96, 0.205, 236, 200, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4782, 4qwsR, 0.8057, 2.70, 0.147, 243, 197, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4783, 4qwsD, 0.8057, 2.98, 0.205, 235, 200, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4784, 4qw5X, 0.8057, 2.98, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4785, 4qvwT, 0.8057, 1.96, 0.230, 195, 191, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4786, 4qvpX, 0.8057, 2.99, 0.205, 235, 200, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4787, 4qvmX, 0.8057, 2.83, 0.146, 243, 198, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
4788, 4qvmJ, 0.8057, 2.99, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
4789, 4qv9X, 0.8057, 2.98, 0.205, 235, 200, YCP BETA5-C63F MUTANT
4790, 4quyX, 0.8057, 2.99, 0.205, 235, 200, YCP BETA5-A49S-MUTANT
4791, 4quyJ, 0.8057, 2.95, 0.205, 236, 200, YCP BETA5-A49S-MUTANT
4792, 4quxT, 0.8057, 2.82, 0.146, 243, 198, YCP BETA5-A49T-MUTANT
4793, 4quxF, 0.8057, 2.82, 0.146, 243, 198, YCP BETA5-A49T-MUTANT
4794, 4no6J, 0.8057, 1.96, 0.230, 195, 191, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4795, 4no1D, 0.8057, 1.96, 0.230, 195, 191, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4796, 4ltcR, 0.8057, 2.72, 0.147, 243, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4797, 4jt0R, 0.8057, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4798, 4jt0D, 0.8057, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4799, 4jsuR, 0.8057, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4800, 4intR, 0.8057, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4801, 4intD, 0.8057, 2.82, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4802, 4hnpR, 0.8057, 2.82, 0.146, 243, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4803, 4fzcR, 0.8057, 1.97, 0.230, 195, 191, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4804, 1rypU, 0.8057, 1.97, 0.230, 195, 191, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4805, 5nifU, 0.8056, 2.98, 0.205, 235, 200, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4806, 5loyA, 0.8056, 2.98, 0.205, 235, 200, HELICAL ASSEMBLY OF A DESIGNED ANBU PROTEIN
4807, 5l64X, 0.8056, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4808, 5l5eT, 0.8056, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4809, 5l5eF, 0.8056, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4810, 5dkiT, 0.8056, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
4811, 5cz9X, 0.8056, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
4812, 5cz9J, 0.8056, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
4813, 5cz5T, 0.8056, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4814, 5cz5F, 0.8056, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4815, 4ya3R, 0.8056, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4816, 4ya3D, 0.8056, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4817, 4ya0R, 0.8056, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4818, 4ya0D, 0.8056, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4819, 4y8gX, 0.8056, 2.96, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4820, 4y8gJ, 0.8056, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4821, 4y81T, 0.8056, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4822, 4y81F, 0.8056, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4823, 4y81D, 0.8056, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4824, 4y7xR, 0.8056, 2.98, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4825, 4y7xD, 0.8056, 2.95, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4826, 4y78D, 0.8056, 2.96, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
4827, 4y6zR, 0.8056, 2.69, 0.147, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4828, 4y6zD, 0.8056, 2.67, 0.147, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4829, 4y6aR, 0.8056, 3.17, 0.189, 229, 206, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
4830, 4y69T, 0.8056, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4831, 4y69F, 0.8056, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4832, 4qz6X, 0.8056, 2.81, 0.146, 243, 198, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4833, 4qz6J, 0.8056, 2.83, 0.146, 243, 198, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4834, 4qwuJ, 0.8056, 1.96, 0.230, 195, 191, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4835, 4qw4T, 0.8056, 1.96, 0.230, 195, 191, YCP IN COMPLEX WITH CARFILZOMIB
4836, 4qw4F, 0.8056, 2.83, 0.146, 243, 198, YCP IN COMPLEX WITH CARFILZOMIB
4837, 4qvwF, 0.8056, 2.83, 0.146, 243, 198, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4838, 4qv1X, 0.8056, 2.99, 0.205, 235, 200, YCP BETA5-M45A MUTANT
4839, 4qv1J, 0.8056, 2.99, 0.205, 235, 200, YCP BETA5-M45A MUTANT
4840, 4qluX, 0.8056, 2.99, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4841, 4qluJ, 0.8056, 2.99, 0.205, 235, 200, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4842, 4no6X, 0.8056, 1.96, 0.230, 195, 191, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4843, 4nnwT, 0.8056, 1.96, 0.230, 195, 191, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4844, 4nnwF, 0.8056, 2.72, 0.147, 243, 197, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4845, 4jsuD, 0.8056, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4846, 4hrdD, 0.8056, 2.97, 0.205, 235, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4847, 4fzcD, 0.8056, 2.97, 0.205, 235, 200, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4848, 4eu2S, 0.8056, 2.97, 0.205, 235, 200, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4849, 3bdmR, 0.8056, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4850, 3bdmD, 0.8056, 2.97, 0.205, 235, 200, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4851, 1g65D, 0.8056, 2.97, 0.205, 235, 200, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4852, 5loyB, 0.8055, 2.98, 0.205, 235, 200, HELICAL ASSEMBLY OF A DESIGNED ANBU PROTEIN
4853, 5lajT, 0.8055, 2.82, 0.146, 243, 198, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4854, 5lajF, 0.8055, 2.82, 0.146, 243, 198, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4855, 5l64J, 0.8055, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4856, 5l60R, 0.8055, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4857, 5l60D, 0.8055, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4858, 5l5zX, 0.8055, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4859, 5l55X, 0.8055, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4860, 5l55J, 0.8055, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4861, 5dkjT, 0.8055, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
4862, 5dkjF, 0.8055, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
4863, 5d0xT, 0.8055, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
4864, 5d0xF, 0.8055, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
4865, 5cz6J, 0.8055, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4866, 5cghX, 0.8055, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4867, 5cghJ, 0.8055, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4868, 4y75T, 0.8055, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4869, 4y75F, 0.8055, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4870, 4y6aD, 0.8055, 2.96, 0.205, 242, 200, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
4871, 4qz1X, 0.8055, 2.95, 0.205, 242, 200, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4872, 4qz1J, 0.8055, 3.05, 0.204, 242, 201, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4873, 4qwuX, 0.8055, 3.05, 0.204, 242, 201, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4874, 4qwfX, 0.8055, 2.96, 0.205, 242, 200, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4875, 4qwfT, 0.8055, 3.18, 0.189, 229, 206, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4876, 4qwfJ, 0.8055, 2.71, 0.147, 243, 197, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4877, 4qwfF, 0.8055, 2.71, 0.147, 243, 197, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4878, 4qw7X, 0.8055, 1.96, 0.230, 195, 191, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4879, 4qw5J, 0.8055, 2.99, 0.205, 235, 200, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4880, 4qw3R, 0.8055, 2.99, 0.205, 235, 200, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4881, 4qw3D, 0.8055, 1.96, 0.230, 195, 191, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4882, 4qvwX, 0.8055, 1.96, 0.230, 195, 191, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4883, 4qvvT, 0.8055, 1.96, 0.230, 195, 191, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
4884, 4qv4X, 0.8055, 2.82, 0.146, 243, 198, YCP BETA5-M45T MUTANT
4885, 4qv3X, 0.8055, 2.82, 0.146, 243, 198, YCP BETA5-M45V MUTANT
4886, 4qv3J, 0.8055, 2.83, 0.146, 243, 198, YCP BETA5-M45V MUTANT
4887, 4qv0X, 0.8055, 2.83, 0.146, 243, 198, YCP BETA5-A49T-A50V-DOUBLE MUTANT
4888, 4qv0J, 0.8055, 1.97, 0.230, 195, 191, YCP BETA5-A49T-A50V-DOUBLE MUTANT
4889, 4jsqR, 0.8055, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4890, 4jsqD, 0.8055, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4891, 4hnpT, 0.8055, 2.71, 0.147, 243, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4892, 4fzgF, 0.8055, 2.71, 0.147, 243, 197, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4893, 3oeuT, 0.8055, 2.98, 0.205, 235, 200, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4894, 3mg0D, 0.8055, 1.97, 0.230, 195, 191, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4895, 3gptC, 0.8055, 1.97, 0.230, 195, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4896, 5loyC, 0.8054, 1.96, 0.230, 195, 191, HELICAL ASSEMBLY OF A DESIGNED ANBU PROTEIN
4897, 5l63T, 0.8054, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4898, 5l63F, 0.8054, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4899, 5l61F, 0.8054, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4900, 5l5zJ, 0.8054, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4901, 5l5yT, 0.8054, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4902, 5l5yF, 0.8054, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4903, 5l5xX, 0.8054, 2.99, 0.205, 235, 200, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4904, 5fgdX, 0.8054, 2.99, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4905, 5fgdJ, 0.8054, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4906, 5d0zX, 0.8054, 2.84, 0.146, 243, 198, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4907, 5d0zJ, 0.8054, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4908, 5cz7T, 0.8054, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4909, 5cz7F, 0.8054, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4910, 5cz6X, 0.8054, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4911, 5cz4T, 0.8054, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4912, 5cz4F, 0.8054, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4913, 5bouX, 0.8054, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4914, 5bouJ, 0.8054, 2.81, 0.146, 244, 198, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4915, 4ya2X, 0.8054, 2.72, 0.147, 244, 197, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4916, 4ya2J, 0.8054, 2.82, 0.146, 237, 198, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4917, 4y8uT, 0.8054, 2.98, 0.205, 242, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4918, 4y8uF, 0.8054, 2.96, 0.180, 241, 200, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4919, 4y7xT, 0.8054, 3.18, 0.189, 229, 206, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4920, 4y7xF, 0.8054, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4921, 4r02T, 0.8054, 2.70, 0.147, 243, 197, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
4922, 4r02D, 0.8054, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
4923, 4qz4X, 0.8054, 1.96, 0.230, 195, 191, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4924, 4qz4T, 0.8054, 2.71, 0.147, 243, 197, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4925, 4qz4J, 0.8054, 2.71, 0.147, 243, 197, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4926, 4qz4F, 0.8054, 1.96, 0.230, 195, 191, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4927, 4qwxF, 0.8054, 1.97, 0.230, 195, 191, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4928, 4qw7J, 0.8054, 1.97, 0.230, 195, 191, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4929, 4qvvF, 0.8054, 1.97, 0.230, 195, 191, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
4930, 4qv8X, 0.8054, 1.97, 0.230, 195, 191, YCP BETA5-C52F MUTANT
4931, 4qv8J, 0.8054, 2.82, 0.146, 243, 198, YCP BETA5-C52F MUTANT
4932, 4hnpD, 0.8054, 2.82, 0.146, 243, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4933, 4fzgT, 0.8054, 1.97, 0.230, 195, 191, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4934, 3gptQ, 0.8054, 2.83, 0.146, 243, 198, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4935, 1jd2Y, 0.8054, 2.83, 0.146, 243, 198, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4936, 5m2bT, 0.8053, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4937, 5m2bF, 0.8053, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4938, 5l62T, 0.8053, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4939, 5l62F, 0.8053, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4940, 5l61T, 0.8053, 2.82, 0.146, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4941, 5l5xJ, 0.8053, 2.82, 0.146, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4942, 5l5wT, 0.8053, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4943, 5l5wF, 0.8053, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4944, 5l5dT, 0.8053, 2.70, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4945, 5cghT, 0.8053, 2.99, 0.205, 235, 200, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4946, 5cghF, 0.8053, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4947, 4ya9T, 0.8053, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4948, 4ya9F, 0.8053, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4949, 4ya1X, 0.8053, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4950, 4ya1J, 0.8053, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4951, 4y9yX, 0.8053, 1.96, 0.230, 195, 191, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4952, 4y9yJ, 0.8053, 2.84, 0.146, 243, 198, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4953, 4y8kF, 0.8053, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
4954, 4y8iT, 0.8053, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
4955, 4y8iF, 0.8053, 2.97, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
4956, 4y8gT, 0.8053, 2.72, 0.147, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4957, 4y8gF, 0.8053, 2.96, 0.180, 241, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4958, 4y82F, 0.8053, 2.89, 0.205, 242, 200, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4959, 4qzzX, 0.8053, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH OMURALIDE
4960, 4qzzJ, 0.8053, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH OMURALIDE
4961, 4qwxT, 0.8053, 2.71, 0.147, 243, 197, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4962, 4qwsT, 0.8053, 2.71, 0.147, 243, 197, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4963, 4qwsF, 0.8053, 2.71, 0.147, 243, 197, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4964, 4qwjT, 0.8053, 1.96, 0.230, 195, 191, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
4965, 4qwjF, 0.8053, 2.71, 0.147, 243, 197, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
4966, 4qw6T, 0.8053, 2.71, 0.147, 243, 197, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4967, 4qw6F, 0.8053, 2.70, 0.147, 243, 197, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4968, 4hrdT, 0.8053, 2.71, 0.147, 243, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4969, 1g65C, 0.8053, 2.71, 0.147, 243, 197, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4970, 1fntU, 0.8053, 2.71, 0.147, 243, 197, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4971, 5lajX, 0.8052, 2.71, 0.147, 243, 197, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4972, 5lajJ, 0.8052, 1.97, 0.230, 195, 191, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4973, 5l6cT, 0.8052, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4974, 5l6cF, 0.8052, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4975, 5l64T, 0.8052, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4976, 5l64F, 0.8052, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4977, 5l60X, 0.8052, 2.73, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4978, 5l60J, 0.8052, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4979, 5l5yX, 0.8052, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4980, 5l5yJ, 0.8052, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4981, 5l5sT, 0.8052, 2.81, 0.146, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
4982, 5l5sF, 0.8052, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
4983, 5l5qT, 0.8052, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
4984, 5l5qF, 0.8052, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
4985, 5l5pT, 0.8052, 2.83, 0.146, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4986, 5l5pF, 0.8052, 2.83, 0.146, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4987, 5l5dF, 0.8052, 2.83, 0.146, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4988, 5l52X, 0.8052, 2.83, 0.146, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4989, 5l52J, 0.8052, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4990, 5fgeT, 0.8052, 2.72, 0.147, 243, 197, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4991, 5fgeF, 0.8052, 2.82, 0.146, 244, 198, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4992, 5d0tT, 0.8052, 2.95, 0.180, 241, 200, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
4993, 5d0tF, 0.8052, 2.72, 0.153, 240, 196, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
4994, 5cz9T, 0.8052, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
4995, 5cz9F, 0.8052, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
4996, 4y8sX, 0.8052, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4997, 4y8sJ, 0.8052, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4998, 4y8pX, 0.8052, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4999, 4y8pJ, 0.8052, 2.71, 0.147, 243, 197, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
5000, 4y8kT, 0.8052, 1.97, 0.230, 195, 191, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
